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Abstract 
 
Over the last 10 years, JP Hugnot’s lab has been focusing on the different pools of
progenitors and stem cells found in the adult spinal cord both in human and mouse. This is 
important to conduct this kind of research as the spinal cord is affected by several
neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and traumatic lesions 
for which there is no cure. In anamniotes such as Zebrafish, the spinal cord can regenerate after 
lesion due to endogenous progenitors/stem cells activation. So by investigating the presence 
and properties of such cells in mammals especially human, one could possibly harness those 
cells toward regeneration including neurons. We conducted RNA profiling to compare human 
vs mouse stem cell niche and lesioned vs non lesioned mouse spinal cord stem cell niche. This 
niche is particularly interesting as in anamniotes, radial ependymoglia cells located in this 
region are multipotent and can generate new motoneurons after lesion. And similar, albeit non 
identical, cells are present in mouse. In mammals, after lesion, niche stem cells actively 
proliferate and migrate to generate mainly astrocytic cells and few oligodendrocytes which 
participate to the glial scar and regeneration by providing neurotrophic factors such as CNTF, 
HGF, and IGF-1. This niche contains at least 5 cell types and here a new dorsal cell type 
expressing Msx1 and Id4 transcription factors was identified. These results indicated that the 
adult spinal cord niche in mouse and human is a mosaic of cells with different developmental 
origin and maintaining high levels of neural developmental genes. Glial-neuronal interactions 
supporting and keeping neurons intact can influence neurodegenerative diseases. One of these 
glial cells is the satellite oligodendrocyte or so called perineuronal satellite cells (PNCs). PNCs 
are tightly associated to the soma of large neurons and widely spread in the grey matter of the 
CNS both cortex and spinal cord. However the cellular properties and functional roles of these 
unmyelinating oligodendrocytes are not yet discovered. In this study, nestin-GFP positive cells 
are associated to neurons immunostained for neuronal nuclear antigen in both cortex and spinal 
cord. We identified PNCs as CNPase positive cells that are neither oligodendrocyte progenitor 
cells (PDGFRa) nor myelinating oligodendrocytes (MBP). These data suggest that PNCs might 
affect neuronal survival as well as the myelination process in demyelinating conditions. Also it 
could be implicated in neurodegenerative diseases such as multiple sclerosis and amyotrophic 
lateral sclerosis due to their interaction with motor neurons.
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Résumé 
 
Au cours des 10 dernières années, l’équipe de recherche de JP Hugnot s’est focalisée sur la 
caractérisation des pools de cellules progénitrices et de cellules souches de la moelle épinière 
adulte, chez l’homme comme chez la souris. Cet axe de recherche est essentiel dans l’objectif 
de proposer un traitement dans le cas de nombreuses maladies neurodégénératives, comme la 
sclérose latérale amyotrophique (SLA), ou encore dans le cas de lésions traumatiques. 
Actuellement, il n’existe aucun traitement curatif. En revanche, chez des animaux comme le 
poisson zèbre, la moelle épinière peut se régénérer après une lésion grâce à l'activation de 
progéniteurs / cellules souches endogènes. Chez les amniotes, cette niche est particulièrement 
intéressante dans la mesure où, les cellules de l'épendymoglie radiale situées dans cette région 
sont multipotentes et peuvent générer de nouveaux motoneurones après une lésion. Ainsi, en 
recherchant la présence et les propriétés de telles cellules chez les mammifères, en particulier 
chez l’homme, on pourrait exploiter ces cellules afin d’initier une régénération, et la formation 
de nouveaux neurones. Nous savons que chez les mammifères, après la lésion, des cellules de 
la niche prolifèrent et migrent activement pour générer principalement des cellules astrocytaires 
(peu d'oligodendrocytes) qui participent à la cicatrice gliale et à la régénération en fournissant 
un facteurs neurotrophique tel que le CNTF, le HGF et l'IGF-1. Nous avons procédé au 
profilage des ARN en comparant 1-ceux issus de la niche de cellules souches humaine et de 
souris, 2- ceux issus de la niche de cellules souches de souris de la moelle épinière lésée et non 
lésée. Nous avons identifié au moins 5 types cellulaires différents et un nouveau type de cellules 
dorsales exprimant les facteurs de transcription Msx1 et Id4. Ces résultats indiquent que la niche 
de la moelle épinière adulte chez la Souris comme chez l'homme est une mosaïque de cellules 
ayant différentes origines développementales et conservant des niveaux élevés de gènes de 
développement neural. Par ailleurs, si les interactions cellules gliales - cellules neuronales 
participent au maintien des neurones intacts elles peuvent aussi influer sur les maladies 
neurodégénératives. L'une de ces cellules gliales est l'oligodendrocyte satellite ou cellules 
satellites périneuronales (PNC). Les PNC sont étroitement associés au soma de gros neurones 
et largement répandus dans la substance grise du cortex et de la moelle épinière. Cependant, les 
propriétés cellulaires et les rôles fonctionnels de ces oligodendrocytes non myélinisants n'ont 
pas encore été découverts. Dans cette étude, les cellules positives à la nestine-GFP sont 
associées à des neurones identifiés par l'antigène nucléaire neuronal NeuN dans le cortex et la 
moelle épinière. Nous avons identifié les PNC comme étant des cellules positives pour la 
20
CNPase qui ne sont ni des cellules progénitrices d'oligodendrocytes (PDGFRa) ni des 
oligodendrocytes myélinisants (MBP). Ces données suggèrent que les PNC pourraient affecter 
la survie neuronale, mais également pourraient être impliquées dans le processus de 
myélinisation. Ainsi, en raison de leurs interactions avec les motoneurones, les PNC pourraient 
être impliquées dans des maladies neurodégénératives telles que la sclérose en plaques et la 
sclérose latérale amyotrophique.
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1. Chapter I: The human and mouse central nervous system
 
1.1 Components of the central nervous system
 
The central nervous system (CNS) is responsible for integrating sensory information and 
responding by motor and cognitive behaviors accordingly. It consists of two main components:
brain and spinal cord. The brain is encased in the skull, and protected by the cranium. The 
spinal cord is continuous with the brain, and is protected by the vertebrae. 
1.1.1 The Brain
The mammalian brain is one of the most complicated structures in living systems, which
consists of more than 100 billion neurons in the adult brain [1]. Each neuron communicate with 
other neurons through synapsis. This structure originates from a simple neural tube, followed 
by various differentiation processes [2]. The brain is usually considered to have seven basic 
parts; the most obvious anatomical structures are the prominent cerebral hemispheres. In 
mammals, the cerebral hemispheres (the outermost portions of which are continuous, highly
folded sheets of cortex) are divided into four lobes (Figure 1). Brain have various functions 
from sleep arousal to body homeostasis, learning and memory, and finally body motor 
coordination. In another word, physiologically, the brain exert a centralized control over the 
other organs of the body [1], [2]. It acts on the rest of the body both by generating patterns of 
muscle activity and by driving the secretion of hormones. This centralized control allows rapid 
and coordinated responses to changes in the environment. Some basic types of responsiveness 
such as reflexes can be mediated by the spinal cord or peripheral ganglia, but sophisticated 
purposeful control of behavior based on complex sensory input requires the information 
integrating capabilities of a centralized brain.
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Figure 1: Anatomy of the brain. 
The architecture and the outer anatomical structure of the human brain [3]. 
 
1.1.2 The Spinal cord
The spinal cord is made from part of the neural tube during development. There are four 
stages of the spinal cord that arises from the neural tube: The neural plate, neural fold, neural 
tube, and the spinal cord. Neural differentiation occurs within the spinal cord portion of the 
tube. The spinal cord is a long, thin, tubular bundle of nervous tissue and support cells that 
extends from the medulla oblongata in the brainstem to the lumbar region of the vertebral 
column [4]. In humans, the spinal cord begins at the occipital bone where it passes through 
the foramen magnum, and meets and enters the spinal canal at the beginning of the cervical 
vertebrae [5]. The enclosing bony vertebral column protects the relatively shorter spinal 
cord. The outer layer of the spinal cord consists of white matter, i.e., myelin-sheathed nerve 
fibers. These are bundled in to specialized tracts that conduct impulses triggered by 
pressure, pain, heat, and other sensory stimuli or conduct motor impulses activating muscles 
and glands. The inner layer, or gray matter, has a butterfly-shaped cross-section and is
mainly composed of nerve cell bodies. Within the gray matter, running the length of the 
cord and extending into the brain, lies the central canal through which the cerebral spinal
fluid (CSF) circulates [3] (Figure 2). The spinal cord functions primarily in the transmission 
of nerve signals from the motor cortex to the body, and from the afferent fibers of the 
sensory neurons to the sensory cortex. It is also a center for coordinating many reflexes and 
contains reflex arcs that can independently control reflexes and central pattern generators.
The spinal cord is the main pathway for information connecting the brain and peripheral 
nervous system (PNS).
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Figure 2: Anatomy of the spinal cord.
Cross section showing the anatomy of the spinal cord [3].
 
1.1.3 Human vs. mouse CNS
Pathologies affecting the CNS have diverse origins and forms, starting with Alzheimer’s
disease affecting the brain and multiple sclerosis (MS) affecting the spinal cord. In many 
instances, there is limited knowledge about the actual pathophysiology of the disease, about the 
succession of neurotoxic events following a damage. These issues make it difficult to assess 
accurately the prognosis of the pathology and the efficacy of treatments [6]. From this point,
studies were conducted on animal models that help understand the disease, its evolution, and to 
develop novel therapeutic strategies. Past animal studies, primarily in rodents (mice and rats), 
have shown that development of distinct areas of the cortex is highly similar to that of the 
developing human cortex. For that reason, rodents were the best and the most used model 
among the mammals, due its availability, were easy to handle, and mainly because they share 
a similar CNS with humans with few differences in the structural organization. Those species 
share similar physiology, for instance, the connections between the striatum, subtantia nigra, 
and the cortex, responsible for Parkinson’s disease (PK) in humans is more or less similar to 
that of the mouse [7]. Moreover, despite the differences in the size of spinal cord between 
human and rodents, they still share a similar architecture (figure 3). Also, parts of the white 
matter of the human spinal cord are almost larger than the entire diameter of the rat spinal cord, 
there is no significant difference in the migration capacity of oligodendrocyte progenitor cells 
(OPCs) to remyelinate axons in rats and humans [8]. 
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Figure 3: Human Vs rodent CNS. 
Upper panel shows a Cross section of human and rodent showing similar brain connectivity [9]. Lower 
panel shows Color-coded representations of human and mouse spinal cords showing similar regional 
organization [10]. 
 
1.2 Cells of the central nervous System
At the microscopic scale, the CNS is made up of a complex and heterogeneous set
of cells forming the neural tissue. The pioneering works of Ramon y Cajal at the end of the 
nineteenth century paved the way for the identification and precise characterization of these 
different cell types. Brain and spinal cord tissues are composed mainly of neuronal, glial, and 
endothelial cells [11], in which the neuronal function is highly dependent on glial cell
physiology (Figure 3) [12].
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1.2.1 Neurons
Neurons are the smallest units of information processing in the CNS. They are electrically 
excitable cells that receive, process and transmit information by electro-chemical signaling 
[11].The neurons then will generate what is called nerve impulse or action potential (AP) at the 
cell body, dendrite and then migrate along the axon. Then this AP will propagate via synaptic 
communication with the dendrites of adjacent neurons. Neurons are characterized by expressing 
markers that can be used to target neurons at different developmental stage and at different 
conditions. Neuronal nuclear antigen (NeuN) is a specific neuronal marker that is exclusively
associated with the nervous tissue. This protein is localized in the nuclear and peri-nuclear
cytoplasm of most of the neurons in the CNS. It emerges in the early embryogenesis in 
neuroblast and remains terminally in the differentiated neurons [13]. Doublecourtin (DCX) is a
microtubule-associated protein expressed by neuronal precursor cells and immature neurons in 
embryonic and adult cortical structures. Neuronal precursor cells begin to express DCX while
actively dividing. Due to the nearly exclusive expression of DCX in developing neurons, 
this protein has been used increasingly as a marker for neurogenesis, which is highly detected 
in the hippocampus and subventricular zone and olfactory bulb (sites of active neurogenesis). 
Microtubule associated protein 2 (Map2) is expressed mainly in neurons; their function is to 
stabilize microtubules in both dendrites and axons, and neuronal morphogenesis [14].
1.2.2 Glial cells
Glial cells were considered a minor cell type with limited function, but nowadays they are 
recognized as essential cell type for vital functions (neuronal homeostasis, 
maintenance of the blood-brain barrier and immune surveillance of the CNS). Glia cells play 
an important role in the development and the function of neural circuitry in the CNS, in which
they constitute at least half the volume of the human brain and spinal cord [12]. There are five 
different types of glial cells:
1.2.2.1 Astrocytes
Astrocytes have a star shaped morphology as described early in 1893 by Mihály Lenhossék.
Astrocytes constitute nearly half of the cells of the CNS, so they are involved in a wide range 
of CNS diseases. They are found in both gray and white matter [12]. Their functions are very 
diverse in which astrocytes control levels of some ions and neurotransmitters [15]. In this way, 
they communicate together via calcium waves and gliotransmitters, they intervene in 
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remodeling the development and the function of synapses, preserve the integrity of BBB, and 
support neuronal survival. It is also found that astrocytes play a major role in brain and spinal 
cord plasticity [12]. Moreover, they contribute to the formation of glial scars after CNS injury.
Astrocytes can be detected by the glial fibrillary acidic protein (GFAP), a major intermediate 
filament protein expressed in astrocytes and neural stem cells. It’s normally present at low
levels in the cerebrospinal fluid (CSF), reflecting base line levels of astrocyte death. However, 
its level rises after TBI and continues to increase few days post-trauma [16].
1.2.2.2 Oligodendrocytes
These are small cells with multiple extensions and ramifications as described in 1928 by Del 
Rio Hortega. They are distributed in the white and gray matter of the CNS. Oligodendrocyte 
lineage cells pass through multiple differentiation process before the full maturation stage.
Oligodendrocytes ensheath axons in the CNS to provide rapid conduction and metabolic 
support [17]. Over the past years it was thought that oligodendrocyte (OL) lineage cells are 
morphologically a heterogeneous population of cells and pass through three differential stages 
and generating three cell lineages [18]. But the advanced techniques proved that, OLs are 
morphologically and functionally diverse and pass through several differential processes and 
generate multiple cell types and subtypes [19]. Marques et al, analyzed 5072 transcriptomes of 
single cells isolated from various brain regions of juvenile and adult mouse, in which all the 
analyzed cells expressed markers from the oligodendrocyte lineage. Clustering methods led 
them to identify 13 distinct cell populations, where the differentiation path connecting OPCs 
and myelinating OLs is narrow that are diversified into six mature states [20]. The 
developmental progression and profile expression is summarized in figure 4, among these cell 
states there are:
? Oligodendrocyte progenitor cells also known as nerve/glial antigen 2 (NG2) glia or 
polydendrocytes [21]. They are widely distributed in the gray matter of the CNS and 
they are the glial stem cells that constitute a major glial population in the developing as 
well as mature CNS. These cells are able to proliferate and are multipotent. In particular, 
they act as a reservoir to ensure and maintain adult myelination in the white matter, and 
could play an important role in situations pathological [22]. Beside their well-
established oligodendrocyte progenitor role, OPCs have been shown to actively 
participate in CNS signaling [23]. Early evidence showed that OPCs could generate 
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neurons, astrocytes, and Schwan cells when residing outside the neocortex.  But recently 
it has been shown that NG2 expression commits the cells towards OLs [24]. OPCs are 
characterized by the specific expression of platelet derived growth factor alpha (PDGFR 
alpha), and NG2 (Cspg4). Several genes (Fabp1 and Tmem100) expressed by OPCs are 
previously described in astrocytes and radial glia consistent with the idea that OPCs 
originated from from glia-like cells, as well as their ability to generate astrocytes in 
response to injury [19]. OPC differentiation is triggered by neuronal chemical signals 
generating newly formed oligodendrocytes (NFO) that are no longer expressing the 
OPC specific markers.
? Different from the OPCs there are the differentiation-committed oligodendrocyte 
precursor cells ???????? ????? ??????? ???? ??????????? ??? ??????? ???? ??????? ????
expressed Neu4 and genes keeping OLs in undifferentiated state (Sox6, BMP4, and 
Gpr17). Unlike OPCs, COPs express low levels of cell cycle genes, but the highly 
express genes involved in migration (Tns3 and Fyn) [20].
? Newly formed oligodendrocytes (NFOs), are generated from the differentiation of OPCs 
in response to differentiation signals from surrounding neurons. Several studies 
mentioned that, NFOs are genetically different from OPCs, and they are of two subtypes 
(NFOL1 and NFOL2). These cells expressed genes induced at early stages of 
differentiation (Tcf7l2 and Casr) while Gpr17 levels decreased. NFOLs are known to 
generate two cell types, myelinating and non myelinating oligodendrocytes. Early 
evidence suggested that NFOs or the non-myelinating OLs die within seven days after 
they born. But recent evidence showed that NFOs are maintained in the CNS as a 
reservoir of OLs in case of sudden injury and degeneration [20].
? Mature myelinating oligodendrocytes (MFOL), are first described by Del Rio Hortega
in 1928. They are derived from the last differentiation step of OPCs. Thus, they differ 
from OPCs by the gene expression, protein profile, morphology, as well as the function.
Marques et al subdivided this population into six subtypes (MFOL 1-6) that differed in 
gene expression, distribution, and function. MFOL1 and 2 are specialized by the 
expression of genes responsible for myelin formation such as myelin basic protein 
(MBP), proteolipid protein (Plp1), and other markers that can be targeted to study OLs.
Due to their protein profile OLs are the myelinating cells in the CNS and MOLs1 to 
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MOLs6 expressed late oligodendrocyte differentiation genes (Klk6 and Apod) [20].
Their small branched morphology let the cells attach to the denuded axons of neurons 
through fine spines to generate myelin sheath in the white matter. So the function of 
OLs is to generate myelin around axons to accelerate the AP, and protect neurons from 
degeneration. While in the gray matter OLs are known to play a trophic role through the 
secretion of a bunch of neurotrophic factors such as, brain-derived neurotrophic factor 
(BDNF) , glial cell-derived neurotrophic factor (GDNF), and insulin growth factor 1 
(IGF-1). Thereafter, in case of injury and degeneration, OLs proliferate extensively and 
migrate to provide support and protection of neurons at the site of injury. On the other 
hand, OLs are vulnerable to oxidative stress, the cause that could deplete OLs from the 
CNS in case of severe degeneration [25].
 
 
Figure 4: Schematic representation of the developmental stages of the OL lineage. 
The morphological features of OPCs, pre-OLs, mature OLs and myelinating OLs and their antigenic 
profile are shown [26].
? Peri-Neuronal satellite cells
In addition to the six described oligodendrocyte cell lineages, several labs and our lab have 
identified a cell type that could belong to the oligodendrocyte lineage cells, but not described 
by Marques et al. Glial cells. They are attached or surrounded neuronal cell bodies including 
oligodendrocytes, astrocytes and microglia [27], [28]. Of these cells those are associated to the 
neuronal cell bodies in the cortex and referred to as perineuronal satellite cells (PNCs) or 
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satellite oligodendrocytes (s-OLs). Several evidence showed the increase of PNCs with age and 
reported that the highest population is derived from oligodendrocytes [27].
However, their cytochemical properties, cytological characteristics, and function are not well 
described yet. Takasaki et al, identified perineuronal oligodendrocytes as 2¢, 3¢-cyclic 
nucleotide 3¢-phosphodiesterase (CNP)-positive cells that are attached to neuronal soma 
expressing MAP2. The unmyelinating oligodendrocytes were immunonegative to specific glial 
markers for astrocytes (GFAP), microglia (Iba-1) and OPCs (NG2). However, almost all PNCs 
expressed glia-specific or glia-enriched metabolic enzymes, such as the creatine synthetic 
enzyme S-adenosylmethionine: guanidinoacetate N-methyltransferase and l-serine biosynthetic 
enzyme, and 3-phosphoglycerate dehydrogenase. Regarding molecules contributing to the 
glutamate–glutamine cycle, none of the PNCs expressed the plasmalemmal glutamate 
transporters GLAST and GLT-1, where nearly half of the perineuronal oligodendrocytes 
expressed glutamine synthetase. Cytologically, PNCs were distributed in deep cortical layers, 
mainly layers IV–VI, and characterized by the direct and tight attachment to neuronal cell 
bodies, inducing a concave shape in the contacted neurons (figure1 A, B). PNCs were more 
attached to glutamatergic principal neurons than to GABAergic interneurons, and this was 
evident at postnatal day 14, the day of cerebral cortex development and maturation. These 
cytochemical and cytological properties suggest that perineuronal oligodendrocytes are so 
differentiated as to fulfill metabolic support to the associating principal cortical neurons, rather 
than to regulate their synaptic transmission [29].
Following the identification of cytochemical properties, cytological characteristics, it was 
interesting to identify the genetic signature of perineuronal oligodendrocytes to reveal their 
unique phenotype. The study provided a genetic framework for a functional investigation of 
pN-OLGs. They identified oligodendrocyte transmembrane protein (OTMP) [30], a novel 
member of the glutamate-binding protein subfamily as the representative marker that highlights 
PNCs. They confirmed that in vitro, the immuno-purified polyclonal Ab, OTMP, co-localizes 
with mAb A2B5 on the surface of cultured live rat Oligodendrocyte progenitors (OLPs), but 
not with O4+ committed OLGs. The OTMP marker doesn’t recognize neurons, differentiated 
OLGs, perineuronal astrocytes, and perineuronal microglial cells, thus OTMP Ab is a selective 
marker for pN-OLGs. Since TFs are the ultimate determinants of cell identity, they provided a 
comparative analysis of the A2B5+/OTMP+ transcriptome database with that of the A2B5+ 
progenitor or the committed O4+ OLGs. Interestingly, the transcription factors (TFs) are 
separated into two main categories. 
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The first set of assembled transcription factors includes DLX1 / 2, OLIG1, OLIG2, SOX10 and 
ASCL1, are known to play critical roles in the acquisition of the myelinating fate. However, 
these TFs stand behind the processes that drive OLPs toward myelin-forming OLGs – revealing 
the switch from the A2B5+ progenitor to the A2B5+/OTMP+ cells, but undergo drastic changes 
when acquiring O4. While the Olig2 expression stays invariant in the three cell types, the high 
expression of Dlx1 transcripts in A2B5+/OTMP+ cells predicts its role as an inhibitor of the 
myelinating phenotype. Also there is an increased expression of both ASCL1 and PAX6 in 
A2B5+/OTMP+ than in O4+ cells. In contrast, OLIG1 and SOX10, whose transcripts are 
increased in O4+ cells confined to their accepted role in determining the myelinating phenotype 
[31], [32].
Considering the second set of transcription factors, it includes PEA3 (aka ETV4), LHX2 and 
OTX2 that are not previously linked to the OLG lineage, but known to be essential for motor 
neurons and Schwann cells. The PEA3 group (ERM, PEA3 and ETV1) is a member of the Ets 
domain of transcriptional regulators expressed in specific motor neuron pool. PEA3 controls 
central position and terminal arborization – a crucial step in the assembly of neuronal circuits. 
The high expression of this TF in in A2B5+/OTMP+ compared with O4+ cells suggest that 
PEA3 contribute to the non-myelinating phenotype. LHX2, and Otx2 has as high presence in 
A2B5+/OTMP+ cells and have important functions during development [32], [33].
Furthermore, the molecular mechanisms and signaling pathways that play crucial roles in 
patterning the CNS, and regulate the cellular processes that guide an A2B5 precursor towards 
either a non-myelinating (A2B5+/OTMP+) or a myelinating (O4) have been identified. The 
major pathways that contribute to oligodendrogenesis are sonic hedgehog (Shh) and Wingless 
(Wnt). As provided previously, Shh high expression is required for the earliest markers for 
??????????????????????????? ?????? ??????????in A2B5+/OTMP+ relative to A2B5+ OLPs. In 
?????????????????????????????????????????????????????????????????????????????– a high-affinity 
??????? ???? ???????? ???? ?? ??????? ????????? ????? ???????????? ???? ??????-dimerization of 
transcripts silence the response of A2B5+/OTMP+ cells to PDGFAA – a ligand for the 
myelinating phenotype [32], [34].
??????????? ???????? ??????-catenin pathway directs the onset of neurogenesis and gliogenesis 
[35], and blocks the differentiation of OLPs [36]. Fzd2 transcript is higher in A2B5+/OTMP+
than in O4+ cells, suggesting that Wnt signaling maybe critical to the biology of PNCs. A 
downstream target of Wnt signaling is the NrCAM protein, an adhesion molecule that is found 
in neurons and Schwann cells, but not in myelinating OLGs. Further invesitgation is required 
to uncover the function of NrCAM in pN-OLGs. 
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Another pathway that contributes to scenario is Notch signaling that act in three distinguishing 
aspects in A2B5+/OTMP+ cells. First during neurogenesis there is a tight cross-regulation 
between Notch and the two transcription factors, ASCL1 and DLX1 / 2, which results in 
sequential specification of progenitors [37]. Second, there is upregulation of the Notch target 
Hes5, an inhibitor of myelin gene expression, and controls the two pivotal genes, Ascl1 and 
Sox10. PNCs have higher Hes5 and Ascl1 while Sox10 transcripts are expressed at a very low 
level, compared to O4+ cells. To conclude, HES5 is responsible for keeping myelin transcripts 
inactive in A2B5+/OTMP+ cells, thus its transcriptional code has to be tailored for the non-
myelinating phenotype [32], [38]. Third, Notch1 drives the increased transcription of lipocalin-
prostaglandin D2 synthase (L-PTGDS) in A2B5+/OTMP+ cells. In contrast to previous data 
that showed that Notch1 decrease PTGDS expression [39]. Indeed, the differentiation 
progression from A2B5+ progenitor into A2B5+/OTMP + cells results in an order of magnitude
higher transcription of L-PTGDS as well as synthesis of the protein.
The previous data was followed by another study which focused on assessing and identifying 
the function of PNCs.  The most important evidence that contribute to the regulation of neuronal 
activity is the tight organization of glial cells around neurons, called the glial syncytium (figure 
6), suggesting essential functional roles of local glia arrangements [40], [41]. In the grey matter 
the most frequent glial type that contribute to this syncytium is OLs, in addition astrocytes and
microglia, can be found in a satellite position around neurons [29], [42]. As mentioned 
previously, PNCs are primarily non-myelinating cells that cannot produce myelin [29], [32]
thus contrasting the main function of myelinating OLs [17]. However, PNCs may provide 
metabolic support for neurons [29], protect neurons against apoptosis [43] or remyelinate axons 
following demyelinating injuries [44]. Interestingly, the presence of these cells directly at the 
base of the soma, close to the axon initial segment (AIS) (figure 1C), the action potential (AP) 
initiation site, enables them to influence AP firing [45]. Arne Battefeld et al investigated the 
functional and anatomical properties of s-OLs, by combining simultaneous whole-cell patch-
clamp recordings and live-confocal imaging with post hoc immunofluorescence and electron 
microscopy of neuron–s-OL coupling in acute neocortical slices from adult mice. In contrast to 
previous studies, s-OLs wraps neurons with compact myelin and action potentials in the host 
neurons exhibit precisely timed Ba2+-sensitive K+ inward rectifying (Kir) currents in the s-
OLs. Unexpectedly, the glial K+ inward current are not mediated by somatically expressed OL-
specific Kir4.1 channels. Instead, the AP-evoked Kir currents are transmitted through gap–
junction coupling with neighbouring OLs and astrocytes that form a syncytium around the 
pyramidal cell body. The repetitive high-frequency AP firing of pyramidal neurons is in part 
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controlled by the glial Kir that constrains the perisomatic [K+]o. In other words neurons with 
s-OLs showed a reduced probability for action potential burst firing during [K+]o elevations. 
These data show that s-OLs are integrated into a glial syncytium and perform multiple 
functional and anatomical roles, including spatially buffering K+ and myelinating axons within 
the perisomatic domain [46].
Little is known about the characteristics and function of PNCs, and most of the data were 
conducted on newly born rats and mice brains. Further investigation is required on the adult 
stage of these species as well as human. It’s also interesting to further confirm the presence of 
PNCs in the intact spinal cord and whether these cells are in a tight cross-talk with motor 
neurons. So part of my PhD focused on characterizing PNCs in the intact and degenerative 
CNS, and studying the in-vitro characteristics of these cells.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Identification and distribution of s-OLs around pyramidal neurons. 
(A) Overview image showing the distribution of oligodendrocytes in the somatosensory neocortex the 
transgenic PLP-ECFP mouse. (B) Electron microscopic image of s-OL (red pseudo-color) in a tight 
association with neuron cell body (green pseudo-color). (C) Heat-map indicating the location 
probability of 145 s-OLs in relation to the soma of an example L5 neuron (grey) [46]. 
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1.2.2.3 Microglial cells
They represent the resident macrophages, a cell type of the immune system, that constitutes 
10% of CNS glia [47] . These small mobile cells are derived from myeloid progenitor cells that
invade neonatal brain. Microglia are located in the parenchyma tissue of the brain and spinal 
cord. Like astrocytes, their function is not well known whether they are helpful or harmful [12].
They have a phagocytic ability, as well as, they secrete cytokines such as tumor necrotic factor 
alpha ????????????? can weaken the BBB integrity. Both in vivo and in vitro studies showed
that microglia control normal function and plasticity of neural circuits of the brain [48]. One 
more important role of microglia is that they modulate synaptic activity, as well as, they
selectively eliminate in appropriate synaptic connections during development of neural circuits
[49]. Ionizing calcium-binding adaptor molecule 1 (Iba1) is a protein that is specifically
expressed in macrophages/microglia and is up regulated during the activation of these cells
[12].
1.2.3 Ependymocytes or ependymal cells
Ependyma is made up of ependymocytes, one of the four types of neuroglia in brain and spinal 
cord canal. They line the CSF-filled regions with a polarized ciliated simple columnar shape. It 
is involved in the production of CSF, act as a permeable barrier exchanges between the cerebral 
parenchyma and the CSF, and is shown to serve as a reservoir for neuroregeneration. Jonas 
Frisén and his colleagues provided evidence that ependymal cells act as reservoir cells in the 
forebrain, which can be activated after stroke and as in vivo and in vitro stem cells in the spinal 
cord. However, these cells did not self-renew and were subsequently depleted as they generated 
new neurons, thus failing to adopt the requirement for stem cells [50].
1.2.4 Endothelial cells 
Endothelial cells (ECs) are the monolayer wall of the blood-brain barrier, and are in direct 
contact with the blood and lymph. They are the major cellular constituents of the CNS, in which
they are involved in CNS development and function. Endothelial cells appear to guide 
developing axons (20). They also aid in providing trophic support as well as differentiation
signals to neurons and stem cells (21). Finally they provide a niche for neural stem cells (NSCs)
[15].
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Figure 6: Schematic representation of glial-neuronal interaction.  
Glial cells surround and interact directly with neurons and for the glial syncytium [51].
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Chapter II: Stem Cells in their environment
 
2.1 Stem Cells outside the CNS
 
2.1.1 History of neural stem cells
Over the last decades till today, adult neurogenesis was a big debate among scientists, whether 
adult CNS was able to generate new neurons or its inability to produce new neurons or 
regenerate damaged ones. In 1962 adult neurogenesis was first described by Altman, J.
However, in 1992 NSC were first isolated from the adult mouse brain, in which Reynolds, B.A 
proved the existence of adult neurogenesis.  Since that time was the «no neurogenesis » dogma 
disproven.  Although the definition of stem cells has yet to be agreed, stem cell research has 
been intensified to better understand, as well as characterize stem cells. They are 
undifferentiated cells that have unlimited expansion capacity, to create progeny through self-
renewal and differentiation processes [52]. The self-renewal state is the ability to go through 
numerous cycles of cell divisions while maintaining undifferentiated state. Whereas the 
differentiated characteristic, which is known as stem cell potency, is the capacity to differentiate 
into specialized cell types that form the different tissues and organs of the body. These cells are 
present in embryonic tissues as well as postnatal and adult tissues. They multiply through either 
symmetric or asymmetric division to produce a pool of stem cells as well as differentiated cell 
types, to replenish dying cells and to regenerate damaged tissues [53].
2.1.2 Characteristics and types of stem cells
CNS stem cells are defined as multipotent, self-renewing cells, which can differentiate into 
specific cellular type. Such cells exist transiently during fetal development but it was also 
confirmed that they exist in the adult mammalian CNS and maintained throughout life. They 
are of several types and have various properties. Neural stem cells (NSCs) are of different 
types and are used widely. In the early 90s several groups reported the isolation of NSCs from 
fetal and adult CNS. 
2.1.2.1 Embryonic stem cells (ESCs)
Are pluripotent stem cells that have indefinite capacity of self-renewal and differentiation into 
cells of all three germ layers (figure 7). They are the ideal source for neural transplantation 
because of their high plasticity as they undergo both symmetrical and asymmetrical divisions. 
For instance, transplantation into damaged brain, ESCs can differentiate, migrate, and make
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innervations. Thus ESCs derived from human or mice fetal CNS have been reported as a source 
of cell transplantation for injury and degenerative diseases in animal models. So transplanting 
either human embryonic stem cells (hESCs) or NSCs derived from mice fetal brain into the 
mice injured brain (at site of injury), showed significant improvement in motor and spatial 
learning functions, as these cells differentiate into neurons and glial cells that aid in tissue 
repair. However, ESCs have the drawback of ethical issue are prone to transplant rejection and 
may create teratomas when administered in-vivo. Although recent studies have isolated ESCs 
from areas of active neurogenesis in the SVZ of lateral ventricle of mice, they can also be 
harvested from the ganglionic eminences of mouse embryos at day 14 of gestation [54].
 
Figure 7: ESCs differentiation steps. 
Differentiation of a single ESC into neurons and glial cells [55]. 
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2.1.2.2 Adult stem cells (ASCs) 
They are multipotent stem cells that can differentiate into unipotent cells of the residing tissue, 
generally for the purpose of repair. Unlike ESCs, ASCs have a decreased potential to self-renew 
and normally differentiate through only one lineage. Their ability to differentiate into neuronal 
cells demonstrated a possible therapeutic avenue for CNS diseases and injury treatment. ASCs 
are harvested from rodent adult brain and spinal cord where they are confined to the SVZ 
surrounding the lateral ventricle and central canal respectively (figure 8). When transplanted 
into the rodent injured CNS at the injury site, ASCs showed survival capacity for an extended 
period in the injured CNS. Moreover these cells migrate away from the injury site into 
surrounding areas, where they express markers of mature glial cells (astrocytes and 
oligodendrocytes). This cell property demonstrates that ASCs became region-specific 
functional cells. In addition to rat ASCs, human adult stem cells (hASCs) can be harvested from 
the same regions. Injection of cells of either source may restore the anatomy and function of 
injured areas [56], [57].
 
Figure 8: ASCs differentiation steps.  
Differentiation of ASCs that are isolated from various CNS regions [58].
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2.1.2.3 Mesenchymal stem cells (MSCs) 
They are adult multipotent stem cells that are derived from non-neural tissue such as bone 
marrow (figure 9). These cells have both the ability to self-renew and the ability to differentiate 
down to multiple cell lineages, so they are considered to have potential therapeutic benefits in 
different neurological injuries. So these cells are harvested from either human or rodent models 
where they showed capacity of neuro-repair and neuroprotection. When they are administered 
intravenously or injected directly into the site of injury, MSCs are migrated away from the 
lesion and subsequently survive, and can differentiate into neurons and astrocytes, leading to 
injury repair and enhanced motor function [59], [60].
 
Figure 9: MSCs differentiation steps.  
Self-renewal and differentiation capacity of mesenchymal stem cells [61].
 
2.1.3 Medical use
Many experimental attempts and trials for treating neurodegenerative diseases and CNS injury 
focus on neuroprotection during the intense period after injury. Despite the fact that this 
methodology holds positive outcomes, numerous individuals might either miss the little 
treatment window or may not completely profit by it. Rehabilitative treatments and medications 
that act on the post-acute period provide greater chance, therefore a long-term strategy may be 
required.  Thus NSCs of both origins (embryonic and adult) represent a candidate to be used in 
the medical field as a long term treatment.
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2.1.3.1 Neural stem cells in degenerative diseases
Studies have suggested that NSCs and neural precursor cells (NPCs) play a critical role in the 
onset and progression of various neurological diseases. NPCs dysfunction is highly associated 
with Parkinson’s diseases (PD), Alzheimer's disease (AD), and Amyotrophic lateral sclerosis 
(ALS). However, functional NSCs and/or bioengineered NSCs is a recently discovered method 
to retain therapeutic potential. Recent work showed the ability to generate new neurons in both 
human and mouse to treat those diseases (figure 10). Currently, three different methods are 
being used to derive neurons from somatic cells. Somatic cells such as skin fibroblasts can be 
reprogrammed to become induced pluripotent cells (iPSC) and then differentiated into neurons 
and glia. They can also be trans-differentiated to become induced neural stem cells (iNSC), or 
directly trans-differentiated to become induced neurons (iN). The aim of these methods is to 
transplant those reprogramed cells or endogenously recruited or exogenously expanded cells in 
degenerative models. The newly generated neurons harbor several neuronal properties and have 
spontaneous activities. They carry sodium and potassium channels and are able to generate AP 
in response to stimulation. Thus after transplantation those neurons are functionally integrated 
and active, resulting in impeding disease progression and enhancing motor and behavioral 
improvements [62], [63].
 
Figure 10: Treatment strategies. 
Stem cells transplantation as a strategy in treating degenerative diseases (Raquel Coronel, 2015).
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2.1.3.2 Neural stem cells in injury
CNS injury is associated with a wide range of post injury complications, where there are no 
FDA-approved drugs to treat traumatic brain injury (TBI) or spinal cord injury (SCI). Several 
neurotherepeutic strategies have been proposed including neurotherapeutic drug administration 
and/or cellular interventions. Among these experimental approaches, endogenously recruited 
or exogenously expanded NSCs have been proposed as next generation neuro-therapeutic 
targets for injury repair (figure 11). These cells represent a promising therapeutic adjuvant for 
regenerative therapy post injury, due to their ability to generate mature, functional neural cells 
able to replace degenerated ones [64], [65]. Several studies have focused on NSCs as a strategy 
to treat TBI. Transplanted cells into the site of injured brain show significant cells 
differentiation, migration, and long-term survival post transplantation with recognized 
improved motor and spatial learning post injury [66]. Therefore the long-term strategy may be 
required through direct transplantation of neural stem cells into the injured CNS that can 
provide a long-term survival and integration by mediating functional recovery through 
mechanisms such as bulk trophic support, cell–cell mediated repair and replacement of cells 
lost by injury [67].
Figure 11: Stem cells transplantation as a strategy in treating CNS injury. 
adapted from [67].  
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2.2 Stem cell niches out of the CNS
Beside the NSCs niche in the CNS, other stem cell niches reside in various organs including 
skin and intestine. These epithelial tissues undergo continuous cell replacement in a process 
called homeostasis [68]. Homeostasis is highly dependent from the stem cell niche that can 
regenerate damaged tissue following injury, facilitate rapid repair and prevent tissue over 
growth. Similar to NSCs, epithelial stem cells possesses the capacity for both long-term self-
renewal and multi-lineage differentiation with a traditional paradigm of a unidirectional, 
hierarchal differentiation trajectory. Epithelial stem cells beginning with a multipotent self-
renewing stem cell and proceeding through transit-amplifying cell stages and then into terminal 
differentiated state. The intestinal epithelium is a single layer of cells that extend invaginations 
(crypts) into the underlying connective tissues (figure 12A). Indeed, the intestinal epithelium is 
one of the fastest self-renewing tissues and completely regenerates within 3-5 days [69].
Intestinal stem cells (ISCs) are of two types,the LGR5+ rapidly cycling cells  are located at the 
crypt base interspaced between Paneth cells [70], whereas slow-cycling, label-retaining 
HOPX+,LRIG+,BMI1+,TERT+, DLL1+ ISCs are located at the +4 position relative to the 
crypt base [70], [71]. These cells are migratory cells and can generate and differentiate into 
various cells types the absorptive or secretory lineages and finally into one of four differentiated 
cell types: enterocytes, mucin-secreting goblet cells, peptide hormonesecreting neuroendocrine 
cells and microbicide-secreting Paneth cells [72].
On the other hand the skin epithelium is a multilayered, stratified epidermis, and fully renewing 
every 7-10 days (Potten et al., 1987). The basal stratified layer is where epidermal stem cells 
(ESCs) reside (Fig.12B), and they initiate a transcriptional program of terminal differentiation 
while migrating upwards to generate to the spinous layer, the granular layer and, finally, the 
cornified layer of dead cells. In addition to the ESCs that maintain the skin epidermis, the hair 
follicle stem cells (HFSCs) maintains the skin hair follicles (Fig. 12B). The hair cycle starts 
with the quiescent HFSCs residing in the so-called bulge niche that are triggered to proliferate 
through complex signaling crosstalk with neighboring niche cells, and migrate to supply the 
cells needed for hair follicle down growth [73], [74].
The regulation of homeostasis and the response of stem cells to injury is coordinated by the 
crucial role of stem cell-to-daughter cell crosstalk. In another words, coordinated by the niche 
signals that originate from stem cell progeny. In the intestine the cross talk is between paneth 
cells that secrete important signaling molecules such as (WNT3, EGF and Notch ligand DLL4) 
and LGR5+ ISCs (figure 12A). Studies confirmed that LGR5+ ISCs can form differentiated 
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intestinal organoids if co-cultured with a paneth cell-enriched population or adding exogenous 
WNT3A [75]. Interestingly, WNT signaling alone is not sufficient to drive LGR5+ ISC self-
renewal, but additional signals from R-spondins are also required. WNT is known to stabilize 
R-spondin receptor expression (LGR4, LGR5, LGR6), thus enabling R-spondin to promote 
stem cell expansion  [76]. These findings suggest that stem cell progeny within the niche 
support stem cell functions through providing the most crucial signals such as WNT, this would 
facilitate robust proper stem cell activities. Similarly, the feedback mechanism – from progeny 
back to stem cells – also exists in the skin, where early HFSC progenitors signal back to HFSCs 
to drive their activity during hair regeneration. In this context, progenitor cell SHH sustains 
HFSC activation during the hair follicle growth phase (figure 12B) [77]. This provides a self-
organizing feedback loop to control HFSC activation to the degree of hair follicle growth. 
Besides progeny stem cell-to- stem cell crosstalk, also stem cells themselves signal to their 
progeny or to themselves, in another word signals can originate from and to stem cells [78].
ESCs express several Wnt genes, and inhibition of WNT secretion leads to their premature 
differentiation, thus autocrine WNT signaling maintains the undifferentiated stem cell state 
during homeostasis [79]. Similarly, in the intestine, Notch signaling promotes LGR5+ stem cell 
proliferation, while preventing differentiation into the secretory cell lineage. In this context, 
deletion of Notch leads to secretory cell hyperplasia [80], while blocking WNT signaling in the 
intestine rescues this secretory cell hyperplasia [81].  So Notch signaling tunes local WNT 
activity, thereby coordinating balance between self-renewal and differentiation within the 
niche. Collectively, this shows the different sources of various factors and signals in intestinal 
and skin niches, and reveal how stem cell behavior is controlled to ensure precise lineage output 
responses to maintain or restore tissue integrity, characteristics that are shared with CNS niches.
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Figure 12: Intestinal and epidermal stem cell niches. 
(A, B) Architecture of the cellular organization and the niche niche signals controlling lineage 
hierarchies and dynamics during homeostasis in intestine and skin tissues [73].  
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Chapter III: Neural Stem Cells in their Neurogenic Niches
3.1 Generalities
In the CNS, NSCs reside in a well conserved, organized, and specialized microenvironments 
called stem cell niches. The lifelong self-renewal of stem cells, and their differentiation into 
specific cell types are well preserved and supported by these highly controlled niches. 
Therefore, NSCs and their interaction with the environment participates in the constitution of 
the niche. Furthermore, Tissue remodeling requires a highly dynamic niches capable of 
changing location and characteristics overtime. Within the niche, intrinsic and extrinsic signals 
as well as cell–cell interactions are key regulators allowing feedback control of stem cell 
activation and differentiation. The accessibility of growth factors and other signals is regulated 
by the basal lamina or stromal cells where stem cells in the niche are anchored. Thus this 
anchoring play a key role in orienting cell division into one or both daughter cells depending 
on the plane of division, in which basal lamina form a substrate for oriented cell division [82].
In addition to this, there is an intimate association with endothelial cells, which regulate stem
cell self-renewal and differentiation. Neurogenic niches are built so that NSCs can receive, 
integrate, and respond to signals from the surrounding microenvironment. Briefly, NSCs are 
(1) closely associated with the vasculature that makes neurogenesis associated with 
angiogenesis, (2) adjacent to a variety of neighboring cells, including their own neuronal 
progeny, resident mature astrocytes and microglia, and (3) in close contact with basal lamina 
components. Adult neurogenic niches maintain the stem cell pool, direct neuronal production, 
and provide protection of ongoing neurogenesis from possible external inhibitory influences
[82]. Functionally, members of the vascular endothelial growth factor (VEGF) family can 
stimulate neurogenesis as well as angiogenesis. It has been unclear whether they act directly 
via VEGF receptors (VEGFRs) expressed by neural cells, or indirectly via the release of growth 
factors from angiogenic capillaries [83]. VEGFR3 is expressed by neural stem cells, neurons, 
glia, and ependymal cells residing in brain and spinal cord. For instance VEGF-C stimulates 
mitosis of VEGFR-3-expressing NSCs, and this ligand receptor coupling promotes
subventricular neurogenesis, but not angiogenesis. Therefore, VEGF-C/VEGFR-3 signaling 
acts directly on NSCs and regulates adult neurogenesis, and may open potential approaches for 
treatment of neurodegenerative diseases [84], [85].
Eventhough, factors mediate these processes are still being elucidated, it is proved that both 
neural and non-neural cell types are key players [82].
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3.2 Location of NSC niches in the adult brain
In the adult brain the primary regions of proliferation and active neurogenesis are sub-
ventricular zone (SVZ) of the lateral ventricle and the sub-granular zone (SGZ) of the 
hippocampus. Therefore extensive work has been made to understand the reason behind these 
active two sites. Studies confirmed that those two regions are the NSC niches of the brain that 
contain a pool of stem and progenitor cells that produce the diverse cell populations of the brain 
(neurons and glia). In addition to that, recent work showed the existence of a third neurogenic 
niche that resides in the third ventricle by the hypothalamus. 
3.2.1 Sub-ventricular zone niche
SVZ is composed of a thin layer of dividing cells that run along the entire length of the lateral 
walls of the lateral ventricles and is largely separated from the CSF by a layer of multi-ciliated 
ependymal cells. The SVZ niche (figure 13) is well characterized and extensively studied, 
where it is considered a persisting zone of active neurogenesis in the adulthood. Briefly, the 
neurogenic niche consists mainly of three cell types that differs ultra-structurally and in the 
activation state. Starting with B1 cells, the in-vivo postnatal and adult NSCs, are characterized 
by the expression of the astrocytic GFAP marker. Their radial glial morphology, apical process, 
and primary cilium put B1 cells in direct contact with CSF and blood vessels, representing two 
pools of extrinsic signals that regulate neurogenic activity. Also the apical end feet of B1 cells 
are surrounded by the ependymal cells a property that creates the hallmark « pinwheel »
structure. In mid embryogenesis B1 cells are quiescent (qNSCs), a sub-population maintain its 
dormancy and another sub-population respond to an activation signal where they generate 
activated NSCs (aNSCs) or what is called transit-amplifying progenitor cells (TAPs or type C 
cells). Those cells divide several times before generating neuroblasts (mainly labeled with 
DCX) the immature neurons of the brain that migrate through the rostral migratory stream 
(RMS) to the olfactory bulb (OB). These DCX+ cells will generate two types of inhibitory 
interneurons that they will integrate in the OB circuitry. This OB neurogenesis will form and 
maintain olfactory memory and odorant discrimination [86]. To a certain extant B1 cells are 
capable of generating oligodendrocyte lineage cells [87]. Other migratory pathways were also 
described in case of injury, several studies showed migrating neuroblasts from SVZ into the 
neighboring striatum and the site of injury [88]. The migration of neuroblasts through the RMS 
is highly dependent and regulated by the GFAP+ ciliated radial glial cells. In fact, B1 cells 
orient and guide the migration from the SVZ through a balance between chemo repulsants and 
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chemo attractants from the SVZ environment. For instance, neuroblasts are repulsed away from 
the SVZ to the OB by the SLIT proteins a chemo repulsive stimulation for axon growth and 
guidance [89].  In addition astrocytes and glial cells play a key role in regulating the dispersion 
and the speed of migration respectively. Neuroblasts are encapsulated by astrocytes and form a 
cordon like a glial tube to prevent their dispersion and their speed of migration is diminished 
by the migration-inducing activity (MIA) secreted by glial cells [90]. Furthermore, a 
coordinated pattern of interactions between extracellular matrix (ECM) cues, cell adhesion 
molecules, and cell-surface integrin signaling receptors regulate the maintenance and guidance 
of neuroblast migration. (1) Polysialated form of neuronal cell adhesion molecule (PSA-
NCAM) responsible for maintaining the strength of the cordon like a glial tube. (2) Integrins 
and integrin ligand (tenascin-C) they convey the ECM-derived signals to the neuroblasts and 
fill the extracellular space between the migrating neurons and astrocytes in the RMS 
respectively [91].
Figure 13: Anatomy and cell types within adult SVZ niche. 
Schema represents a frontal section of the adult mouse brain showing the SVZ (orange), and the cellular 
types and their organization within the niche [91].
 
3.2.2 Sub-granular zone of the hippocampus
The dentate gyrus (DG) of the hippocampus is the second brain region where active 
neurogenesis occurs. Neurogenesis originates from the precursor population that resides in the 
SGZ niche (figure 14), found between the hilus and the granular cell layer that was described 
by Joseph Altman in 1975. The active proliferative spots are close to the vasculature suggesting 
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a role of blood vessels in regulating neurogenesis [92]. Adult hippocampal precursors within 
the niche are multipotent, they generate granule neurons, astrocytes, and oligodendrocytes in 
certain conditions. Briefly new neurons will migrate at a short distance to the granule layer 
where they extend dendrites to the molecular layer and axons to the mossy fiber path. There 
they are implicated in learning and memory [91]. Radial astrocytes or type1 cells are abundant 
in the SGZ with a rare dividing property. They express the astrocytic marker GFAP, and 
function as the stem cells of the SGZ. They send projections to the molecular layer and the 
contact blood vessels. They generate the high proliferating intermediate progenitor cells or type 
II progenitors, that give rise the mature functional neurons [93]. Type1 and type 2 cells differ 
morphologically and by the expression of markers. They share expression of some markers 
suggesting a reciprocal interplay between the two types. Unlike type 2, type 3 cells (neuroblast) 
are slowly and rarely proliferating and express neuronal markers where glial markers expression 
is lost [94].
Figure 14: Anatomy and cell types within adult SGZ niche. 
Schema represents a frontal section of the adult mouse brain showing the SGZ of the hippocampus, and 
the cellular types and their organization within the niche [91].
 
3.2.3 Third ventricle by the hypothalamus
Various reports showed that Adult brain harbors a third less studied neurogenic niche resides 
in the third ventricle by the hypothalamus (figure 15). Ependymal layer lining the third 
ventricles and harbors tanycytes, the stem cells of this niche. They are multipotent cells, under 
physiological conditions they generate neurons and glia, as well as neurospheres in-vitro [95].
Tanycytes are ciliated cells with elongated radial glial-like morphology with long basal 
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processes, resembling neural stem cells in other neurogenic niches. Such features created a 
similar stem cell niche-like cyto-architecture between SVZ and hypothalamus. However the 
regulation and neural stem/progenitor cell potential of hypothalamic tanycytes, as well as, the 
functional role of hypothalamic neurogenesis should be deeply investigated. In addition, the 
potential involvement of hypothalamic tanycytes in adult human neurogenesis needs to be 
addressed (M. Perez-Martin, 2010). But as hypothalamus is involved in sleep, circadian rhythm, 
and blood pressure, it is suggested that hypothalamic neurogenesis could be involved in the 
control of the body’s energy balance [96]. Recent study showed that, hypothalamic neurons 
(pro-opiomelanocortin (POMC+)) innervates the V-SVZ niche. So enhancing the activity of 
those neurons will enhance the number of NKx2.1+ cells as POMC+ neurons directly contact 
NSCs as well as niche cells. As such, the effect on NSC proliferation caused by modulating
hypothalamic POMC neuron activity could be due to direct stimulation of NSCs, volume 
transmission, or via niche cells. Hypothalamic neuronal innervation can target different spatial 
domains in the V-SVZ stem cell niche and selectively affect distinct pools of adult NSCs. 
Neural circuits from diverse brain regions may therefore underlie the regulation of 
heterogeneous adult NSCs by mosaically innervating the V-SVZ stem cell niche. Moreover, 
the hypothalamic neural circuits link physiological states to regional NSC proliferation and the
production of discrete OB interneuron subtypes. As such, they provide a logic of how diverse 
physiological states may lead to on-demand adult neurogenesis [97].
Figure 15: Anatomy and cell types within adult hypothalamic niche. 
Schema represents a frontal section of the adult mouse brain showing the hypothalamus, and the cellular 
types and their organization within the niche [98].  
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3.3 Location of NSC niche in the spinal cord
Little was known about the location of the neurogenic niche of the spinal cord, as well as the 
regulation and function of this niche [99]. Stem/Progenitors Cells (SPCs) were residing in the 
central canal, a slow proliferating zone and the main source of NSCs (figure 16). The 
parenchyma of the spinal cord could be a niche where rapidly proliferating stem cells and glial 
progenitors reside [100].
The spinal cord has no defined sub-ependymal layer, in which ependymal cells are the main 
source of stem cells both in-vivo  and in-vitro. Bruni and his colleagues identified various types 
of cells that constitute the ependymal cell niche [50]. Cells varies from cuboidal, to tanycytes 
and radial cells that contact the lumen, and to ciliated ependymal cells. Under physiological 
conditions the ependymal niche is quiescent, in which rare proliferation takes place, but this 
niche turns to be active in response to spinal cord injury, where the niche becomes highly 
proliferative and generate astrocytes and oligodendrocytes [50], [101]. In addition to that, cell 
transplantation studies, have demonstrated that, spinal cord derived NSCs are able to generate 
glial cells when grafted in the injured spinal cord, also they generated new neurons when grafted 
into the neurogenic hippocampus [102]. Thus at least a subpopulation of the ependymal cell 
layer possess NSCs properties with multipotent differentiation potential.
 
Figure 16: Anatomy and cell types within adult spinal cord niche.  
Schema represents the adult mouse spinal cord showing the ependymal cells lining the central canal 
niche [103].  
 
The ependymal neurogenic niche has been described in various species (rodents, macaque, and 
human), showing differences and similarities in the anatomy of the niche. 
1- In rodents Alfaro-Cervello et al 2012 described the ependymal central canal by toluidine 
blue-stained spinal cord sections. The ependymal zone (EZ) is a pseudo-stratified epithelium 
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derived from the developing ventral neuroepithelium due to the fusion of the dorsal wall zones 
and is controlled by SHH signaling [104]. In the cervical part the central canal is rounded with 
a wide lumen, while the dorsal and lumbar central canal is collapsed with elongated shape, and 
the lumen is reduced [105]. Despite these anatomical differences, cell types and their 
organization is similar among the spinal cord parts. EZ cells are highly polarized with different 
morphologies and protein expression (figure 17). Similar to zebrafish, dorsal and ventral 
midline (tanycytes) cells have a radial morphology and characterized by a long filament process 
that extends to the pia matter [106]. While lateral ependymocytes have a cuboid or radial 
morphology with processes contacting the blood vessels. To summarize, ependymocytes within 
the EZ share common features: electron-dense cytoplasm rich in intermediate filaments, a 
nucleus with small chromatin clumps, and a radial expansion [105]. For detailed data see table 
1.
 
 
 
 
 
 
 
 
 
 
 
 
Table1: Morphological features of the various cell types in the adult mouse central canal. 
+, few; ++, intermediate; +++, abundant; ++++, extremely abundant [105].  
 
2- In non-human primates such as macaque monkey, the ependymal zone was described by 
Alfaro-Cervello 2013, using high-resolution electron and confocal microscopy. As in rodents, 
the primate central canal is surrounded by pseudo-stratified epithelium, with rounder and wider 
cervical canal, and a restricted elongated thoracic and lumbar canal. The EZ and peri-EZ consist 
of 5 cells types, in addition to astrocytes and neurons, there are three subtypes of ependymal 
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cells that differ in the number of cilia they possess (uniciliated, biciliated, and multiciliated). In 
contrast to the mouse EZ, non-proliferating multiciliated cells are the most abundant cell type 
in the monkey EZ, and reside in the lateral wall of the canal (figure 17). On the other hand, 
proliferating uni and biciliated cells reside in the dorsal and ventral roof of the canal. Similar to 
rodents, ependymal cells have long radial processes that contact the vessels, and characterized 
by the electron-dense cytoplasm. Despite the number of cilia, ependymal cells share the same 
cytoplasmic contents [105], [107].
3- In humans little data is available on the EZ, even though it was studied by von Lenhossék in 
1891. Histological analysis on post mortem infant human sections showed a wide opened 
central canal [108], and a pseudostratified epithelium with two or three cell layers. Similar to 
rodents and macaque, roof and floor cells in the human possess a long radial processes that 
extend to the pial surface and express Nestin [109]. It’s suggested that these cells could be 
involved in guiding descending and ascending axons, and could provide supply for neurons 
until vessels appear [110]. Like macaque, infants showed three subtypes of ependymal cells 
while adult humans showed only two subtypes of ependymal cells characterized by two or more 
cilia. Like macaque, multiciliated cells are the most abundant cell type in the EZ. Human appear 
to have astrocytes similar to those of mice central canal astrocytes, but central canal contacting 
neurons were not detected in humans [105], [107] (figure 17). Unlike rodents and macaque, no 
proliferation was observed in the human EZ using proliferation markers, or rare events of 
proliferation could be missed [107], [111]. The major difference between rodents and primates 
is the presence of hypocellular layer formed by the increased level of GFAP filaments around 
the EZ in primates [107], [112]. This layer also exists next to the SVZ niche thus considered a 
distinctive property of primates, and could be the reason behind the absence of regeneration in 
primates. Another interesting distinctive feature of the human central canal is that, the canal 
showed displaced ependymal cells resulted from the invagination and folding of the ventricular 
sur????????????????????????????????????????????????????????????????????????????????????????????
levels of the spinal cord in humans, while it is maintained at the level of the medulla [113]–
[115].
To conclude with the location and anatomy of NSC niche in the spinal cord, there is differences 
between ependymal central canal of rodents and primates. Of the major differences is the 
abundancy of multiciliated cells in primates, and this could be due to the larger lumen [116].
Another distinctive difference is the existence of hypocellular layer around the central canal 
that could be the main obstacle for regeneration in primates [114], [117]. However some 
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similarities between mice and rodents are observed such as the presence of proliferating 
uniciliated and biciliated cells to maintain length extension [105]. Finally, in this context it’s 
necessary to go further in studying the EZ in these species and compare it to regenerative 
species such as zebrafish. So single cell sequencing will unravel the gene expression in the 
central canal to indicate the genes that are switched on and off, and to understand why humans 
have low or no regenerative capacities [118]. Thus a comparative approach of the EZ cells is a 
promising analysis to unravel the steps of inhibiting gliogenesis and switching regenerative 
neurogenesis after SCI and degeneration.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: The organization of the ependymal zone across vertebrates. 
A schematic representation showing cellular organization within the EZ of different species [117].
3.4 Heterogeneity of neural stem cells
NCS in their neurogenic niches are highly diverse and heterogeneous. Fiona Doetsch and 
colleagues studied extensively the heterogeneity of the brain niches, and showed the functional, 
regional and morphological heterogeneity within neural stem cell niches. Heterogeneity was 
studied using various transgenic models targeting stem cell markers in the niche, until the Single 
cell transcriptomic technology emerged that depends on sequencing hundreds to thousands of 
RNA in single cell [119]–[121]. This technology could also be coupled with the lineage tracing 
that provides a deep analysis of cell emerging, activation, and differentiation. However time is 
a key regulator of aNSC heterogeneity, where mRNA expression levels change over time, thus 
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affecting the single cell transcriptome analysis. Moreover the generation of various OB 
interneuron subtypes is highly dependent on the developmental periods (embryonic and adult). 
Adding to this changes in chromatin structure is time dependent, thus epigenetics is an 
additional factor of NSC heterogeneity that should be studied. So future studies are required to 
dissect NSCs heterogeneity over various factors to provide a better understanding of the normal 
brain function, plasticity and repair.
3.4.1 Heterogeneity in the sub ventricular zone
Heterogeneity in SVZ niche is studied extensively by Fiona Doetsch and colleagues, where 
they uncovered the NSC diversity, function and morphological differences [122], [123]. It’s 
well known that SVZ postnatal and adult NSCs continue to generate neurons and OLs 
throughout life but the detailed mechanism of how NSCs differentiate is not well described, 
which is necessary to understand their behavior and function in vivo.
SVZ niche is composed mainly of quiescent neural stem cells (qNSCs), the term quiescent 
refers to the dormant state of the cells that maintain self-renewal, cell replacement, and DNA 
integrity. Thus they constitute the reservoir of various cell types that are recruited when needed. 
Over the last 15 years qNSCs was thought to be type B cells that express GLAST and GFAP 
markers, a structural and molecular feature of astrocytes. With their radial morphology GFAP+ 
cells possess a small process that extend a primary cilium to contact the CSF at the center of 
ependymal cell pinwheels (figure 18A), while from the basal side they send a long process that 
terminates at the blood vessels. Type B cells contacting the ventricles have a light cytoplasm 
and are quiescent, but when activated they give rise to the dividing transient amplifying cells 
(TACs) or type C cells that generate neuroblasts or type A cells. Neuroblasts will migrate to the 
OB and differentiate into OB interneurons. Adding to this scenario, type B cells also generate 
oligodendrocytes and astrocytes. The difference between the niche astrocytes and the other 
brain astrocytes was identified, to conclude that the niche astrocytes are themselves diverse and 
heterogeneous and have different structural and morphological features. So type B cells are 
now subdivided into quiescent type B1 and activated primed type B2, thus identifying 
additional markers is a key for better understanding astrocyte diversity and unmask new NSC 
in the niche [122], [124].
The detailed architecture of the niche indicates the various types of cells and the interplay 
between them. Using a GFAP-GFP mouse model in combination with antibody labeling against 
different proteins or performing single cell analysis on sorted cells was a good approach to 
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understand the interplay of cells inside the SVZ niche. Codega P et al., were able to identify 
and isolate qNSCs from their niche, through visualizing the SVZ astrocytes using the GFAP-
GFP transgenic mice. As described before type B cells are in direct contact with the ventricle 
at the center of pinwheels, those cells are expressing GFAP that localized with the GFP, on the 
other hand they are immune-?????????????????????????????????????????????????????????????
cells turned out to be CD133+, a marker of ependymal cells and cilia of type B cells, but the 
expression profile of CD133 was different among the GFAP+ cells. Interestingly a 
subpopulation of the GFAP+ cells expressed CD133 at the tip of the primary cilium, this 
population referred to the qNSCs. While the other GFAP+ population had a diffused CD133 
expression along the apical surface and lacked a primary cilium, in addition they were immune-
positive to EGFR and those represented the aNSCs. Both cell types had a radial morphology 
and were in direct contact with the ventricle and blood vessels. Therefore they identified two 
CD133+ astrocyte populations that had different protein profile, thus a different functional state
(figure 18B) [122], [123], [125].
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Properties of V-SVZ stem cells and their progeny in pinwheel structure.
(A) Schema showing different cell Types organized as pinwheel structure. (B) Schema showing the 
differentiation stages and properties of V-SVZ stem cells and their progeny [122].
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These findings suggested that these two population of cells have different cell cycle properties. 
To confirm this hypothesis they immune-stained sorted cells with either proliferation markers 
or with a single pulse of bromodeoxyuridine (BrdU), both approaches confirmed that GFAP+ 
CD133+ lacked the expression of proliferation markers such as Ki67 and MCM2 and were 
BrdU- indicating that this population of cells is highly dormant. On the other hand, Ki67 and 
MCM2 were highly expressed during the G1 phase in the GFAP+ CD133+ EGFR+ population 
and were BrdU+, indicating the highly active dividing state of the cells. 
Transplantation studies of qNSCs and aNSCs into the brain of adult mice showed that, both 
populations are able to generate neuroblasts that migrate to the OB through the RMS and were 
able to generate OB interneurons as well as were able to generate OLs. In fact aNSCs were able 
to engage in this process after only 1 week of transplantation while qNSCs took almost 1 month 
to generate neuroblasts. Therefore both populations are able to generate neurons and maintain 
the in vivo long term potential of the neurogenic niche, but they differ in their cell generation 
kinetics.
Combination of several approaches showed that qNSCs and aNSCs also differed in their 
molecular signature. Microarray analysis, qPCR, and immunostaining on purified cells showed 
that nestin, the intermediate filament protein and the hallmark of NSCs [126] is only expressed 
in aNSCs, where qNSCs had low levels of the nestin mRNA but were immune-negative for the 
nestin marker. But when qNSCs were plated in vitro, those cells up regulated the expression of 
nestin upon activation. Therefore upon activation, qNSCs gain the expression of EGFR and 
nestin and contribute to the lineage during regeneration. In addition to this, qNSCs were 
enriched in genes related to cell communication, response to stimulus, cell adhesion, and lipid 
metabolism, also they were enriched in factors known to be markers of quiescence such as 
VCAM1 and Lrig1. In contrast, aNSCs highly expressed cell cycle, transcription and 
translation, and DNA repair related genes. Moreover a subset of adult neurogenesis regulating 
genes were highly expressed in aNSCs and were a distinctive features of this population such 
as Dlx1, Dlx2, Sox4, Sox11, and Ascl1 [122], [123], [125].
In vitro both populations showed distinct behavior with reversible state capacity. aNSCs were 
characterized by the ability of colony formation unlike qNSCs that rarely form colonies and at 
low kinetics. Moreover qNSCs were rarely forming neurospheres and the neurosphere 
formation was delayed, on the contrary aNSCs significantly generated neurospheres. Both 
sources of neurospheres were multipotent generating neurons, astrocytes and oligodendrocytes, 
and able to survive several passages. Upon activation qNSCs are able to retain the property of 
highly forming neurospheres. In addition to that, in both cultures it was noticed that the culture 
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is heterogeneous, in other words neurospheres derived from qNSCs can give rise to GFAP+ 
CD133+ EGFR+ cells in addition to the GFAP+ CD133+ cells, similarly was noticed for 
neurospheres derived from the aNSCs. Therefore, the two populations can reversibly propagate 
between quiescent and activated state with the ability to generate all other populations, but 
differed in colony and neurosphere formation kinetics [122], [123], [125].
This study was followed by more detailed studies using high technologies to dissect the 
heterogeneity in the SVZ niche. Of these studies the one done by Ben Dulken in 2017 who used 
the single transcriptome analysis to define the dynamics in the adult stem cell lineage and 
showed how NSCs propagate along different states within the niche before generating mature 
differentiated cells. In this study they used the same transgenic mice (GFAP-GFP) and the same 
cell purification protocol described by codega et al, 2014, but instead they used another 
approach to identify heterogeneity depending on single cell analysis. So they identified and 
purified four populations of cells (figure 19):
Niche astrocytes are the GFAP-GFP+ CD133- EGFR- cells that were very similar to the GFAP-
GFP+ CD133+ EGFR- qNSCs as describe previously [122]. aNSCs GFAP-GFP+ CD133+ 
EGFR+ were placed after qNSCs depending on the clustering and as cells propagate from 
quiescence to activation they upregulated Rpl3 a gene responsible for ribosomal genesis, then 
followed by the upregulation of cell cycle genes [127]. Interestingly, ki67 cell cycle markers 
showed that during transition from quiescent to activation there is an intermediary state 
characterized as the “cell cycle low” aNSCs as they expressed EGFR but not Ki67 unlike the 
“cell cycle high” aNSCs. So aNSC were subdivided in two different populations low and high 
cycling. As they improved the clustering of genes and referred to four-way stochastic gradient-
boosting classification model [128], they were able to capture and understand activation, 
commitment, and dynamics of differentiation. So they identified a new subtype within the “cell 
cycle high” cells (GFAP+ EGFR+ KI67+), in which a subpopulation of cells expressed Dlx2 
pro-neural marker responsible for neuronal differentiation [31], [82], [94]. Then aNSCs are 
followed by the last committed cells the NPCs GFAP-GFP- EGFR+ that are ordered at the end 
of cell hierarchy. NPCs are known to be the last state before the emergence of neuroblasts as 
they express markers of indicators of neurogenesis regulation such as Dcx, Sp8, and Sp9 and 
others. Therefore the new cell clustering showed that the cells propagate along a well-defined 
continuum starting from quiescence to activation then commitment and differentiation. Along 
this continuum cells are as follows: qNSC-??????????????????-????????????????????????-mid 
(Egfr+ Cdk1+ Dlx2 low), aNSC-late (Egfr+ Cdk1+ Dlx2 high), and NPC-like (Dlx2+ Dcx+), 
ending up with five distinctive molecular states. Interestingly comparative single cell analysis 
60
on in vitro cultured cells from different populations revealed that in vitro cells referred to the 
in vivo mid aNSCs with significant differences in the up regulation of inflammatory genes and 
cytokine signaling genes in the in vitro cultured cells [122], [123], [125].
Figure 19: Cellular heterogeneity and linear progression in the SVZ of adult mice. 
Scheme for the enrichment of astrocytes, qNSCs, aNSCs, and NPCs from the SVZs of adult mice [123].  
3.4.2 Heterogeneity in the dentate gyrus
It is interesting to study hippocampal heterogeneity as it is highly related to better understand 
adult neurogenesis in the SGZ. Briefly kempermann et al 2015 showed that NSCs generate 
TACs that give rise to neuroblasts, then differentiate into mature neurons that migrate to the 
granule layer and integrate into cognitive functions such as learning and memory [129]. Various 
studies were done to unravel the heterogeneity of the hippocampal neurogenic niche using 
combination of NSC markers such as nestin, GFAP, and Prominin1 [123], [127], [130]. In a 
very recent study of Benedetta Artegiani, et al 2017 they used the nesting-GFP mouse model 
to FACS sort NSCs from the niche coupled with other NSC markers. They purified the GluR1-
/cd24- cells a marker of mature granule cells and immature neurons respectively , and 
performed single cell sequencing [131]–[133]. In the hippocampal neurogenic niche several 
cell populations are described and subdivided into subpopulations (figure 20). First the 
neurogenic lineage is constituted by the NSCs and NPCs that express GFAP, Sox2, Sox9, and 
Id4; and DCX, Ccnd2, and Neurod1 respectively. Second oligodendrocyte lineage cells 
??????????? ?????????? ????????????????????????????????????? ?????????????ng mature OLs 
(expressing Mbp, Plp, and Mog). Finally other glial cells subdivided into astrocytes and 
???????????????????????????????????????????????????????????????????????????????????????????????
identified such as interneurons (Reln), pericytes (Tbx18), and endothelial cells (Vwf). 
According to the clustering system they were not able to detect the intermediate states as the 
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cells progress from quiescence to activation, rather they were able to detect the change of 
marker expression along the continuum. At early stages cells were enriched in quiescent genes 
(Apoe, and Id3) and then along the continuum they gain the expression of activation genes 
(Fgfr3, and egfr) as described in the SVZ by Codega et al., 2014. Similar to the SVZ, 
proliferation markers were not expressed in early NSCs instead they were highly expressed in 
late NSCs as cells entered G1 and S phases (Codega et, 2014; shin et al, 2015). Also mature 
NSCs expressed low level of genes similar to NPCs such as Sox11 and Hmgn2 indicating that 
both NSCs and NPCs are distinct cell populations. NPCs are further subdivided into early 
(Ccnd2, and Hmgn2), intermediate, and late progenitors (DCX, and sox11), where early 
progenitors showed higher expression level of the proliferation genes (Ki67, and MCM2). 
These data unraveled the genetic and cellular signature of the hippocampal neurogenic niche
[133], [134].
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Cellular heterogeneity and linear progression in the SGZ of adult mice. 
Scheme showing linear progression of radial glia-like cells (RGLs) in the SGZ, and the markers 
distinguishing different stages of the lineage progression in adult neurogenesis in the DG [134].  
3.4.3 Heterogeneity within the ependymal
Epithelial cells lining the central canal wall in both postnatal and adult life and among various 
species remained poorly described. Several studies didn’t provide a detailed description of 
central canal cells, for instance Mothe and Tator, 2005 identified ependymal and tanycyte cells 
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within the niche. While Meletis et al, 2008 identified three types of cells cuboidal, radial 
ependymal cells, and tanycytes. Another study done by Hamilton et al, 2009 who described 
new cell types in the canal niche apart from the ependymal cells and tanycytes, such cells are 
the astrocytes contacting the canal, oligodendrocytes, and the CSF contacting neurons. In his 
????????????????????????????????????????????????????????????????????????????????????????
cells, and few NG2+ and olig2+ cells were close to the ependymal canal cells.
Heterogeneity in the ependymal zone is species dependent, for instance it is less diverse in 
zebrafish compared to mice, and humans (figure 17). Unlike mammals, zebrafish shows an 
active regenerative neurogenesis, so it’s interesting to show the cellular characterization of the 
EZ in zebrafish compared to the mammalian EZ. The zebrafish EZ constituted of one astroglia-
like-cells called radial glial cells.  Those ependymoglial cells are characterized by having their 
soma at the central canal a key feature of forming the ependymal layer, and with a long radial 
process extending vertically away from the canal (figure 17). Moreover those cells have 1 or 2 
cilia where they express the foxj1 transcription factor responsible of cilia motility to maintain 
constant CSF flow. Combined together, these characteristics are at the origin of identifying the 
cells as ependymo-radial glia (ERG) [135], [136]. ERGs are enriched in GFAP, GLAST, and 
BLBP expression, in addition those cells are highly branched and their cilia sense signal from 
the central canal, thus they maintain a homeostatic function of ependymal cells and astrocytes 
[137], [138]. SCI studies showed that ERGs act as progenitor cells that generate several types 
of neurons unlike mammal cells that are destined to the glial fate [101]. Thus in response to 
injury ERGs generate several types of interneurons as well as motor neurons [139], [140].
Therefore ERGs are the promoters and only source of neuron generation and axon regeneration. 
In rodents the central canal niche is highly diverse and consisted of several types of polarized 
ependymocytes (figure 17). Dorsal and ventral cells extended long processes and referred as 
tanycytes, and differed from the ependymocytes of the lateral walls that contact blood vessels 
and lack cilia [141]. Diversity among ependymocytes referred to distinct cellular morphologies 
and marker expression. Majority of Ependymocytes ????????? ??????????? ????????
CD24+, EphrinB1+, SOX2+, SOX9+ and CD133+ profile, while roof an floor radial midline 
cells showed low expression of vimentin and CD24 but high level of GFAP expression. 
Additional marker analysis revealed a dorsal-ventral and rostro-caudal regionalization, for 
instance, NKx6.6, Nkx2.2, and NATO3 are mainly expressed ventrally in the niche, while 
PAX6 covers the dorsal and the lateral walls of the canal only [105], [142]. This regionalization 
is maintained from development till adult stage [143]. In addition to the identified 
ependymocytes, the EZ niche harbors two non-ependymocyte cell types. First there are the 
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central canal contacting astrocytes (Accs), they are colonized in the dorsal and ventral canal 
and unlike ependymocytes they possess cilium. They extend long processes and they are 
heterogeneous population of cells, where some Accs express vimentin and nestin intermediate 
filaments [105], [144]. Second there are the CSF contacting neurons (CSF-N) that reside at 
different levels of the spinal cord. This cellular type is heterogeneous as it has different location, 
origin, function, and properties, and they are of two types lateral and ventral CSF-Ns [145], 
[146]. They are not a result of neurogenesis rather they are generated from two ventral domains 
of the spinal cord lately during development [146]. In addition to the immature neuron marker 
DCX, CSF-N maintain the expression of several transcription factors such as such as NKX6.1, 
NKX2.2, FOXA2, GATA2/3 that probably maintain the immature electrophysiological 
properties of these neurons [145], [146]. These neurons express functional ATP-gated P2X2 
receptors, as well as high levels of the polycystic kidney disease-like channels (PKD2L1 and 
PKD1L2), which are distinctive markers for these neurons [147]. It has been confirmed that 
CSF-N have a GABergic property with an extended axon to the caudal part of the spinal cord 
and a small process extended to the lumen terminated by a large vesicle-containing budge. The 
expression of ion channel markers and their anatomical structure could explain the role of these 
cells. Due to the channels, these cells could respond to pH, osmolarity, and mechanical 
stimulation. While the existence of the budge inside the lumen is an indication of the secretory 
role into the CSF, thus they could be involved in the CSF composition and flow movement. 
Finally it was reported that in other CNS niches GABAergic signaling regulates quiescence and 
proliferation, so it has been suggested that, those CSF-N could have a similar role in the 
ependymal niche [148], [149].
In human and non-human primates (macaque), cellular heterogeneity has been described using 
electron microscopy, MRI, and marker analysis. Where most of the studies done on children 
and young individuals, data showed nearly a patent and a similar canal niche to that described 
for macaque and rodent niches with some particular properties (figure 17) [107], [143].
However, few studies have been reported that, the adult human canal niche has a completely 
different cellular structure and pattern. In adults the patent canal niche is almost absent, rather 
they have a randomly distributed morphologically heterogeneous cells (astrocytes, 
ependymocytes, and rosette pseudo-canal cells) [107], [111].
Although the pattern of the spinal cord niche is different among children and adults, it is highly 
heterogeneous at both ages. Three major characteristics define the niche of humans related to 
the cellular heterogeneity and organization (figure 17). Starting first with the active gliosis due 
to the presence of astrocytes represented by the GFAP+ cells that form a dense mesh around 
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the ependymal accumulation with dorsal, ventral and lateral extensions. The dense mesh formed 
by the GFAP+ cells is known as hypocellular layer, and could be responsible of inactive 
neurogenesis.
A second feature is the presence of two subtypes of vimentin+ ependymocytes (two cilia or 
multi-ciliated cells). These are protoplasmic cells with eccentric nuclei expressing CD15 and 
GLAST and found in masses with beta-catenin+ junctions. Finally, the third feature is the 
presence of pseudo-canals or rosettes that are oriented around a highly vascularized mass of 
cells (presumed lumen) and separated from the hypocellular layer. Only a subset of these cells 
are vimentin+ indication of heterogeneity within this population. Of note the proliferation 
within the human niche was absent as no Ki67+ cells were observed unlike rodents and 
macaque, but bad tissue preparation could mask low proliferating cells [107], [111], [150].
According to several marker studies, the human niche is highly diverse with a highly conserved 
architecture. Like rodents and zebra fish only a subset of EZ cells express nestin or GFAP, also 
some markers are expressed only dorsally (CD15, and PAX6) others are expressed dorsally and 
ventrally (NESTIN), thus these data showed cellular heterogeneity and dorsal-ventral 
regionalization within the human EZ niche. Of the other markers expressed in the EZ niche, are 
those typically expressed by immature NSCs such as vimentin, FOXA2, SOX2 and SOX11
[104], [142], [151].
Other studies confirmed the existence and persistence of neural progenitor cells in the adult 
human spinal cord. Dormard et al., generated nestin+/sox2+ neurospheres in vitro, these 
neurospheres were multipotent and able to generate astrocytes, oligodendrocytes, and neurons. 
As they were unable to be passaged those cells were derived from proliferation-limited 
progenitor cells. While Mothe et al., were able to generate same multipotent neurospheres that 
could be passaged several rounds using different culture conditions [56], [112].
To conclude with this part, several studies showed the structural and anatomical, cellular 
composition, and genetic profile differences in the EZ niche among the three species. The 
fundamental differences are likely existing between progenitor cells among species. So the 
cellular heterogeneity and organization is highly conserved and different, this created what is 
called the regenerative and non-regenerative species.
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3.4.4 Functional significance of spinal cord ependymal cells 
The EZ niche has been described and reported as a highly heterogeneous pool of cells. In the 
SVZ stem cells are self-renewing by symmetric division from either unipotent or multipotent 
progenitor cells. Niche environment, physiological cycles, and pathological conditions regulate 
the state of stem cells, starting from quiescence to activation and then differentiation in case of 
active neurogenesis [122], [152]. In the EZ of spinal cord the scenario is more complex, 
ependymal cells are latent neural stem cells with well characterized stem cell properties [50].
So one question to assess is whether all ependymal cells are stem cells or it’s only a 
subpopulation of ependymal cells? 
To answer this question, Alfaro-Cervello et al showed by electron microscopy that, unlike SVZ 
ependymocytes, the spinal cord ependymocytes self-duplicate with a degree of differentiation. 
On the other hand, in vitro studies by Weiss et al provided evidence about the existence of a 
subpopulation of NSCs in the EZ through the neursophere assay [105]. The generation of EZ 
derived neurospheres were confirmed by several groups and using various strategies. 
The first strategy was the microdissection of the EZ central canal region, in which they 
confirmed the ability of cells to generate neurospheres that can be passaged for a long time 
(figure 21) [153]. The second strategy was the use of cell surface markers (CD24, and CD133) 
to pool out specific types of cells, interestingly these strategy was able to give an idea about 
cell types that were able to generate neurospheres in culture [154].
The third strategy is the use of transgenic animals that label a specific cell type in the EZ, where 
it was a good strategy to follow several NSCs in the EZ and whether they were able to generate 
neurospheres or not. The hGFAP-GFP mouse or the hGFAP-CreERT2 are widely used, and 
they showed that GFAP-GFP+ cells were able to form neurospheres and generate astrocytes 
and neurons in culture (figure 21). But one difference is that whether they have limited or 
unlimited self-renewal capacity, and this discrepancy could be due to the use of different design 
of the transgene or due to the different culture conditions [144], [153]. Where fiorelli et al 
suggested the existence of another source of neurosphere-forming cells, yet to be confirmed. 
But this suggestion was confirmed recently by Xu et al where he showed the formation of 
neurospheres by Oct4+ primitive NSCs in the EZ [155]. Another transgenic mice models were 
used to monitor other ependymocyes, foxj1 and nestin were good candidates. Nestin-CreERT 
and Foxj1-CreERT mice [50], [156], both transgenic mice showed that, foxj1+ and Nestin+ 
cells were able to generate multipotent neurospheres. Interestingly combining several data from 
various study they showed that, Foxj1 is expressed in most of the EZ cells including subset of 
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the GFAP+ cells [157]. This confirmed the hypothesis of the generation of neurospheres of 
various cell origins. Thus it is interesting to assess whether Foxj1+/GFAP+ and Foxj1+/GFAP-
cells have different neurosphere-forming ability. Another group they used the recombined 
Glast-CreER mouse, Glast labels type A pericytes and a small subpopulation of ependymal 
cells [105], [158]. Glast-CreER cells were residing in the dorsal EZ where proliferating 
ependymocytes are mostly concentrated. So BrdU injection of this mouse model confirmed the 
proliferating state of GLAST cells, but the rate was different from other ependymocytes, 
suggesting the existence of other proliferating subpopulation of ependymocytes. Moreover 
those GLAST cells were able to generate neurospheres and could be maintained over four 
passages, thus suggesting their limited self-renewal capacity. Unlike the GFAP+ neurospheres 
that could propagate for a long-term [153], the GLAST+ cells were better considered as neural 
progenitor cells [144]. The same group represented by Sabelström H, et al they used the Troy-
CreER mouse, troy is a tumor necrosis factor receptor that labels a small subpopulation of 
ependymocytes and subset of pericytes. Troy+ cells were quiescent in vivo, but unlike GLAST 
cells they generated neursopheres that are maintained over several passages, confirming their 
sustained self-renewal potential.
In conclusion, spinal cord ependymal cells have different ability of forming neurospheres with 
different differentiation abilities, thus ependymal cells are functionally heterogeneous showing 
proliferating progenitors and quiescent latent stem cells.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Schematic diagram of neurospheres derived from spinal cord cells in juvenile and adult 
mice.
Juvenile ependymal cells have higher intrinsic self-renewal capacity compared to adults in vitro, and 
can generate oligodendrocytes and neurons after differentiation [156] .
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Chapter IV: Molecular regulation of the NSC niche in the spinal cord
Neural stem cells have the ability to self-renew and differentiate along multiple lineages, 
driving tissue homeostasis and regeneration. These processes are highly controlled by 
extracellular signaling molecules and the local NSC microenvironment, the "niche." There is a 
wide spectrum of niche-derived biochemical, and mechanical inputs that define stem cell states 
during morphogenesis, homeostasis and regeneration, and highlight how these diverse inputs 
influence stem cell plasticity [73].
Although neural stem cells have the highest potential to generate distinct progeny, they are 
themselves slowly cycling (quiescent) in adulthood, and through this behavior they regulate the 
maintenance of tissue homeostasis and regeneration throughout life. In the adult SVZ niche, 
qNSCs are found in the ventricular wall while activated NSCs (aNSCs) are found in the 
periventricular region, suggesting that unique cues in those microenvironments tightly regulate 
the positional identity of quiescent and activated NSCs (figure 13 and 19) [122], [159].
While several molecules produced by the niche cells have been identified to regulate adult 
neurogenesis, a systematic profiling of autocrine/paracrine signaling molecules in the 
neurogenic regions involved in maintenance, self-renewal, proliferation, and differentiation of 
NSCs has not been identified. These studies further suggest that certain signaling cues in the 
NSC niche govern the neurogenic potential of NSCs. However, the nature of niche signals is 
not fully elucidated.
In the spinal cord, multiple signaling pathways regulate the development and early patterning 
processes. These pathways involved in regulating cell division, rearrangement, and 
differentiation that are coordinated in time and space. Of these pathways, three essential signals 
are identified and play a crucial role in the development and and are retained in the adult stage; 
the Wnt/B catenin, the Bone morphogenetic protein, and the Sonic hedgehog pathways (figure 
22A) [160]–[162]. These pathways are known to shape the EZ during the developmental 
process and maintained in the adult stage, in which they regulate the NSCs in their niche.
4.1 Integration of Wnt/BMP signaling
Wnt/BMP signal integration regulates various processes in the spinal cord during development 
and patterning. The early patterning in the dorsal spinal cord requires BMP gradient. As BMPs 
are expressed in the roof plate (figure 22A), the dorsal-most portion of the neural tube, dorsal 
progenitor cells are specified by BMP signals. These signals are known to drive mitogenic Wnt 
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gradient from the dorsal midline of the neural tube. The BMP/Wnt signals then influence 
domains of Wnt ligand, receptor, and antagonist expression that regulate cell cycle influencing 
progenitor expansion [163], [164]. As Wnt signal drive cells to exit the cell cycle, cells migrate 
and adopt neural identities, where the dorsal identities involve various transcription factors at 
the early stages (Pax7) and late stages (Ngn1 and Mash1) [165]. So patterning is regulated by 
BMP, linking this process to neuronal differentiation via Wnt-mediated proliferation (figure 
????????????????????????????????-catenin component of the wnt pathway plays an essential role in 
proliferation, cell-intrinsic and environmental properties might change over time during 
development, thus modulating the response of the cells [166]. The continuous growth of the 
dorsal spinal cord is predicted by the presence of Wnt gradient along the dorsoventral axis and 
the closure of neural tube closure and spinal cord formation has to be terminated in the dorsal-
most spinal cord through limited neuroepithelial expansion. So these processes are controlled 
by the rate limiting steps in the previously mentioned signaling cascades [167]. Ille et al showed 
in his study that Wnt-mediated proliferation can be antagonized by BMP signaling. Moreover, 
BMP-dependent differentiation is encountered by Wnt, indicating that proliferation and 
differentiation in the dorsal spinal cord are controlled by cross-inhibitory interactions between 
Wnt and BMP signaling (figure 22B). So the integration of Wnt/BMP signal regulates the 
balance between proliferation and differentiation of neuroepithelial cells in the dorsal spinal 
cord [168].
 
Figure 22: Signal cross-talk in the spinal cord.
(A) Dorsal Wnt/BMP VS ventral Shh. (B) Cross inhibition of proliferation-inducing Wnt signaling and 
differentiation inducing BMP signaling [168], [169]. 
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Another process that requires Wnt/BMP signal during development and patterning is the 
specification of spinal cord neurons [170]. A combination of various bHLH transcription factors 
like Olig3, Mash1, and Ngn1/2 and homeobox factors like Gsh1/2 reveal distinct progenitor 
domains (figure 23A) [171], [172]. Six types of interneurons, dI1–dI6, are identified in these 
progenitor domains (p1–p6). These neurons are located in the mantle zone laterally and can be 
distinguished by the expression of homeobox transcription factors such as Foxd3, Isl1/2 and 
Lbx1 (figure 23A) [165], [172]. For instance, Olig3 transcription factor is expressed in p1–p3
progenitor cells and it is essential for correct and normal development of the dorsal 
interneurons. A mutation of Olig3 in mice decreases the number of dI1 neurons and abolishes 
the generation of dI2 and dI3 neurons [172]. On the other hand, Mutation of Math1, a 
transcription factor expressed in p1, abolishes the specification of dI1 neurons [173], [174],
while double mutations of Ngn1/Ngn2 affects the generation of dI2 neurons [174]. Various 
studies and lines of evidence showed that members of the BMP family, like Gdf7, pattern the 
progenitor domains in the dorsal spinal cord and specify dI1–dI3 neurons [175], [176]. While, 
Wnt1 and Wnt3a members of the Wnt family, were also implicated in the specification of dorsal 
neurons, where double mutation of Wnt1/Wnt3a caused a reduction in the generation of dI1 and 
dI3 neurons is observed [177]. In addition to this effect Wnt signals in spinal cord exert a strong 
proliferative activity on progenitors secreted it, however, it is difficult to assess to what extent 
Wnt signals are essential for patterning or proliferation of dorsal progenitors [178]. Zechner et 
al showed in his study that the expression of Olig3 is controlled by canonical Wnt signals in the 
dorsal spinal cord, where ?-catenin gain-of-function induced a massive expansion of the Olig3
expression domain and the appearance of extra dI2 and dI3 neurons. This implies that Olig3 is 
??????????????????-catenin-induced generation of supernumerary dI2 and dI3 neurons, but not 
for the enhanced growth of dorsal progenitors. Again the integration of Wnt/BMP signals 
coordinately control the expression of the transcription factor Olig3 and the specification of 
dorsal spinal cord neurons [170].
Moreover, little is known about the cellular origin and the molecular signals that regulate spinal 
cord ependymal cells. Various labs focused on this point including Xing et al who demonstrated 
and characterized the Wnt-responsive progenitor cells throughout spinal cord development. 
Also he showed that this population of cells is restricted to the dorsal midline and give rise to 
?????????????????????????????????????????????????????????? ????????????????????????????-catenin and 
inhibition of Wnt secretion in Wnt-activated ependymal cells resulted in impaired proliferation. 
??? ??? ???? ?????????? ???? ?????? ???????? ?????????? ?????? ????????? ??? ???????? ?????-catenin 
signaling activity that promotes ependymal cell proliferation. ?????-catenin signaling has been 
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also implicated in determining dorsalization of the postnatal subventricular zone and neural 
stem cell specification into oligodendrocytes and glutamatergic neurons [179]. In the report of 
Xing et al and by using genetic lineage tracing, they revealed the developmental origin of 
ependymal cells in the spinal cord. In the contrary to previous reports they pointed that 
ependymal cells are not derived exclusively of ventral origin of ependymal cells [180], rather 
they may retain positional identities in relation to their neural progenitors. In fact, the vast 
????????????????????????????????????????????????????????????????????????????????????-catenin 
signaling target gene Axin2????? ??????? ???????????????????????????????????????? ????-catenin 
??????????????????????????????????????????????????????????????????????????????? ????-catenin 
signaling regulates ependymal cell development and adult homeostasis [181].
In vertebrates, another transcription factors could be implicated in the patterns of neuronal 
differentiation set during the development of the CNS that form the basis of functional neural 
circuits in adults. For instance, PAX6 and MSX1 transcription factors (TFs) are among the first 
to be expressed in the dorsal proliferating neuronal progenitors [182]. Followed by the basic 
helix-loop-helix (bHLH) pro-neural TFs that are expressed within stripes and organized along 
the dorsoventral axis of the neural tube. There, they act as specifiers by exerting a neuronal 
identity on the cells, aligning their future location in the spine, and regulating their connections 
to their specific target [183]. Thus, the three dorsal most progenitor pools, known as dp1, dp2 
and dp3, are respectively specified by Atoh1 , Neurog1 and Neurog2, and Ascl1 [174]. The 
sharp expression profiles of these four genes is driven by the morphogenic gradients of BMP 
and Wnt proteins secreted from the RP  as well as the repressive interactions between the bHLH 
TFs [184]. Whereas the expression of Msx genes in the early stage of the neural plate, then 
during neuronal patterning and neurogenesis in the dorsal neural tube, the function of TFs Msx1,
Msx2 and Msx3 remains unclear. Later after development, Msx1 and Msx2 expression domains 
become progressively restricted to the RP, whereas Msx3 is expressed in the dorsal part of the 
spinal cord excluding the RP [185]. Later on various studies described the function of Msx 
genes by analyzing spinal cell fates within mouse embryos mutant for Msx1 and Msx2. They 
showed that these two TFs interfere essentially during dorsal spinal cord neurogenesis, and they 
are necessary for Atoh1 expression and dI1 interneuron generation. In addition, the expression 
domains of a set of TFs (Pax7, Olig3, Neurog1 and Ascl1) is mispatterened in the absence of 
Msx1 and Msx2. Whether BMP signal is maintained and the function and the expression of 
MSX is reserved in the adult spinal cord, is still an open question to be answered. All together, 
these studies showed a novel function of Msx1 and Msx2 as transcriptional activators acting 
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upstream of Atoh1, and provided new insights into the transcriptional machinery control of 
spinal cord patterning by BMP signaling [186].
4.2 Integration of SHH signaling
Understanding the mechanism of how dorsal spinal cord ependymal cells are patterned and 
specified, led the way to uncover and understand the mechanism that control the neuronal 
identities and how positioned in a defined manner within the ventral spinal cord. The mature 
characteristic features of neurons in the adult organisms are coordinately regulated and gained 
during early development [169], [187]. A set of genes are identified and known to regulate the 
expression of these features, for that the generation and specification of ventral neurons during 
development is a precise and reproducible multistep process that occur in a spatiotemporal 
manner [188], [189]. The proper functioning of these processes is mediated by the main 
extrinsic activity of the Shh protein secreted from the floor plate (figure 22A). In the ventral 
spinal cord, Shh, patterns the generation of motor neurons and certain classes of ventral 
interneurons in a concentration-dependent manner [189]. Neurons are generated progressively 
more in ventral regions of the neural tube and required correspondingly higher concentrations 
??? ???? ???? ?????? ??????????? ????????? ??? ???? ????????? ?????? ?????? ???????? ???? ????????
interneurons fail to develop [190]. In the ventral part, a set of homeodomain TFs expressed by 
neuronal progenitors respond and interpret Shh signaling. Indeed, subdivides the ventral spinal 
????? ????? ???? ??????????? ????????? ????? ??? ?????? ?????????? ?? ????????? ?????? ??? ????-mitotic 
neurons (figure 23B) [191]. Based on their mode of regulation by Shh, these homeodomain TFs 
can be categorized into class I and class II factors. Shh signaling represses the class I proteins 
(Pax7, Dbx1, Dbx2, Irx3, and Pax6), whereas the class II proteins (Nkx6.2, Nkx6.1, Olig2, 
Nkx2.2, and Nkx2.9) are enhanced by Shh signaling [192], [193].
Both in vivo and in vitro, expression of Shh can induce the differentiation of motor neurons and 
ventral interneurons, while eliminating Shh signaling blocks their differentiation. Although Shh 
can induce all ventral cell types, the generation of the dorsal-most interneurons of the ventral 
neural tube is Shh signaling independent. Instead retinoids from the paraxial mesoderm or from 
neural plate cells can induce these interneuron subtypes. So retinoid signaling seems to play a 
sequential role in spinal cord development, initially imposing the identity of spinal cord and 
later specifying the identity of some of its component neurons [187].
Shh signaling acts through the activation of Shh effectors namely, Gli transcription factors, that 
helps create a pattern of neural progenitor domains along the dorsal-ventral axis [194], [195].
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There are three Gli proteins, identified as the principal transcriptional effectors of the Hedgehog 
pathway, where Gli1 and Gli2 act as transcriptional activators, whereas Gli3 functions primarily 
as a repressor [104]. However, Gli2 can function as a repressor in the absence of Gli3, and 
conversely, Gli3 can act as an activator in the absence of Gli2. Thus, the ratio of activator and 
repressor forms of Gli proteins can control and regulate the effect of Shh signaling within the 
embryonic spinal cord.
Shh gradient is sensed by a specialized cell structures called primary cilium, that mediates Gli 
processing and activity, which in turn activates target gene expression. These ciliary structures 
are important in Shh signal transduction as their loss leads to defects similar to those caused by 
mutant Shh components. Cilia are enriched in the smoothened (Smo), a Key component of the 
Shh signaling pathway [196], [197].
Smo in cilia enhance in a way the processing of Gli into activated forms. Gli then activates 
transcriptionally some target genes, such as Patched1 (Ptch1), becomes localized to the base of 
cilia [198]. Indeed, in response to Shh signaling, Ptch1 blocks cellular responsiveness to Shh 
by inhibiting Smo-dependent activation of the Gli effectors [199]. Conversely, when Hedgehog 
proteins bind to Ptch1, it diminishes its inhibitory influence on Smo, thus enhancing the 
activator forms of Gli proteins. As a result of the Gli transcriptional activity, several key target 
genes are strongly upregulated such as FoxA2, Nkx2.2, and Olig2, which specify floorplate, V3 
interneuron, and motorneuron progenitor programs, respectively [200]. The mutual repressive 
transcription factor network limits the extent of Shh signaling, stabilize the cell fates within 
developing neural tissue, and refines dorsal-ventral domains of neural progenitor cells [201].
In conclusion, the prevailing view of molecular pathways and morphogen signaling in the 
developing spinal cord addressed that opposing concentration gradients of Shh ventrally, and 
Wnts and BMPs dorsally, are at the origin of specifying distinct cell fates along the dorsal-
ventral axis (figure 23). The system appears to be finely-tuned, since a small change in 
morphogen concentration is sufficient to alter cell fates illustrating the complexity of 
morphogen dynamics in vertebrate patterning [201], [202].
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Figure 23: Expression of transcription factors and progenitor cells specification in the spinal cord.  
(A) Schematic dorsal representation of the six progenitor cell subpopulations, p1–p6, and their 
combinatorial expression of transcription factors of the bHLH and homeodomain families [170]. (B) 
Schematic ventral representation of the six domains of progenitor cells, FP, p3, pMN, p2, p1, and p0, 
which generate V0–V3 and MN neuronal subtypes, and their combinatorial expression of transcription 
factors [203].  
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Chapter V: Spinal cord injury
Spinal cord injury is the interruption of the spinal cord tissue, particularly it is the damage of 
axons and death of neurons. So it is a massive cell death and a loss of motor function and 
sensory inputs below the injury level. SCI affects CNS intrinsic neural cells (neurons, 
astrocytes, OPCs, ependymal cells), CNS intrinsic non-neural cells (microglia, pericytes, etc.) 
and immune cells from the blood and they all respond differently to an injury (figure 24) [204].
Upon SCI, the acute phase, is characterized by the immediate damage of spinal cord, which
leads to the loss of both neurons and glial cells, including oligodendrocytes that should be 
remyelinating the surviving neurons. As a consequence, the loss of neurons leads to the 
dysfunction of the motor and sensory system. While during the sub-acute phase, microglial cells 
are activated in response to the production of free radicals, and secreted chemokines, and 
cytokines from ongoing necrotic neurons and glial cells [205]. In response to the activation, 
microglia and other inflammatory activated cells (macrophages, lymphocytes) infiltrate the 
lesion site for further inflammatory response that is accompanied by generation of free radicals 
that will kill the myelinating oligodendrocytes, thus keeping axons denuded and vulnerable, 
therefore a massive death of neurons takes place [205], [206]. Following the sub-acute phase 
of SCI, Wallerian degeneration, an ordered process of axonal death is undertaken [207]. In 
response to injury, the axonal skeleton of the nerve fiber disintegrates, and the axonal membrane 
breaks apart, causing axonal degeneration and release of myelin debris. Myelin debris has found 
??? ??? ???? ??????? ??? ???????? ?????????? ?????????? ?? ?????????? ???????????????? ???????
glycoprotein (OMgp) and myelin-associated glycoprotein (MAG) that act as axonal 
regeneration inhibitors [208]. However, the slowly infiltrating immune cells and the low myelin 
clearing capacity of oligodendrocytes cause accumulation of myelin in the CNS tissue after 
injury. This accumulated myelin in turn participates in the apoptosis of oligodendrocytes and 
further contributes to the failure of remyelination and regeneration [205], [209].
5.1 Scar formation, Niche activation, and regenerative potential
SCI is directly followed by the formation of glial scar which is the hyper-activation of 
astrogliosis that could hold both positive and negative effects on the lesion repair (figure 24). 
Normally the glial scar could lead to permanent functional defects as it could cause cell death 
and disruption of spinal cord barrier. The scar is composed of both fibrotic and glial components 
that have beneficial functions from limiting tissue damage to preventing neuron loss. Fibrotic 
component is known to be in the center of the scar and composed of blood vessel–associated 
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type A pericytes derived somatic cells [158], [210]. The fibrotic scar was believed to be 
nonfunctional or it could participate in a way to axon regeneration [204], [211]. However, it 
has been studied recently and confirmed that the absence of type-A pericytes or ependymal 
cells derived astrocytes prevents the sealing of wound and therefore worsen SCI outcomes
[211], [212]. So fibrotic scar is a key component for sealing injury where its absence cause 
tissue healing defects. On the other hand, even though it was widely believed that reactive 
astrocytes migrate to the injury site and contribute to glial scar formation, recent fate-mapping 
and live imaging studies showed that astrocytes do not migrate to the lesion site after SCI and 
most of the astrocytes are not migratory after brain injury [213]. Rather, the glial scar is the 
generation of astrocytes from the ependymal cells and NSCs of spinal cord, as well as from 
self-duplicating astrocytes and upregulate the GFAP expression [50], [101]. This reactive 
astrogliosis may attenuates axonal regrowth, but it serves as a barrier to block inflammation 
and immune cell infiltration to the lesion and prevent further tissue damage, thus enhancing 
axon growth after damage [64], [214]. The debate about whether it attenuates or enhance axonal 
growth was solved by impairing the formation of glial scar by transgenic mouse models.  This 
model blocks the cell cycle of ependymal cells generating astrocytes or kills proliferative 
astrocytes. These studies have shown that the significant loss of glial scar leads to worsened 
secondary injury to the tissue and the loss of axonal regeneration [64], [212].
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Schematic illustration of the responses in spinal cord in response to injury. 
The diagram demonstrates the initiation of hypertrophic astrocytosis, invasion of inflammatory cells, 
and neuronal Wallerian degeneration [215].  
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In the spinal cord, it was shown long time ago that the ependymal cells have a high capacity to 
react directly to spinal cord injury. So it was interesting to study the activation of the niche and 
the response of ependymocytes to an injury, knowing that these two mechanisms differed 
among species. So it is interesting to highlight the differences in the ependymal neurogenic 
niche activity in response to SCI among regenerating and non-regenerating vertebrate species. 
Zebra fish represent a good regenerative model in vertebrates to understand the molecular 
mechanisms behind spinal cord regeneration. In physiological conditions zebra fish shows low 
or rare proliferation events and neurogenesis in the niche. However spinal cord lesion showed 
a high regenerative capacity, in which lesion induced activation of the niche in which 
ependymal radial glial (ERGs) cells activated, proliferated, migrated, and dedifferentiated. 
Finally these cells will exhibit a final differentiation step and generate motor neurons that 
integrate into the circuitry and muscle tissue (figure 25) [139], [216]. These data was confirmed 
by Michel M. Reimer when he used transgenic mice that targets ERGs and motor neurons 
through Olig2 and HB9 respectively. First his study showed that zebrafish has quiescent spinal 
progenitor cells in physiological conditions, and those cells got activated after injury. So the 
lesion in the spinal cord induced proliferation of ERGs where he noticed significant increase in 
the olig2+/BrdU+ cells around the stem cell niche. Furthermore, he confirmed by 
immunofluorescence the increase in motor neurons in the lesioned spinal cord represented by 
HB9-GFP+/BrdU+ cells. Finally he confirmed by the same assay that the newly generated 
motor neurons are derived from the proliferating ERGs represented by Olig2+/HB9+ where 
those cells are only present in the lesioned spinal cord but not in the intact one. The mechanism 
of spinal cord repair took only six weeks the period where proliferation and differentiation 
returns to normal levels. So the hallmark of motor neuron regeneration and spinal cord repair 
is the plasticity of quiescent Olig2+ ERGs after SCI [217].
Further studies confirmed the activation of the niche in zebra fish that showed a regenerative 
capacity after lesion. Of these studies the one launched by Kazuhiro Ogai where they depended 
on the use of the sex determining region Y-box2 (Sox2) gene to study its function and 
contribution to SCI repair in zebra fish. In fact this came from the observation of increased 
Sox2 expression in ependymal cells in zebrafish [137]. So they assessed the function of Sox2 
following lesion, where data showed a significant up regulation of Sox2 in ependymal cells in 
response to injury. Interestingly the increased Sox2 expression preceded the proliferation of 
ependymal cells, where Sox2 knockdown caused decreased ependymal cell proliferation. 
Furthermore Sox2 up-regulation decreased GFAP reactivity around the canal an indication of 
ependymal dedifferentiation. Therefore Sox2 is one of the earliest transcription factor activated 
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in ependymal cells after SCI that act as an initiator of proliferation, and could be implicated in 
ependymal dedifferentiation [137], [218].
Figure 25: Schematic illustration of the multistep regeneration process in zebrafish spinal cord.  
Spinal cord in zebrafish undergoes regeneration through activation, bridging, and remodeling [219].  
 
The scenario of spinal cord repair differed in mammals from that of zebra fish. Although in 
mammals SCI cause permanent functional impairment, the NSCs activation or transplantation 
represent a promising tool for spinal cord repair. How the ependymal niche reacts to spinal cord 
injury?
Neural stem/progenitor cells, including ependymal cells, astrocytes, and OPCs are highly 
proliferative after SCI and display different cellular responses (Figure 26). Ependymal cells 
were found to be the only cell type displaying multipotency after SCI [50], [101]. Ependymal 
cells rarely divide around the central canal and can only generate a small number of 
neurospheres in cell culture under physiological condition. FoxJ1 (expressed in cells with 
motile cilia) and Nestin (expressed in stem/progenitor cells) are two transgenic mouse lines 
expressing tamoxifen-dependent Cre recombinase (CreER). These two lines restricted the 
expression to the cells lining the central canal, thus it allow the fate mapping of a subset of 
NSCs by targeting FoxJ1 and Nestin [50]. Using these mouse models they studied the response 
of ependymal cells to SCI. A lesion in the dorsal funiculus away from the ependymal layer, 
significantly increased the proliferation of ependymal cells. In addition to the massive 
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proliferation of recombined FoxJ1 and Nestin cells, there is a massive migration of these cells 
out of the ependymal layer. Recombined migrating cells lost FoxJ1 expression and lost their 
ependymal phenotype, instead they expressed Sox2, Sox3, Sox9, and the astrocytic marker 
GFAP. Also migrated cells where dependent from stromal cell-derived factor-1 (SDF1) and its 
major signaling receptor, CXCR4 and it is confirmed by using CXCR4-EGFP and SDF1-EGFP 
transgenic reporter mice. So the ependymal cells within the niche are activated after SCI and 
migrated due to SDF1/CXCR4 coupling which is present in these cells [220].
 
 
 
 
 
 
 
 
Figure 26: The response of endogenous cells after SCI. 
Following a dorsal funiculus lesion, ependymal cells self-renew, differentiate, and the progeny migrate 
to the lesion site to form the glial scar with astrocytes (red) and pericytes (yellow) [65].  
 
Following activation of the niche, ependymal cells contribute to glial scar formation (figure 24, 
and 26). Glial scar formation resulted from the migrating recombined cells expressing FoxJ1 
and Nestin, and restricted to the injury site. Marker analysis of the ependymal progeny at the 
lesion site revealed that the majority of cells are sox9 and vimentin positive with astrocyte like 
morphology, and they colonize the center of the scar. On the other hand, there is a small 
subpopulation of recombined nestin cells that express the GFAP astrocytic markers and those 
cells were more close to the spinal cord surface and form the boarder of the scar. These results 
indicated that, the glial scar is a heterogeneous tissue made up of two astrocyte like cell 
populations, abundant sox9+/vimentin+ ependymal derived population and a GFAP+/nestin+ 
reactive resident astrocyte population [50]. It has been published that ependymal cells derived 
astrocytes are the main source of neurotrophic factors after SCI. NSC-derived cells synthesize 
several neurotrophic factors such as ciliary neurotrophic factor (CNTF), hepatocyte growth 
factor (HGF), and insulin growth factor (IGF-1). These factors are known to play a role in 
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neuron support, and their levels increase as Foxj1 proliferate after injury. So the glial scar 
formed by NSCs or astrocyte duplication they contribute positively to the injured tissue. 
Ablation studies of astrocytes showed massive infiltration of immune cells that enlarged the 
injury volume, and increased neuronal death [64].
Another event that takes place after SCI is the generation of oligodendrocytes by ependymal 
cells (figure 26) [101]. OPCs are the dividing cells in intact spinal cord and they increase after 
injury, to generate myelinating oligodendrocytes. Ependymal cell progeny showed 
oligodendroglial like ultrastructural morphology and marker profile. Further analysis on these 
cells showed that, ependymal-derived progenitors are located in the formed glial scar, where 
few Olig2+ cells are scattered in the grey and white matter bordering the injury. The Olig2+ 
cells displayed a morphology similar to that of mature oligodendrocytes. First they showed 
expression of mature markers such as MBP, second fine process were able to enwrap 
immunoreactive axons surrounding their myelin sheath. Moreover, ependymal cells from an 
injured spinal cord generate a significantly higher number of neurospheres in vitro and can be 
passaged with higher self-renewal capacity than those from the non-injured condition. 
Differentiation assays showed that ependymal cell-derived neurospheres have higher potential 
to generate oligodendrocytes and neurons in vitro after SCI. This observation suggests that the 
stem cell potential of these neural stem cells is activated by SCI, regarding self-renewal and 
differentiation [120].
Furthermore, the inflammatory system is a potential regulator of ependymal cell responses to 
SCI. lesion to spinal cord will trigger resident NSCs to secrete proinflammatory signals that are 
maintained by activated immune cells and enhance the release of pro- and anti-inflammatory 
cytokines [221]. Microglial activation is associated with morphological changes and alteration 
in cytokine expression. Furthermore, lymphocytes are rapidly recruited to the lesion site by the 
activated and circulating neutrophils and monocytes-derived macrophages [222], [223]. After 
one weak of injury only macrophages and lymphocytes are present, and like astrocytes 
macrophages and microglia have dual effect, a protective beneficial role (protect and activate 
OPC proliferation) and a negative toxic role (induce cytotoxicity and demyelination) [224].
Early postinjury microglia and macrophages release Proinflammatory cytokines, such as tumor 
necrosis factor-a (TNFa), interleukin (IL) 1b, and IL-6. These factors are responsible for 
secondary tissue damage, modulating axonal remyelination, and stimulating astrogliosis. These 
changes are accompanied by the induction of adhesion molecules expression and the production 
of chemotactic factors, such as IL-8, monocyte chemotactic protein (MCP)-1, and macrophage 
inhibitory protein (MIP)-1a [225]. Studies on selective depletion of monocyte-derived 
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macrophages showed improved recovery of function, protected myelination, and stimulated 
sprouting and regeneration of axons following SCI [226].
On the other hand, neuroprotective molecules such as transforming growth factor (TGF)-b, and 
NT-3 are secreted by microglia/macrophages. The autocrine effect of TGF-b will inhibit 
microglia activation that blocks proinflammatory cytokine and reactive oxygen intermediate 
production, and together with BDNF and NT-3 they promote neuronal survival. The double 
function of microglial/macrophage population could be due to the existence of at least two 
subpopulations, M1 and M2, showing neurotoxic and proregenerative properties, respectively 
[227]. Shifting the polarization of these cells towards the M2 phenotype is a promising area of 
investigation [224]. It is unknown whether endogenous neural stem cells could be enhanced by 
modulating the levels of inflammation associated cells and their released factors after CNS 
injury.
To summarize up the similarities and differences between regenerating and non-regenerating 
species, first cells in the EZ of both species differ morphologically but they express 
transcription factors related to « stemness », such as Sox2. Second, the neuronal lineages of 
progenitor cells are fully expressed in zebrafish, while in mammals this potential is restricted 
by environmental factors. Third, EZ cells in both species massively proliferate in response to 
lesion signals after injury, where EZ cells are pushed out of their quiescence to start 
proliferating. Therefore, both species could share similar lesion induced intracellular 
mechanisms. However, differences in the activity levels of Notch and hedgehog could explain 
the difference in the net outcomes in terms of gliogenesis versus neurogenesis. Finally, these 
findings suggest that ependymal cells act as a scaffold to reinforce the injured spinal cord by 
restricting secondary enlargement of lesions [64], [117].
Even though neural cells intensively respond to SCI with their specific potential, the self-
recovery potential of the spinal cord after injury seems to decline during aging [228], [229]. It 
was reported that neural stem cell’s potential decreases during aging after traumatic brain injury 
due to the quiescence but not the loss of neural stem cells, and also due to the change of their 
differentiation potential [230]. Indeed, astrocytes and ependymal cells significantly change 
their morphology and molecular signatures during brain aging, and their proliferation capacity 
decreases over time [231]. After SCI, markers of astroglial and inflammatory increase near and 
at the lesion site in the aged animals, and the mammalian CNS undergoes an age-dependent 
decline in axonal regeneration and becomes less regenerative [232].
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Besides the changes in the microenvironment, the intrinsic regenerative potential of 
stem/progenitor cells is also age-dependent. At early age (P10), the spinal cord stem cell 
potential is entirely represented by ependymal cells, where their self-renewal capacity, and their 
differentiation capacity to oligodendrocytes significantly decreases at the juvenile stage and 
even more in adulthood in mice in both physiological and injured conditions (Figure 21, 27).
Similarly, the recruitment and differentiation capability of OPCs in aged animals decline over 
time. These findings suggest that the decreased self-recovery capacity with increased aging is 
partly due to the decreased endogenous recruitment and remyelination potential by ependymal 
cells and APCs [156].
At early age, astrocytes, ependymal cells and type A pericytes are highly proliferative and pro-
regenerative compared to adult stage, where these cells rapidly proliferate and contribute to the 
scar formation in both juvenile and adulthood in response to injury. However, following a SCI, 
juvenile ependymal cells are highly activated in vitro, showing greater self-renewal capacity 
and more oligodendrocyte differentiation, and higher sealing efficiency compared to adult cells 
[101], [233]. In comparison to adult lesions, juvenile lesions have a smaller fibrotic core and 
smaller glial scar, as well as less infiltration of microglia and blood-derived macrophages 
(Figure 27). Interestingly, even though ependymal cells have a higher stem cell potential in 
juvenile mice, their contribution to scar formation is lesion-severity dependent. They act as a 
backup reserve unless the lesion is large and more cells are need to be sealed [156]. Although 
ependymal cells are required for restricting enlargement of the lesion in adult [233], the same 
transgenic mouse model in which the cell cycle of ependymal cells is blocked showed a 
different phenotype in juvenile animals. Thus in the juvenile spinal cord other cell types could 
contribute to lesion sealing, while blocking ependymal cell proliferation does not lead to deeper 
lesions [156]. This suggest that the area of glial scar and the lesion core are also smaller even 
when ependymal cells are not able to proliferate. These data is in line with the clinical studies 
that have shown that juveniles have better functional recovery than adults in human [228].  
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Figure 27: Ependymal cells and resident cells respond to SCI. 
Under both physiological and injured conditions, ependymal cells show different self-renewal and 
differentiation capacity in juvenile mice compared to adult mice in vitro, and that the response is age-
and lesion size-dependent in vivo [156].  
 
5.2 Regenerative approaches
Deciphering the various scenarios occurring in the niche after a SCI, paved the way to better 
find a promising therapeutic potential for enhancing functional recovery. Regenerative 
strategies are many and could target several aspects in injury vicinity, it could be by (1) cellular 
replacement through transplantation, (2) modulating the injury microenvironment, or (3) 
modulating the injury response from endogenous cells.
1-Although there are a number of challenges for clinical applications, cell transplantation-based 
therapies have given some promising results for patients with SCI. Studies have focused on 
cellular replacement by transplanting NSCs to derive functional recovery after SCI as it caused 
massive loss and reduction in neurons and oligodendrocytes [234]. One of the most commonly 
used cell types for transplantation in SCI studies is MSCs that could be derived from bone 
marrow, umbilical cord, amniotic liquid and adipose tissue. Cellular damages by SCI can be 
reduced as a result of MSC transplantation, partly due to the secretion of trophic factors by 
MSCs, including vascular endothelial growth factor (VEGF), nerve growth factor (NGF), 
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GDNF and BDNF [235]. The clinical score of American Spinal Injury Association, 
electromyography and magnetic resonance imaging in clinical trials have shown that SCI 
patients after MSC transplantations gain motor and sensory improvements [236], [237].
Embryonic stem cells (ESCs) are good candidate as it could compensate for the massive cell 
loss after SCI. ESCs can be obtained from embryonic tissues or clonally derived from ESC 
cultures. Animal studies showed that transplanted ESCs (figure 11) can differentiate into 
neurons [238] or oligodendrocytes [239] in SCI models, and promote significant motor 
functional recovery. Another group used a combination therapy of ESCs transplantation 
combined with docosahexanoic acid (DHA) treatment in the brain. In their study they indicated 
that NSCs transplantation into the injured cortex and DHA supplementation are promising 
therapies to treat TBI. The injected cells migrated to the injured area as well as to other brain 
regions implicated in motor activity. Furthermore, they demonstrated their effect on enhancing 
neurogenesis that is necessary for injury repair as well as motor recovery [66]. Recently, a new 
protocol showed that transplanting human ESC-derived neural stem cells into rats with SCI 
improved significantly the functional recovery as they differentiate into diverse neuronal and 
glial fates in vitro [240]. Despite the significant efficacy of ESC transplantation in preclinical 
studies, the ethical concerns with the uncontrollable side effect of teratoma formation limits 
the potential clinical applications of ESCs [241].
Although ependymal cells have a potential to generate neurons in culture, but are incapable of 
to do so after SCI, rather they generate astrocytes and oligodendrocytes. This is due to the fact 
that, the spinal cord environment favors gliogenesis over neurogenesis, thus pushing 
transplanted NSCs toward the gliogenic fate [50], [101]. However, when same cells are 
transplanted in the hippocampus neurogenic niche they differentiate into neurons [102]. Even 
though engineering NSCs to express pro-neural gene Neurogenin2 (Ngn2) generated glial cells 
after transplantation [242], thus the spinal cord environment is selective and highly restrictive 
for neurogenesis and neuron survival. However, Lu and colleagues, reported an increased 
neuronal differentiation, axonal growth and connectivity in the grafts and improved functional 
recovery by embedding NSCs transplants in fibrin matrices containing a cocktail of growth 
factors including BDNF, IGF-1, HGF, EGF and bFGF [67]. Although this study showed 
impressive data but it could be due to the administration of growth factors in the fibrin matrices.  
After what have been reported regarding the gliogenic nature of the adult spinal cord, it might 
be more interesting to modulate or enhance the generation of non-neuronal cells than to replace 
dying neurons to promote functional recovery. 
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Autologous glial cells specifically, olfactory ensheathing cells (OECs) transplantation also 
leads to improved outcomes after SCI. OECs which are located in the olfactory system can 
support and guide axonal growth from the peripheral nervous system to the CNS during 
development, as well as support adult neurogenesis or axonal regeneration. Therefore, OECs 
secrete many neurotrophic factors, such as BDNF, GDNF, VEGF, NT-3, etc. [243], thus they 
promote axonal regeneration, neuroprotective effects and functional recovery after being 
transplanted into the injured spinal cord [244]. As OECs are highly differentiated cells in 
comparison to ESCs, OEC transplantation upon SCI overcomes the risk of teretoma formation 
[245]. Interestingly, some studies showed the effect of olfactory bulb-OECs (bOECs) on 
ependymal cells using FoxJ1-CreERT2-YFP mouse. Transplantation of bOECs after SCI can 
enhance proliferation of ependymal cells in vivo and self-renewal capacity in vitro. 
Furthermore, bOECs trigger ependymal cells to differentiate into astrocytes, reduce the 
expression of axonal regrowth inhibitors, such as CSPGs and Neurocan, and promote adult 
neurogenesis after SCI. All together suggest that bOEC transplantation stimulates endogenous 
stem/progenitor cells, leading to beneficial effects on recovery of the injured spinal cord [246], 
[247]. The main strategies using cell transplantation therapies upon SCI are summarized in 
(figure 28 below).
2- Although cell transplantation has benefits on functional recovery, but this could be due to 
the modulation of the spinal cord microenvironment. Cell transplantation could replace lost 
cells and promote axonal regeneration through bridging the scar. This could not be due to the 
transplanted cells themselves, but rather due to the fact that, the environment is modulated in a 
beneficial way by the transplanted cells. For example transplanted mesenchymal cells secrete 
various factors such as BDNF, NGF, and VEGF that promotes axonal growth and survival 
where no cell replacement is observed [249]. The same functional recovery was observed after 
fibroblast transplantation or neurotrophic factors administration [250].  The administration of 
factors is known to increase sprouting, axonal growth, neuronal and/or oligodendrocyte 
survival, as well as it enhance proliferation of ependymal cells [250], [251].
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Figure 28: Schematic illustration of the main stem cell based transplantation. 
(A) The cartoon illustrates the overview of transplanted stem cells in injured spinal cord. (B) The cartoon 
illustrates a detailed view of transplanted stem cells inside the injured spinal cord showing the detailed 
interplay driving anti-inflammatory and proregenerative processes on neuronal cytoarchitecture in SCI
[248].  
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3- Modulating the injury response from endogenous cells is triggered by three ways. First, 
modulation of the astrocytic contribution to the glial scar. It appears that the astrocyte 
population contains two subtypes a growth-promoting and a growth-inhibiting ones [233], 
[252]. Reactive astrocytes prevent axon growth and limit the regeneration due to the expression 
of inhibitory factors, such as chondroitin sulfate proteoglycans [253], [254]. In contrast to this, 
several studies demonstrated the beneficial effects of the glial scar in tissue repair [204], [212].
Faulkner and colleagues showed that, by eliminating reactive astrocytes, the massive infiltration 
of inflammatory cells, thus a larger lesion volume and increased neuronal loss [253], [254].
Other studies showed that deleting the protein suppressor of cytokine signaling 3 (Socs3) in 
Nestin-positive cells (including ependymal cells) enhanced astrocyte reactivity, migration, scar 
formation, and functional recovery [255], [256]. Indeed, recent studies showed that spinal cord 
astrocytes are very phenotypically and functionally heterogeneous in the CNS and after SCI 
[213]. Blocking the subtype of astrocytes derived from ependymal cells after SCI for instance, 
leads to a more severe lesion and worsen functional recovery [233]. Combined together, these 
data report that the scar formation inhibits inflammatory response thus induce functional 
recovery.
Second, ependymal cells respond to injury by enhancing the differentiation of 
oligodenndrocytes, since oligodendrogenesis can enhance functional recovery [65], [233].
Following an injury, a zone of unrepaired demyelination appears, in this manner both OPCs 
and ependymal cells can generate oligodendrocytes in response to injury. Ependymal-derived 
oligodendrocytes represent 3% of the total ependymal progeny [101]. The low percentage of
ependymal-derived oligodendrocytes is due to the massive secretion of astrocytes-promoting 
factors such as IL-6 related cytokines and BMPs. Supporting the idea of stimulating 
oligodendrocyte generation from spinal cord ependymal cells, neurospheres overexpressing 
neurogenin-2 are more capable of generating oligodendrocytes, enhance myelination, and 
enhanced motor and sensory functional recovery when transplanted into injured spinal cord 
[242]. So from a clinical point of view, it is interesting to induce oligodendrocytes production 
from endogenous ependymal cells. This will be a strategy to avoid invasive cell transplantation 
and enhance immunosuppression. However it is not known if this strategy can overcome the 
effect of astrocytes-promoting environment.
Third, modulating injury response from endogenous cells through enhancing neuronal 
differentiation is one of the strategies that could be used. The major cause of functional deficits 
after an injury is the loss of neurons. So providing neuronal substrate could stimulate 
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neurogenesis and integration of neurons into the circuitry and could promote functional 
recovery through electrical signals that bridge the lesioned area [257].
Over the past years several trial were taken into consideration to overcome the challenges 
behind treating SCI by endogenous NSCs. So in this manner studies have proposed two novel 
functions of ependymal cells that are latent NSCs in the spinal cord. First, they have a 
scaffolding function by preventing the enlargement of the injured area by restricting the 
secondary injury after the initial damage. Second, ependymal cells supply neurons with the 
necessary neurotrophic factors to prevent them from dying in the spinal cord toxic environment. 
Also it has been proven that glial scar contributes positively into the SCI, where they identified 
the mechanisms that could be targeted to modulate responses to injury and enhance recovery
[65], [212], [233].
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A key question one could ask, why mammalian spinal cord do not regenerate? And why 
evidence of neurogenesis is still abscent? To answer those questions it is interesting first to 
understand the mammalian spinal cord environment particularly the endougenous stem cell 
niche environment that is the source of repair in regenerative species. However the various cell 
types that reside in the niche are not yet well identified in both mouse and human. Moreover 
the signaling pathways that regulate the quiescence and activation of the niche are ill defined, 
and whether these pathways are involved in spinal cord patterning during development are 
regulating the nich in the adult. To have a clear view on the differences illustrated in the 
introduction about regenerative and non-regenerative species and to understand the difference 
between mouse and human spinal cord niche, a comparative analysis is needed to unravel the 
differences, finally it is interesting to mimic the regenerative models by stimulating the stem 
cell niche and look for regenerative evidences. The goal of this thesis is to study deeply the 
genetic signature of the human and mouse spinal cord stem cell niche in intact and injured 
spinal cord. Also trying to generate a new stem cell niche model representing all cell types that 
resides in the niche and their characteristics. Interestingly, to identify the transcription factors 
expressed by the cells and the molecular pathways that regulate them. The specific aims are:
? To unravel the genetic signature of the central canal niche in intact and injured spinal 
cord;
? To identify the subtypes of cells residing in the canal and their response to spinal cord 
injury;
? To characterize the identity of peri-neuronal cells in the spinal cord.
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Part I
  
The spinal cord central canal: A diverse regionalized stem cell 
niche
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Adult human and mouse spinal cord ependymal region 
maintain an embryonic-like dorsal-ventral regionalization 
with dorsal Msx1+ neural stem cells 
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SUMMARY
Anamniotes, rodents, and young humans maintain neural stem cells in the ependymal zone (EZ) around the central canal of the spinal
cord, representing a possible endogenous source for repair in mammalian lesions. Cell diversity and genes specific for this region are ill
defined. A cellular and molecular resource is provided here for the mouse and human EZ based on RNA profiling, immunostaining, and
fluorescent transgenic mice. This uncovered the conserved expression of 1,200 genes including 120 transcription factors. Unexpectedly
the EZmaintains an embryonic-like dorsal-ventral pattern of expressionof spinal cord developmental transcription factors (ARX, FOXA2,
MSX1, and PAX6). Inmice, dorsal and ventral EZ cells expressVegfr3 and are derived from the embryonic roof and floor plates. The dorsal
EZ expresses a high level of Bmp6 and Gdf10 genes and harbors a subpopulation of radial quiescent cells expressing MSX1 and ID4 tran-
scription factors.
INTRODUCTION
The adult central nervous system maintains neural stem
cells in specific areas called niches (Gage and Temple,
2013). The main stem cell pools are in the subventricular
zone (SVZ) and in the hippocampus. A third stem cell niche
is found in the adult spinal cord around the central canal in
anamniotes, rodents, and humans (Becker et al., 2018;
Marichal et al., 2017; Stenudd et al., 2015). This niche orig-
inates from the embryonic neuroepithelium and forms the
spinal cord ependymal zone (EZ) organized as a pseudo-
epithelium. As in the brain, this stem cell niche is highly
organized and contains stem and non-stem cells. Four
different cell types, namely ependymocytes, cerebrospi-
nal-fluid-contacting neurons (CSF-N), vessels, and long
radial cells have been described in mice. In particular, the
EZ presents a dorsal-ventral regionalization with long
radial glial fibrillary acidic protein (GFAP)+ cells in the dor-
sal part (Sabourin et al., 2009). In contrast to brain, spinal
cord ependymal cells slowly proliferate to self-renew (Al-
faro-Cervello et al., 2012; Pfenninger et al., 2011). In cul-
tures, a fraction of these cells can also generate passageable
neurospheres (i.e. clonal expansion of neural precursor
cells) which can generate astrocytes, oligodendrocytes,
and neurons after differentiation (Weiss et al., 1996). The
identity of these neurosphere-forming cells in the EZ is still
not completely clear as both GFAP+ and GFAP! ependymal
cells can behave as neural stem cells in vitro (Barnabe´-
Heider et al., 2010; Fiorelli et al., 2013; Sabourin et al.,
2009; Xu et al., 2017). Recent single cell analysis has iden-
tified neurogenesis in the adult spinal cord (Habib et al.,
2016); however, whether these new neurons are derived
from the EZ is not yet established. It has been known since
1962 (Adrian andWalker, 1962) that the EZ can readily acti-
vate and produce new cells upon injury (Becker et al.,
2018). Depending on the lesion type and severity, EZ-
derived cells can significantly contribute to the glial scar
formation (Ren et al., 2017; Stenudd et al., 2015).
In comparisonwith the brain niches, less is known about
the adult spinal cord EZ. Reminiscent of the mouse niche,
in human, ependymal cells around the central canal
display immature features such as expression of NES (nes-
tin), VIM (vimentin), and SOX2 (Becker et al., 2018). How-
ever, with aging the central lumen can disappear and the
EZ is disorganized (Garcia-Ovejero et al., 2015). Multipo-
tent neurospheres with a limited proliferation ability
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have been derived from the human spinal cord (Dromard
et al., 2008) and using alternative culture conditions,
Mothe et al. (2011) were able to maintain a sustained pro-
liferation of multipotent human-derived neural stem cells.
A detailed transcriptomic profiling of the human and
mouse EZ is currently lacking. This would help us to under-
stand the specificity and diversity of these cells as well as
identify gene expressions and molecular pathways
conserved between primates and rodents. It would also
provide important insights into why, in contrast to anam-
niotes, mammalian ependymal cells cannot regenerate
neurons after spinal cord injury (Becker et al., 2018).
Here we provide a cellular andmolecular resource for the
mouse and human EZ based on RNA profiling, immuno-
staining, and fluorescent transgenic mice. This uncovered
the conserved expression of 1,200 genes specifically ex-
pressed in the EZ, including 120 transcription factors
(TFs). Unexpectedly, the EZ maintains an embryonic-like
dorsal-ventral pattern of expression of spinal cord develop-
mental TFs. New subpopulations of cells expressing specific
genes were identified in the dorsal and ventral part of the
EZ. In mice, dorsal ependymal cells were found to be
derived from the embryonic spinal cord roof plate.
RESULTS
Genes Enriched in the Adult Human and Mouse EZ
An epithelial organization of the EZ is observed both in hu-
man and mouse as evidenced by CTNNB1 (b-catenin) and
CD24 stainings (Figures 2 and 3). To identify gene expres-
sion enriched in the EZ, we microdissected this region
and adjacent tissue in two human samples and four mice
(Figure 1A). For human, we selected two samples with a
lumen from patients aged 17 and 46 years. Microarrays
were used for RNA profiling and heatmaps indicated
adequate clustering of EZ samples (Figure 1B). Volcano
plots showed 8,733 and 2,122 genes enriched (fold
change R2) in the mouse and human EZ, respectively,
and 1,223 genes commonly enriched in both species (Fig-
ures 1C and 1D). Table 1 shows the top 15 genes commonly
enriched in the human and mouse EZ and genes that are
more specifically enriched in human or mice. Figure S1A
shows examples of identified genes whose specific expres-
sion in the mouse EZ is confirmed in the Allen brain atlas
(Lein et al., 2007). In mouse and human, GO (Gene
Ontology) and KEGG (Kyoto Encyclopedia of Genes and
Genomes) pathway analyses revealed an enrichment for
genes involved in cilia formation, smoothened and hippo
pathways, cell division, and transcription (Figure 1E and
Tables S1, S2, and S3). In addition, consistent with their
position at the interface between CSF and the nervous
parenchyma, ependymal cells also expressed 129 and 34
members of the solute carrier family in mice and human,
respectively (Tables S1, S2, and S3). Some of them are
very specifically (fold change >30) expressed in the mouse
EZ such as Slc26A3, Slc14a1, and Slc16a12, which transport
chloride, urea, and monocarboxylic acid, respectively. Un-
expectedly, Cftr, a chloride transporter responsible for
cystic fibrosis, was found to be specifically expressed in
the EZ in both species (Table 1). Using a single cell tran-
scriptome approach in the mouse spinal cord, two recent
studies (Rosenberg et al., 2018; Zeisel et al., 2018) provided
a limited number of genes (<50) enriched in spinal cord
ependymal cells and CSF-N, and most of them were identi-
fied in our study (Table S4). Interestingly, only Tmem212, a
gene coding for a transmembrane protein with few annota-
tions, was identified in the three studies (including ours) as
being enriched in the ependymal cells. With regard to
CSF-N, Espn (Espin) and Pkd2l1 were identified in the three
studies (Table S4).
We and others have reported that the dorsal and ventral
parts of the mouse EZ have distinctive features such as the
presence of radial cells expressing NES protein (Alfaro-Cer-
vello et al., 2012; Becker et al., 2018; Hamilton et al.,
2009) and the preferential expression of the TF ZEB1 in
the dorsal part (Sabourin et al., 2009). Further exploration
of regional gene expression was done by microdissecting
the dorsal, lateral, and ventral parts of the mouse EZ (Fig-
ure 1F, n = 4 mice). Only few regionally-expressed
genes were identified (Figure 1G and Table S5). In the
ventral part, we found a strong expression of three genes
Figure 1. RNA Profiles of the Mouse and Human EZ
(A) Aspect of EZ in the mouse (mEZ, thoraco level) and human samples (hEZ1 and hEZ2, thoracolumbar level). A lumen was present in mice
and in the two human (aged 17 and 46 years) samples. Microdissected EZ and peri EZ regions are delimited with dotted circles. Scale
bars, 100 mm.
(B) Heatmap of hierarchical clustering of genes expressed in EZ and peri EZ (pEZ) regions in the four mouse and two human samples.
(C) Volcano plots of genes whose expression is enriched in the mouse and human EZ (fold changeR2).
(D) Venn diagram of genes enriched in the mouse and human EZ.
(E) Genes enriched for ciliogenesis, smoothened pathway (Smo.), division, and transcription factors in the mouse and human EZ.
Expression of genes in red was subsequently confirmed at the protein level (Figures 2 and 3).
(F) Microdissected subregions of the mouse EZ.
(G) Genes enriched (top 9) in the ventral and dorsal EZ (full lists are in Table S5).
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Table 1. Three Lists of Genes (Top 15) Enriched in Mouse, Human, and Mouse and Human EZ
Top 15 Human EZ-Specific Genes Top 15 Mouse EZ-Specific Genes
Gene Description
hEZ
(log2)
Peri hEZ
(log2)
Fold
Change p Value Gene Description
mEZ
(log2)
Peri mEZ
(log2)
Fold
Change p Value
C7orf57 chromosome 7 open
reading frame 57
10.9 4.9 61.8 0.0013 Rsph4a radial spoke head 4
homolog A
10.9 3.8 133.1 2.32 3 10!13
VWA3B von Willebrand factor
A domain-containing 3B
11.4 5.7 52.8 7.43 3 10!5 1500015O10Rik RIKEN cDNA
1500015O10 gene
11.1 4.0 132.7 1.38 3 10!12
NEK5 NIMA-related kinase 5 11.1 5.5 47.9 6.43 3 10!5 Stoml3 stomatin (Epb7.2)-like 3 10.4 3.5 121.7 8.47 3 10!13
CD36 CD36 molecule 10.5 5.0 45.8 3.50 3 10!5 1700007K13Rik RIKEN cDNA
1700007K13 gene
11.1 4.2 120.3 2.66 3 10!11
EFHB EF-hand domain family,
member B
11.2 5.7 44.0 0.0004 Slc26a3 solute carrier family
26, member 3
11.2 4.4 110.5 2.05 3 10!12
MYLK3 myosin light-chain kinase 3 11.4 6.0 42.6 0.0044 Tnnc2 troponin C2, fast 10.1 3.4 105.2 8.39 3 10!5
CCDC39 coiled-coil domain-
containing 39
10.0 4.6 42.4 0.0001 2810047C21Rik1 RIKEN cDNA
2810047C21
9.8 3.2 103.2 4.85 3 10!11
ODF3B outer dense fiber of
sperm tails 3B
9.9 4.5 41.5 0.0008 Chil3; Chil4 chitinase-like 3;
chitinase-like 4
11.5 4.8 102.2 4.87 3 10!5
ZBBX zinc finger, B-box domain-
containing
10.6 5.3 41.3 2.38 3 10!5 C1qtnf3 C1q and tumor necrosis
factor related protein 3
10.7 4.1 97.9 1.63 3 10!11
CCDC114 coiled-coil domain-
containing 114
11.3 6.0 40.3 0.0005 Cfap161 cilia- and flagella-
associated protein 161
10.5 3.9 95.3 5.65 3 10!13
FAM216B family with sequence
similarity 216, member B
9.9 4.5 39.8 0.0012 Fam183b family with sequence
similarity 183, member B
11.5 4.9 91.8 1.06 3 10!11
CFAP43 cilia- and flagella-
associated protein 43
11.3 6.0 39.1 0.0003 Gm11992 predicted gene 11.992 9.8 3.3 91.6 7.02 3 10!13
FMO3 flavin-containing
monooxygenase 3
9.9 4.6 38.9 0.0014 Iqca IQ motif containing with
AAA domain
11.0 4.5 90.4 1.12 3 10!10
(Continued on next page)
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Table 1. Continued
Top 15 Human EZ-Specific Genes Top 15 Mouse EZ-Specific Genes
Gene Description
hEZ
(log2)
Peri hEZ
(log2)
Fold
Change p Value Gene Description
mEZ
(log2)
Peri mEZ
(log2)
Fold
Change p Value
CFAP70 cilia- and flagella-
associated protein 70
11.3 6.0 38.5 0.0023 Capsl calcyphosin-like 9.6 3.1 87.3 5.95 3 10!12
SPATA17 spermatogenesis-
associated 17
10.3 5.1 37.1 0.0003 Acta1 actin, alpha 1, skeletal
muscle
10.7 4.2 85.5 0.0002
TOP15 Human and mouse EZ-specific genes
Gene Description hEZ (log2) peri hEZ (log2) Fold Change p Value mEZ (log2) peri mEZ (log2) Fold Change p Value
CCDC39 coiled-coil domain containing 39 10.0 4.6 42.4 0.0001 9.6 3.5 68.5 9.13 3 10!12
ODF3B outer dense fiber of sperm tails 3B 9.9 4.5 41.5 0.0008 10.5 4.4 68.7 1.01 3 10!10
RSPH4A radial spoke head 4 homolog A
(Chlamydomonas)
9.8 4.9 30.0 0.0004 10.9 3.8 133.1 2.32 3 10!13
ARMC4 armadillo repeat containing 4 10.3 5.1 36.7 3.27 3 10!5 9.9 4.1 58.9 9.43 3 10!12
CAPSL calcyphosine-like 11.3 6.4 31.0 0.0001 9.6 3.1 87.3 5.95 3 10!12
MNS1 meiosis-specific nuclear structural 1 11.0 6.1 30.7 0.0014 10.4 4.2 72.3 3.96 3 10!13
DYNLRB2 dynein, light chain, roadblock-type 2 11.2 6.2 30.6 0.0007 11.3 5.1 72.4 1.63 3 10!12
TTC29 tetratricopeptide repeat domain 29 9.7 4.9 28.4 6.06 3 10!5 9.5 3.4 67.9 8.98 3 10!13
TEKT1 tektin 1 9.8 5.0 27.3 0.0004 10.1 4.1 64.7 2.59 3 10!11
WDR63 WD repeat domain 63 10.0 5.3 26.3 0.0005 9.6 3.5 66.4 2.21 3 10!12
ARMC3 armadillo repeat containing 3 9.7 5.0 26.0 0.0002 9.1 2.9 73.2 4.72 3 10!11
ZMYND10 zinc finger, MYND-type containing 10 9.0 4.5 23.5 0.0002 9.8 3.8 62.8 5.05 3 10!12
STOML3 stomatin (EPB72)-like 3 9.3 4.8 23.4 7.92 3 10!5 10.4 3.5 121.7 8.47 3 10!13
SPEF2 sperm flagellar 2 9.3 4.8 22.0 1.46 3 10!5 7.2 3.2 15.6 2.52 3 10!9
CFAP52 cilia and flagella associated protein 52 12.0 7.6 21.3 0.0013 10.6 4.3 81.3 1.07 3 10!11
Top 15 Human and Mouse EZ Transcription Factors
Gene Description hEZ (log2) Peri hEZ (log2) Fold Change p Value mEZ (log2) Peri mEZ (log2) Fold Change p Value
ARX aristaless-related homeobox 8.6 4.6 16.4 0.0012 6.7 3.3 10.6 2.15 3 10!9
RFX2 regulatory factor X, 2 9.6 5.6 16.2 0.0018 7.6 3.5 17.3 5.10 3 10!8
(Continued on next page)
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Table 1. Continued
Top 15 Human and Mouse EZ Transcription Factors
Gene Description hEZ (log2) Peri hEZ (log2) Fold Change p Value mEZ (log2) Peri mEZ (log2) Fold Change p Value
SOX6 SRY box 6 10.4 8.3 4.5 0.0016 9 5.3 13.1 1.84 3 10!8
PAX6 paired box 6 9.7 7.5 4.5 0.0385 7.6 3.8 13.6 4.18 3 10!10
NFIB nuclear factor I/B 9.4 7.2 4.4 0.0582 9.3 5.7 12.8 1.18 3 10!8
ID4 inhibitor of DNA binding 4 11.6 9.5 4.4 0.0724 11.8 8.5 10.1 2.79 3 10!8
MYB v-myb avian myeloblastosis viral
oncogene homolog
6.4 4.3 4.3 0.0001 10.2 4.4 59 1.48 3 10!11
NR4A3 nuclear receptor subfamily 4,
member 3
6.3 4.3 4 0.0037 11.2 5.7 45.6 1.02 3 10!11
REST RE1-silencing transcription factor 9.1 7.2 3.8 0.0032 7.1 4.1 8 2.53 3 10!9
KDM3A lysine (K)-specific demethylase 3A 8.3 6.5 3.6 0.0262 8.9 5.8 8.9 1.86 3 10!9
SOX2 SRY box 2 12.5 10.7 3.5 0.0301 12.1 9.2 7.3 3.92 3 10!8
SOX9 SRY box 9 11.5 9.8 3.4 0.0255 9 4.4 24.2 2.16 3 10!10
NR2F1 nuclear receptor subfamily 2,
member 1
11.4 9.7 3.3 0.0165 11 7.8 8.9 1.46 3 10!9
SALL1 spalt-like transcription factor 1 11.5 9.9 3.1 0.0278 9.9 4.6 38 2.76 3 10!10
RFX3 regulatory factor X, 3 5.4 3.8 2.9 0.0031 9.2 5.2 16.5 1.01 3 10!9
Top 15 Human and Mouse EZ Transport-related genes
Gene Description hEZ (log2) Peri hEZ (log2) Fold Change p Value mEZ (log2) Peri mEZ (log2) Fold Change p Value
CFTR cystic fibrosis transmembrane
conductance regulator
9.5 5.1 21.2 3.86 3 10!6 8.5 3.4 34.8 6.82 3 10!11
SLC44A1 solute carrier family 44, member 1 9.5 7.3 4.5 0.0082 8.9 6.5 5.3 2.58 3 10!8
OCA2 oculocutaneous albinism II 8.2 6.2 4.1 0.0026 6.2 4.0 4.6 6.24 3 10!6
SLC15A2 solute carrier family 15, member 2 8.2 6.3 3.8 0.0069 7.5 4.7 7.1 0.0003
SLC38A6 solute carrier family 38, member 6 7.5 5.6 3.6 0.0842 7.0 5.5 3.0 5.09 3 10!5
SLC40A1 solute carrier family 40, member 1 10.2 8.6 3.1 0.0473 7.2 5.8 2.7 0.0083
LRP6 low-density lipoprotein receptor-
related protein 6
10 8.4 3 0.0099 7.7 6.4 2.4 0.0016
FOLR1 folate receptor 1 (adult) 6.6 5.1 2.9 0.0164 9.0 4.3 25.0 4.04 3 10!11
(Continued on next page)
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(Arx, Foxa1, Sulf1) involved in SHH signaling, a pathway
known to be crucial for ventral specification of spinal
cord during development. The proteoglycan Decorin
(Dcn) was also expressed in the ventral part, a gene posi-
tively regulated by SHH signaling (Ingram et al., 2008).
To identify the cellular origin of Dcn, we performed dou-
ble immunofluorescence (IF) for DCN and PKD2L1, a spe-
cific marker for CSF-N (Becker et al., 2018) (Figure S2).
Indeed, co-localization indicated that these neurons ex-
press a high level of DCN, a result supported by recent
single cell RNA-sequencing (RNA-seq) databases (Zeisel
et al., 2018) (Figure S5A). Contrasting with ventral SHH
signaling, a robust expression of two bone morphogenetic
protein (BMP) morphogens (namely Bmp6 and Gdf10/
Bmp3b) involved in the dorsal patterning of the devel-
oping spinal cord (Wilson and Maden, 2005) were de-
tected in the dorsal EZ (Figure 1G and Table S5). Two
genes, Prokr2 and Thbs2, modulating neural stem cell
fate in the SVZ (Benner et al., 2013; Prosser et al., 2007),
were also enriched in the dorsal part. The dorsal or ventral
expression of Arx, Bmp6, Dcn, Foxa1, Gdf10, Prokr2, Sulf1,
and Thbs2 in the EZ was confirmed in the Allen brain atlas
(Figure S3A).
The Mouse and Human EZ Show a Conserved Dorsal-
Ventral Regionalization of Transcription Factor
Expression
One hundred twenty-one TFs were found more specif-
ically-expressed (fold change EZ/periEZ R 2) in the hu-
man and mouse EZ (Figure 1E). Examples of expression
in the Allen brain atlas are illustrated in Figure S1B. IF
confirmed the presence of corresponding proteins for
some of them (ARX, FOXJ1, ID4, MEIS2, MSX1, NFIA,
PAX6, PBX1, SOX4, SOX9, and SOX11) both in human
(17-year-old) and mice (Figures 2 and 3). The histological
quality of the second human spinal cord (46-year-old) was
reduced compared with that of the first patient, although
we could confirm protein expression for FOXJ1, ID4,
MEIS2, NFIA, and PAX6 in this sample (Figure S4A). Unex-
pectedly, some of these TFs showed a dorsal-ventral asym-
metric expression. Both in human (17-year-old) and in
mouse, PAX6 protein stained dorsal and lateral cells while
ventral cells were negative (Figures 2 and 3), which was
also observed in the GENSAT gene expression atlas (Fig-
ure S1B). Another clear regionalized-expression was found
for MSX1 protein in mouse and in human (17-year-old).
In the human sample, MSX1 was weakly expressed by
ependymal cells but cells in the dorsal part had a much
stronger staining (Figure 2). In mice, MSX1 protein was
confined to a few cells constituting the roof of the EZ (Fig-
ure 3), which was confirmed in gene expression atlases
(Figure S3B). These MSX1+ cells typically exhibit a higher
level of ID4 staining in mice (Figure 3). Contrasting withT
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the dorsally-expressed proteins, we detected a ventral
expression of ARX, a TF expressed by the floor-plate dur-
ing spinal cord development. ARX protein was confined
to a group of ventral cells both in human and mouse EZ
(Figures 2 and 3). This led us to investigate by IF the
expression of FOXA2, another TF involved in floor plate
formation (Cho et al., 2014). Foxa2 specificity for the EZ
was under our selected threshold in mice and in human
(fold change EZ/periEZ = 1.7 and 1.3, respectively) howev-
er the FOXA2 protein was detected in a group of ventral
and ventral/ventro-lateral cells in human and mice
respectively (Figures 2 and 3). In human, the same popu-
lation of ventral cells expressed ARX and FOXA2 (Fig-
ure S4B) whereas in mice, FOXA2 was expressed by
ventral CSF-N expressing DCN and PKD2L1 but did not
express ARX (Figure S2). In addition to these evolution-
arily-conserved TFs, we also detected genes whose expres-
sion appears to be specifically expressed in the mouse or
the human EZ (Table S3). This was checked at the protein
level for Tal1 (also known as Scl), a well-known TF
involved in hematopoiesis but also expressed during spi-
nal cord development (Smith et al., 2002). IF for TAL1 re-
vealed the presence of positive subpopulations in the
mouse EZ (Figure S2) which co-labeled with PDK2L1,
thus identifying these cells as CSF-N. This was confirmed
by single cell CNS RNA-seq database (Zeisel et al., 2018)
(Figure S5A). In contrast, no convincing staining for
TAL1 and PDK2L1 proteins was detected in the two hu-
man spinal cord EZs (not shown), and DCN labeling
was restricted to vessels in the parenchyma (Figure S5B)
as expected from the literature (Jarvelainen et al., 2015).
A recent single cell CNS RNA-seq database (Zeisel et al.,
2018) identified six markers for mouse CSF-N (Crct1,
Dcn, Espn, Pkd1l2, Pkd2l1, and Pdzk1ip1), which we found
enriched at the transcriptional level in the mouse EZ but
not in the human EZ (Figure S5C).
Collectively, these results indicate a conserved dorsal-
ventral regionalization of TF expression in the mouse and
human EZ; however, no evidence could be found for the
presence of CSF-N in human.
Vegfr3-YFP Transgenic Mice Reveal Distinct MSX1+
and ARX+ Cells in the Roof and Floor of EZ
The regionalized expression of TFs in the EZ was indica-
tive of specific cells located in the roof and floor of the
EZ. This was also suggested by the specific expression of
the immature neural marker NES in these regions (Becker
et al., 2018). The Vegfr3-YFP transgenic mouse has been
used to detect subpopulations of neural precursor cells
in the neurogenic SVZ (Calvo et al., 2011), which promp-
ted us to use it in the spinal cord EZ context. Indeed, sub-
populations of EZ cells expressing YFP were observed in
all sections and were specifically enriched at the roof
and floor portions (Figures 4A and 4B). These cells were
positive for TFs strongly expressed by ependymal cells
such as FOXJ1 and SOX2 while only the dorsal YFP+ cells
express PAX6 (Figure 4C). In addition, in the roof part,
67% (41 among 61 cells, two mice) of YFP+ cells expressed
the MSX1 TF (Figure 4C), which was further confirmed by
generating a double transgenic mouse (Vegfr3-YFP 3
Msx1-Tomato, see below, Figure 6F) in which approxi-
mately 77% of the dorsal YFP+ cells were also Tomato+
(37 among 48 cells, two mice). It was previously reported
that the c-RET receptor is present in a subpopulation of
radial dorsal cells in the EZ (Pfenninger et al., 2011),
and we observed that 71% of YFP+ (20 among 28 cells,
two mice) were positive for this receptor (Figure 4C). In
the EZ floor, 90% of YFP+ cells (60 among 66 cells, three
mice) expressed the ARX TF (Figure 4C). Finally, some dor-
sal Vegfr3-YFP+ cells were clearly positive for GFAP and
NES intermediate filaments (Figure S6A), whereas we
could not establish this with confidence for ventral cells.
These results support the existence of distinct EZ roof and
floor cells expressing Vegfr3 and specific TFs.
RoofMSX1+ and Floor ARX+ Ependymal Cells are Born
Early during Development
We next questioned the developmental origin of MSX1+
and ARX+ cells by performing IF at multiple develop-
mental stages (embryonic day 13 [E13], E18, postnatal
day 1 [P1], P6, P22, and P38) (Figure 5A). At E13, a group
of MSX1+ cells was detected at the dorsalmost part of the
developing spinal cord while a group of ARX+ cells were
present in the ventralmost region. These cells, situated
at positions corresponding respectively to the embryonic
floor and roof plates, had elongated nuclei oriented along
the dorsal-ventral axis, evocating migration. At E18, ARX+
and MSX1+ cells appeared to have migrated centrally to
delimit a small group of cells presumptive of the adult
EZ. At P1 and P6, the number of ARX+ and MSX1+ cells
was reduced and at P22 and P38 only a few cells remained
in the roof and floor of the EZ (Figure 5A). To analyze
Figure 2. Human EZ Characterization
IF of the indicated proteins in the human EZ (patient aged 17 years). White arrowheads show negative cells indicative of the staining
specificity. Yellow arrows show ventral ARX+ cells, dorsal MSX1+ cells, and ventral PAX6! cells. Note that SOX4 is mostly cytoplasmic.
Images are oriented with ventral part at bottom. Labelings were performed at the thoracic (control, ARX, CD24, FOXA2, MSX1, SOX4, SOX9)
or lumbar level (CTNNB1, FOXJ1, ID4, MEIS2, NFIA, PAX6, PBX1, SOX11). These images are representative of at least eight sections.
Scale bar, 50 mm (applies to all images).
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further the developmental origin of adult EZ MSX1+ cells,
we used a genetic tracing approach based on a Msx1-
CreERT2/Rosa-Loxed Tomato transgenic line (hereafter
referred to as Msx1-Tomato [Lallemand et al., 2013]).
Tamoxifen injection in adult mice revealed the presence
of Tomato+ cells residing in the EZ roof (Figures 6A and
S6B), which validated this tool. Tomato+ cells were very
rarely observed in the ventral part of the EZ or in the pa-
renchyma (not shown). Tamoxifen was then injected in
pregnant transgenic mice at E11.5 to permanently label
embryonic MSX1+ cells and explore their fate (Figure 5B).
Analysis of sections taken from cervical and lumbar spinal
cord levels of P30 mice (n = 2 mice) revealed the constant
presence of Tomato+ cells situated in the EZ roof (Fig-
ure 5B). Altogether, these data demonstrate an early em-
bryonic origin of ARX+ and MSX1+ spinal cord EZ cells.
Roof MSX1+ Cells Are Radial Quiescent Cells
We previously reported an enrichment of neurosphere-
forming cells in the dorsal half of the EZ (Sabourin
et al., 2009). This was associated with a high content of
GFAP+ radial glial-like cells. As MSX1+ cells were found
almost exclusively in the roof of the EZ, further charac-
terization of these cells was done. This was also moti-
vated by the reported expression of Msx1/2 in some
stem cells during eye development (Be´langer et al.,
2017) and its role in promoting regeneration of ampu-
tated tail including spinal cord (Beck et al., 2003) in Xen-
opus. The intense fluorescence observed in Msx1-Tomato
mice enabled morphological characterization of these
cells, notably using clarification of the whole spinal
cord and 3D reconstruction. Tomato+ cells have a long
radial morphology and send their process toward the
pial surface (Figures 6A, 6B, and S6B). Their soma make
contact with the lumen, but radial Tomato+ cells can
also be observed more dorsally and at distance from the
EZ (Figure 6A, yellow arrow). Horizontal sections also re-
vealed the existence of Tomato+ processes running longi-
tudinally along the EZ roof (Figure 6C).
By performing IF for c-RET, FOXJ1, GFAP,NES, and SOX2,
we observed that most Tomato+ cells also express these
markers (Figures 6D and S6C). We next crossed Msx1-
Tomato mice with hGFAP-GFP transgenic mice, which
have been widely used to purify adult neural stem cells
(Nolte et al., 2001). Contrasting with GFAP immunostain-
ing (Figure S6C), only a small fraction of Tomato+ cells
(15%, 8 double-positive cells among 54 Tomato+ cells;
n = 2mice) were GFP+ (Figure 6E). Often GFP+ and Tomato+
cells were found to be associated, suggesting close interac-
tions between them. We then explored the proliferation
rate of Tomato+ cells by injecting tamoxifen for 5 days in
Msx1-Tomato mice to label MSX1+ cells, then 5-ethynyl-
20-deoxyuridine (EdU) injections were performed for 5
additional days (twice a day) before sacrificing on day 11
(Figure 6G). As previously reported, few EdU+ cells were
found in the EZ (approximately one cell per section), how-
ever no Tomato+ EdU+ could be observed (Figure 6G). This
indicates that MSX1+ cells are quiescent or proliferate at a
much slower rate comparedwith theother ependymal cells.
DISCUSSION
In this article, RNA profiling was used to generate a cellular
and molecular resource for the adult human and mouse
spinal cord EZ. Our findings reveal important and new
characteristics of this poorly defined region.
In accordance with the presence of neural stem cells in
the EZ, this region shows enrichment for smoothened/
SHH and Hippo/YAP signaling genes, which are involved
in stem cell maintenance (Alvarez-Buylla and Ihrie, 2014;
Mo et al., 2014). Echoing their localization at the interface
between CSF and the spinal cord parenchyma, ependymal
cells also highly express genes involved in transport and
ciliogenesis including three TFs of the RFX family and
FOXJ1 (Figure 1E). Compared with brain, spinal cord epen-
dymal cells proliferate (Alfaro-Cervello et al., 2012; Pfen-
ninger et al., 2011), which is also reflected at the RNA level
by enrichment for genes involved in cell division (Fig-
ure 1E; Tables S1 and S2). A set of 120 TFs conserved be-
tween mice and humans was identified and the expression
at the protein level was confirmed for 12 of them. MEIS2
and PBX1 expressions are particularly interesting, as these
TFs dimerize and are essential regulators of adult SVZ neu-
rogenesis (Grebbin et al., 2016). Ependymal cells also ex-
press high levels of NFIA and SOX9, two TFs involved in
gliogenesis during development (Kang et al., 2012). Post
lesion, these cells mostly generate astrocytes (Barnabe´-
Heider et al., 2010) and the expression of NFIA and SOX9
may be responsible for their glial fate restriction.
One unexpected observation was the conserved and
regional expression of four homeodomain-containing TFs
Figure 3. Mouse EZ Characterization
IF for the indicated proteins in the adult mouse EZ (lumbar level). Images are oriented with ventral part at bottom. The yellow arrows on
PAX6 staining show negative cells in the ventral part. Note the higher expression of ID4 in cells localized in the dorsal part, which also
express MSX1. FOXA2+ and TAL1+ cells are localized in a subependymal position and express PKD2L1 a marker specific for CSF-N (Figure S2).
Note that SOX4 is mostly cytoplasmic. These images are representative of ten sections per animal, n = 4 mice analyzed. Scale bar, 20 mm
(applies to all images).
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in the niche, namely ARX, FOXA2, MSX1, and PAX6. This
situation is reminiscent of the developing spinal cord neu-
roepithelium where cells along the dorsal-ventral axis ex-
press different combinations of homeogenes (Wilson and
Maden, 2005). Both in human and mouse, ARX and
FOXA2 are expressed by ventralmost cells that do not co-
express PAX6. Of note, whereas FOXA2 was expressed by
ventral CSF-N in mice (Figure S2 and Petracca et al.,
2016), no such cells have been identified in human so far.
The two other markers we identified in mice for these cells,
DCN, an extracellular matrix protein (Jarvelainen et al.,
2015), and TAL1, a hematopoietic transcription factor,
were not observed in the human EZ. This indicates a diver-
gent organization of the ventral EZ between rodents and
humans. In the dorsal portion of the EZ, highMSX1 expres-
sionwas restricted to few cells located in the EZ roof both in
mouse and human. By tracing the origin of ARX+ and
MSX1+ cells during spinal cord development in mice, we
observed that they are already present at E13.5 in the spinal
cord roof and floor plates. Their number is then reduced
and they appear to migrate centrally to generate the roof
and floor of the adult EZ. The early developmental origin
(at least E11.5) ofMSX1+ cells was further demonstrated us-
ing genetic tracing. Thus, in contradiction to what was pre-
viously established (Fu et al., 2003), ependymal cells are
not entirely derived from the ventral neuroepithelium
but also incorporate cells from the dorsal part of the devel-
oping spinal cord. Another distinguishing feature of the
dorsal and ventral EZ cells is the expression of Vegfr3 (also
known as Flt4, the receptor for VEGFC), which was
observed using Vegfr3-YFP transgenic mice. Part of these
Vegfr3-YFP+ cells express MSX1 and ARX. During brain
development Vegfr3 is expressed in the ventricular zone
and radial glial cells (Ward and Cunningham, 2015). It is
also expressed in brain adult neural stem cells where it reg-
ulates their activation and proliferation (Calvo et al., 2011).
A similar role for Vegfr3 may apply for adult spinal cord
ependymal cells.
These results provide evidence for the persistence of em-
bryonic floor and roof plate cells in the adult spinal cord
niche. Recent studies, based on a Wnt-reporter mouse la-
beling dorsal neural tube cells (Xing et al., 2018) and on a
Nato3-reporter mouse labeling floor plate cells (Khazanov
et al., 2017), reached similar conclusions. During develop-
ment, these floor and roof plate cells secrete morphogens
such as SHH and BMP6, acting as growth factors and
patterning signals (Wilson and Maden, 2005). Our results
(Figure 1G) and expression atlas (Figure S3A) indicate that
dorsal EZ cells express morphogen genes (Bmp6 and
Gdf10). This suggests a specific role for these cells in the spi-
nal cord niche, which warrants further exploration.
As the presence of MSX1+ cells has not been reported in
the spinal cord EZ, we characterized these cells further
and observed that they have distinct features compared
with the other cells of the niche. They have a long radial
morphology and express FOXJ1, GFAP, NES, and SOX2pro-
teins. They also express c-RET, the receptor for GDNF and
NTN growth factors, which is important for hematopoietic
stem cells and neural crest cells (Kubota et al., 2004). By
crossing Msx1-CreERT2/Tomato and hGFAP-GFP trans-
genic mice, only a minority of Tomato+ cells were double-
positive, thus revealing the presence of a cellular heteroge-
neity in the dorsal part of the niche and of MSX1+ cells.
The existence of subpopulations of quiescent neural
stem cells has been reported in the hippocampus and the
SVZ niches (Codega et al., 2014; Llorens-Bobadilla and
Martin-Villalba, 2017; Llorens-Bobadilla et al., 2015).
Importantly, data mining of single cell RNA-seq analysis
performed in the SVZ revealed thatMsx1 and Id4 are highly
enriched in quiescent neural stem cells (Llorens-Bobadilla
et al., 2015) (Figure S5D). These two TFs are regulated by
the BMP signaling (Ramos and Robert, 2005; Ruzinova
and Benezra, 2003) and, indeed, expression of Bmp6 and
Bmp3b/Gdf10 is also restricted to SVZ quiescent stem cells
(Figure S5D). A similar situation may also be present in
the dorsal part of the spinal cord EZ. Indeed, we found
that Bmp6, Bmp3b/Gdf10, and Msx1 are highly expressed
in the dorsal part of the spinal cord EZ and thatMSX1+ cells
express a higher level of ID4 transcription factor (Figure 3).
EdU incorporation also revealed that MSX1+ cells are less
proliferative than the other cells of the niche (Figure 6G).
This suggests that dorsal radial MSX1+ cells may behave
as quiescent neural stem cells in the adult spinal cord.
Further work is needed to support this hypothesis.
Figure 4. EZ in Vegfr3-YFP Mice
(A) Representative images of the spinal cord EZ (lumbar level) in Vegfr3-YFP mice (IF anti-GFP). Images are oriented with ventral part at
bottom. YFP+ cells are mainly present in the dorsal and ventral regions (yellow arrows). Boxed areas show dorsal cells sending a process
toward the lumen. These images are representative of at least 20 sections per animal (n = 3 mice analyzed). Ventral YFP+ cells are present
in >95% of sections whereas dorsal YFP+ cells are present in approximately 25% of examined sections.
(B) Quantification of YFP+ cells in the lumbar EZ (187 YFP+ cells counted) indicated a preferential ventral and dorsal localization. One-way
ANOVA + Tukey’s post test (n = 3 mice).
(C) Phenotypic characterization of YFP+ cells with indicated protein (images are representative of 20 sections, n = 3 mice). Yellow arrows
show double-positive cells. Images at the bottom are high magnification of arrow-pointed areas. Hoe., Hoechst. Scale bar, 20 mm (applies
to all images).
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In summary, our results uncovered that the adult spinal
cord EZ region is conserved, regionalized, and composed
of a mosaic of cells with different embryonic origin and ex-
pressing different types of TFs. This corpus of knowledge on
the organization and genes expressed in the EZ will help to
explore this adult stem cell niche further and will also be
Figure 5. MSX1 and ARX Expression in the Developing Spinal Cord
(A) IF for MSX1 and ARX during spinal cord embryonic development (E13 and E18) and postnatal stages (P1, P6, P22, P38). All images are
oriented with ventral part at bottom. Images are representative of ten sections (n = 2 embryos and pups analyzed per stage).
(B) Representative images (n = 20 sections each levels, two mice) of the EZ of a P30 Msx1-CreERT2/Rosa-Tomato mouse derived from an
embryo subjected to tamoxifen at E11.5.
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useful to shed light on ependymoma, a rare type of tumor
that can arise in the human spinal cord EZ.
EXPERIMENTAL PROCEDURES
Human Samples
Human spinal cords were collected at the Montpellier Hospital
from two organ-donor patients (17 [male] and 46 [female] years
old, accidental death) in strict agreementwith the French bioethics
laws (articles L1232-1 and -6) and after approval by the French
institution for organ transplantation. An informed consent from
the families was obtained by the organ procurement organization
for this study. Surgery was performed as described previously
(Bauchet et al., 2013), and the thoracolumbar segments were
immediately placed in liquid nitrogen before processing for micro-
dissection and immunofluorescence.
Animals
Mice were handled following the guidelines of the Animal Care
and Use Committee of the National Institute of Health and Medi-
cal Research (INSERM) who approved this study in accordance
with the European Council directive (2010/63/UE) for the protec-
tion and use of vertebrate animals. Adult CD1 mice (3 months,
Charles River, France) were used for microdissection, RNA
profiling, and histology.Msx1-CreERT2/Rosa-Loxed Tomato trans-
genic line (Lallemand et al., 2013) was obtained from Y. Lallemand
(Pasteur Institute, Paris). To induce recombination in Msx1-
CreERT2 animals, we injected 100 mL of tamoxifen (Sigma,
T5648, 20 mg/mL dissolved in corn oil) intraperitoneally for
4–5 days. hGFAP-GFP (Nolte et al., 2001) and Vegfr3-YFP (Calvo
et al., 2011) transgenic mice were obtained from Prof. H. Ketten-
mann (MDC, Berlin) andDr. J.L. Thomas (ICM, Paris), respectively.
Tissue Microdissection
For human and mouse, after collection the spinal cords were flash
frozen in N2 without chemical fixation. Frozen sections (30 mm
thick, T9-T10 thoracic part for mouse and thoracolumbar for hu-
man) were obtained at !23$C to prevent RNA degradation using
a CM3050S microtome (Leica Microsystems, Wetzlar, Germany)
and were mounted on PEN-membrane 1-mm glass slides
(P.A.L.M. Microlaser Technologies, Bernried, Germany) that had
been pretreated to inactivate RNase. Sections were then fixed in a
series of pre-cooled ethanol baths (40 s in 95%, 75% and 30 s in
50%), stained with cresyl violet 1% for 30 s, and dehydrated in a
series of pre-cooled ethanol baths (30 s in 50%, 75%, and 40 s in
95% and 100%). Immediately after dehydration laser microdissec-
tion was performed using a PALM MicroBeam microdissection
system version 4.6 equipped with PALM RoboSoftware (P.A.L.M.
Microlaser Technologies). Laser power and duration were adjusted
to optimize capture efficiency, andmicrodissection was performed
at 633 magnification. Samples were collected in adhesive caps
(P.A.L.M. Microlaser Technologies). To limit RNA degradation, we
collected samples for up to 15 min per slide and lysed microdis-
sected tissue with 250 mL of lysis buffer (Promega, Madison, WI,
USA). The samples were stored at !80$C until extraction was per-
formed using the ReliaPrep RNA cell Miniprep System (Promega)
according to the manufacturer’s protocol and eluted with 14 mL
of RNase-free water. The concentration of RNAwas determined us-
ingNanodrop 1000 and the integrity of RNAwas determined using
the RNA 6000 Pico Kit and Bioanalyzer (Agilent Technologies,
Santa Clara, CA, USA). The RNA integrity number was above 7/8.
RNA Profiling and Bioinformatics Analysis
RNA profiling was performed using Affymetrix microarray technol-
ogy.Hybridization targetswere obtained following a double-amplifi-
cation procedure according to the protocol developed by Affymetrix
(GeneChipTwo-Cycle Eukaryotic Target Labeling Assay; Affymetrix,
USA). A hybridization mixture containing 10 mg of biotinylated
cRNA was generated. The biotinylated cRNA was hybridized to
HT_HG-U133_Plus_PM (human) and HT_MG-430_PM (mouse) Af-
fymetrix microarrays. Four mouse and two human samples (EZ
and peri EZ regions each, Figure 1A) were analyzed in total. The mi-
croarrayswere scannedusing theAffymetrixGeneAtlas scanner. The
data files were generatedwith Affymetrix Expression Console v1.2.1
and gene expression data were normalized with the GC-RMA algo-
rithm. Gene expression profiles were analyzed using the Affymetrix
TAC4.0software (TranscriptomeAnalysisConsole). Thefiltercriteria
were set to a linear fold changeR2 between EZ and peri EZ regions.
Gene lists were analyzed with DAVID Bioinformatics Resources 6.83
for gene enrichment analysis (Huang et al., 2008).
Human and Mouse Histology
Mice were anesthetized by intraperitoneal injection of sodium
pentobarbital (50 mg/kg) and perfused intracardially with 10 mL
of PBS followed by 50 mL of 4% formaldehyde-PBS solution
(pH 7.0). After dissection, spinal cords were post-fixed in the
same solution for 1 h at 4$C and cryopreserved by successive im-
mersion in 10%, 20%, and 30% sucrose solutions in PBS for at least
6 h. Cervical, thoracic and lumbar parts of the spinal cordwere cut,
Figure 6. Characterization of Dorsal MSX1+ Cells
(A) Radial morphology of MSX1+ cells observed in Msx1-CreERT2/Rosa-Tomato mice. Yellow arrow shows rare radial Tomato+ cells
outside EZ. Images are oriented with ventral part at bottom.
(B) 3D reconstruction of Tomato+ cells (coronal, intermediate, and lateral views).
(C) Dorsal view of the dorsal EZ region showing rostral-caudal oriented Tomato+ processes.
(D) Expression of c-RET receptor in Tomato+ cells (n = 10 sections).
(E and F) Representative images (n = 20 sections, two mice) of the EZ in double transgenic hGFAP-GFP/Msx1-CreERT2/Rosa-Tomato (E) and
Vegfr3-YFP/Msx1-CreERT2/Rosa-Tomato (F) mice. White arrows indicate double-positive cells and yellow arrows Tomato+-only cells.
(G) EdU incorporation (5 days) in the EZ. Images show EdU+ cells (yellow arrows) not positive for Tomato (white arrows) in Msx1-CreERT2/
Rosa-Tomato mouse sections. Quantifications are provided on right-hand graph (112 spinal cord sections, 5,120 cells examined, unpaired
t test, n = 4 mice).
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embedded in OCTmedium, rapidly frozen in liquid N2-cooled iso-
pentane, and cryosectioned (14 mm) (Leica apparatus). For develop-
mental studies using time-mated embryos (Figure 5A), the day the
plug was found was considered as E0.5. The embryos and pups
(entire animal for P1, P6, and dissected spinal cord for P22) were
fixed by direct immersion in 4% formaldehyde-PBS solution for
1 h then processed as for the adult spinal cord. P38 animals were
perfused intracardially and post-fixed as for adults. To access the
proliferation rate of Tomato+ cells (Figure 6G), we injected adult
mice with EdU twice a day for 5 days (50 mg/kg), perfused them
intracardially, and processed them for EdU staining (Baseclick kit).
For human, unfixed spinal cords at thoraco or thoracolumbar
levelswere directly cryosectioned (20 mm) and sectionswere imme-
diately fixed by direct immersion in ice-cooled 4% formaldehyde-
PBS solution for 20 min, followed by three washes with PBS.
Immunofluorescences were performed with primary antibodies
(listed in Table S6) on sections permeabilized for 1 h with 0.1%
Triton X-100 and 5% donkey serum. Secondary antibodies (Alexa
488- or Alexa 594-conjugated species-specific anti-mouse, -rabbit,
or -goat) were purchased from The Jackson Laboratories. Incuba-
tions without primary antibody or with antibody recognizing an-
tigens not present in the sections (monoclonal anti-DYKDDDDK
tag or polyclonal antibodies against GFP) were used as negative
controls. Nuclei (blue in all images) were stained with 1 mg/mL
Hoechst for 10 min. The quality of staining was evaluated by two
independent investigators (J.-P.H. and H.G. or C.R.). Images were
taken using optical sectioning with structured illumination (Zeiss
apotome microscope) or using a multi-photonic microscope (Zeiss
LSM 7MP OPO) (Figure 6B). All presented images for mice are
representative images, and the number of examined sections and
animals are indicated in the figure legends. For human labelings,
images are representative of at least eight sections for the first
(17-year-old) patient and four sections for the second (46-year-
old) patient. Clarification of mouse spinal cord was performed
with protocol described in Tomer et al. (2014), and Imaris software
was used for image treatments and 3D reconstruction.
Statistical Analysis
All experiments and stainings were performed at least twice, most
of them three times. Data are represented asmeans± standard error
of mean. Statistical differences in experiments were analyzed with
tests indicated in the figure legends (GraphPad Prism software).
Significance is denoted by ***p < 0.001, **p < 0.01, and *p% 0.05.
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Supplemental Information 
 
Fig S1: Allen brain atlas validation. Related to Figure 3 and table S1. A: Examples of genes found enriched 
in the spinal cord EZ in the present study which are also validated in the Allen brain atlas based on in situ 
hybridization.  B: Examples of transcription factors found enriched in the spinal cord EZ which are also validated 
in the Allen brain atlas. For Pax6, the Gensat Atlas image (based on transgenic mice) is presented. The black 
arrow indicates ventral Pax6 negative cells. 
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Fig S2: Characterization of ARX+, DCN+, FOXA2+ and TAL1+ cells in the mouse EZ. Related to Figure 3. 
Co-IF show that DCN, TAL1 and FOXA2 are expressed by CSF-N detected by PKD2L1 staining. ARX/PKD2L1 
antibody incompatibility precluded double labeling, however ventral ARX+ cells are distinct from FOXA2+ and 
DCN+ cells and are thus unlikely to be CSF-N. Presented images are representative of at least 10 sections per 
animal (3 mice analyzed). Nuclei (blue) are stained with Hoechst. Scale bar, shown on first image, is the same for 
all images. Insets at the bottom are high magnification of boxed areas. 
 
  
DCN PKD2L1FOXA2
ARX
PKD2L1
DCN FOXA2 FOXA2
DCN
TAL1
PKD2L1
ARX
10 µm
3 
 
 
Fig S3: Atlas validation of regionalized gene expression. Related to Figure 3 and Table S5. A: Allen brain 
atlas examples of dorsally and ventrally expressed genes identified in table S5. B: Validation of expression of 
Msx1 in the dorsal EZ in Allen brain (post-natal P4) and Gensat atlases. EZ region is shown by dotted line oval 
shape. 
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Fig S4: human EZ characterization. Related to Figure 1 and 2. A: IF for the indicated proteins in the human 
EZ (second patient aged 46, lumbar level). As often observed in aged human tissues, this second sample presented 
non-specific red autofluorescence aggregates (most likely lipofuscin) which are observed with the control 
antibody. White arrowheads show negative cells indicative of the staining specificity. Images are oriented with 
ventral part at bottom. These images are representative of 4 sections. B: Co-localization of FOXA2 and ARX in 
the ventral part of the human EZ (patient aged 17, n= 4 sections).  
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Fig S5: Comparison with single cell databases. Related to Figure 2 and 3. A: Single cell RNA expression 
confirms that Tal1/Scl and Dcn are expressed by CSF-N in the spinal cord. These data were obtained from the 
website (http://mousebrain.org/) associated to this publication (Zeisel et al, Cell. 2018 Aug 9;174(4):999-1014). 
Adult cell subtypes showing Tal1 and Dcn expression are indicated by a blue rectangle and arrows point to the 
spinal cord CSF-N population (referred to as SCINH11 in Zeisel’s article). Quantitative expression for these cells 
is presented as a blue circle and underneath value. B: Immunofluorescence for DECORIN (DCN) in the human 
spinal cord EZ (17-year-old patient) showing highly stained vessels (arrowheads) but no labeling in the EZ. C: 
Fold change expression (EZ/peri EZ), retrieved from our study, of 6 mouse CSF-N markers in mouse and human 
samples (17 and 46-year-old; (y.o.)). Compared to the mouse EZ, no enrichment is observed for these markers in 
the human EZ. D: Single cell RNA expression shows that Msx1, Id4, BMP6 and GDF10/BMP3b are mainly 
expressed in quiescent neural stem cells in the brain SVZ. These data were retrieved from the website 
(https://martin-villalba-lab.shinyapps.io/scRNAseq_CSC2015/) associated to this publication (Llorens-Bobadilla 
E et al Cell Stem Cell. 2015 Sep 3;17(3):329-40).  
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Fig S6: Mouse EZ characterization. Related to Figure 4. A: Characterization of EZ YFP+ cells in the 
Vegfr3-YFP mice. IF for GFAP and NES (nestin), show that dorsal YFP+ express these two intermediate 
filaments. Co-localization of GFAP and NES in the ventral YFP+ cells were ambiguous and inconclusive. These 
images are representative of 10 sections per animal (3 mice analyzed). B and C: Characterization of dorsal 
Tomato+ cells in Msx1-CreERT2/Rosa-Tomato mice. B: examples of clusters of Tomato+ cells found in the 
EZ roof at the cervical and thoracic-lumbar spinal cord levels. C: IF for indicated proteins showing co-
expression in Tomato+ cells. Presented images are representative of 10 sections per animal (3 mice analyzed). 
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Supplemental Tables 
 
Table S1: mouse EZ genes (Excel file). This file includes 3 lists of genes whose expression is enriched in the 
mouse adult EZ (fold change ≥2.0, n=4 mice) (full list + transport-related genes + transcription-related genes) + 
analyses (3 GO terms, KEGG pathway, upkeywords) + bar plots of GO analyses. Genes belonging to the solute 
carrier family (Scl) are in red in the transport-related spreadsheet.  
 
Table S2: human EZ genes (Excel file). This file includes 3 lists of genes whose expression is enriched in the 
human EZ (fold change ≥2.0, n=2 samples,17- and 46-year-old) (full list + transport-related genes + transcription-
related genes) + analyses (3 GO terms, KEGG pathway, upkeywords) + bar plots of GO analyses.  Genes 
belonging to the solute carrier family (Scl) are in red in the transport-related spreadsheet.  
 
Table S3: Comparison of mouse and human EZ-enriched genes (Excel file). This file includes 3 lists of genes 
whose expression is enriched in the human and mouse EZ (fold change ≥2.0) (full list + transport-related genes + 
transcription-related genes) + analyses (3 GO terms, KEGG pathway, upkeywords) + bar plots of GO analyses. 
The gene lists also include columns showing genes which are more specifically enriched in one specie.   
 
Table S4: Comparison with spinal cord ependymal and CSF-N specific genes identified in two other studies 
(Excel file).  This table shows genes which are commonly identified in our study and in these two other studies: 
1-Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding" Science. 2018 
Apr 13;360(6385):176-182 and 2-Molecular architecture of the mouse nervous system.  Cell. 2018 Aug 
9;174(4):999-1014). Genes which are identified in the three studies are highlighted in green, those identified in 
two studies including ours are in red.   
 
Table S5: Dorsal, lateral and ventral EZ-enriched genes (Excel file). This file shows 3 lists of genes which 
are specifically enriched in the different parts of the mouse adult EZ (n=4 mice). 
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Table S6: Antibody list   
 
 
 
 
 
Supplementary Data Related to the paper 
 
  
Materials and Methods 
 
Spinal cord neural stem cell cultures 
Neurosphere cultures were derived from adult mouse spinal cords using the protocol and 
medium detailed in (Hugnot, 2013). Cell growth (fig 6I and 7I) was measured by seeding 
dissociated cells (1000 or 5000 cells per well) in 1 ml of media in 24-well plates coated with 
poly-HEMA (Sigma P3932) to inhibit cell adherence. After 5 or 7 days, the NS were directly 
dissociated by addition of trypsin in the wells (0.5% final) and the cell number was measured 
with an automated cell counter (Z2, Beckman Coulter). To determine the percentage of NS 
formation at clonal density, Tomato+ and Tomato- cells were seeded at 1 cell/well in 96-well 
plates using an automatic cell seeding device (Aria cytometer BD). After two weeks, the 
number of spheres and their size was visually determined. To assess the differentiation of adult 
spinal cord stem cells, NS were enzymatically dissociated and seeded on poly-D-
lysine/laminin-coated coverslips with medium containing 2% serum without growth factor. 
After 4 days, the coverslips were fixed for 20 min with 4% formaldehyde PBS-solution and 
processed for IF. For EdU incorporation (fig 6I, 7I), cells were incubated with EdU 10 µM for 
3 hours and processed for staining following manufacturer’s recommendation (Baseclick kit). 
 
Virus 
To access the effect of MSX1 overexpression on neural stem cells, inducible lentiviruses 
combining an EGFP-T2A-Puromycine resistance gene and the coding sequence for mouse 
Msx1 or luciferase, controlled by a Tre3G promoter, were built (Vectorbuilder). A third 
lentivirus was built to express a blasticidin resistance gene and the doxycycline-regulated Tet3G 
activator. Growing spinal cord NS were co-infected with luciferase or Msx1 lentiviruses and 
Tet3G virus and selected for 2 weeks with blasticidin (0,5 µg/ml) and puromycine (0,2 µg/ml). 
The expression of MSX1 or luciferase was induced by adding doxycycline 1 µg/ml in the 
medium. To access the effect of ID4 on neural stem cells, cells were infected with a retrovirus 
combining expression of GFP with and without ID4 and a blasticidin resistance gene (gift from 
Dr E Huillard’s lab, ICM, Paris). Cells were selected for 2 weeks with blasticidin 0.5 µg/ml 
before accessing their growth (fig 7I). For activated RAS overexpression (fig 7), we used a 
lentivirus containing a K-RAS (G412 mutation) cDNA under the control of the PGK promoter 
(Addgene #35633). 
 
QPCR 
RNA was extracted from growing or differentiated spinal cord NS using RNeasy kit (Qiagen). 
cDNA was obtained by reverse transcription with random hexamers and reverse transcriptase 
(Superscript II, Promega). Quantitative PCR were performed using a Sybr PCR kit (Kapa) and 
a LightCycler 480 apparatus (Roche). Primers sequences: Id4 
(GTTCACGAGCATTCACCGTA& AAGGTTGGATTCACGATTGC); GAPDH 
(TGTCCGTCGTGGATCTGAC & CCTGCTTCACCACCTTCTTG). 
 
Western blot (WB) 
Protein extraction and western blot were performed according to classical procedures. Cells 
were collected and lysed in RIPA buffer (Sigma) containing proteases- and phosphatase 
inhibitors (Roche). Protein concentration was determined using a protein assay kit (Biorad). 
Proteins (20 µg) were separated by SDS-PAGE, and transferred onto PVDF membranes 
(Biorad). Peroxidase secondary antibodies (Jackson Immunoresearch Laboratory), ECL kit 
(Biorad) and ChemiDoc apparatus were used for revelation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
Limited NS formation of MSX1+ roof cells and negative influence of MSX1 on 
proliferation of spinal cord neural stem cells  
Multipotent NS can be derived from the adult EZ (Barnabé-Heider et al., 2010; Becker et al., 
2018). Reminiscent of the situation in the SVZ stem cell niche, we investigated whether the 
Tomato+ roof cells were able togenerate NS as several types of cells in the spinal cord niche 
do.  Attempts to generate NS directly from a limited number of Tomato+ cells obtained using 
fluorescence-activated cell sorting (FACS) of dissociated spinal cords were negative (n=4, 50-
100 cells each experiment). We then performed NS cultures from unsorted cells, directly 
dissociated from Msx1-Tomato mouse spinal cord. After one week, observation of NS grown 
at low density and derived from a single Msx1-tomato mouse showed that the vast majority of 
NS (diameter > 200 µm) were Tomato negative thus indicating that Tomato+ cells are not the 
main NS-forming cells in the EZ. Careful examination of the culture over days indicates that 
most Tomato+ cells remained assingle cells or generated small NS (<50 µm). However, we 
constantly observed that a small number of NS with a size > 200 µm (3.4% of total NS, n=3 
independent experiments) were completely red (fig 1’A) and grew larger over days. After 10 
days of culture, we used FACS to purify the Tomato+ cells and reseeded them. These cells were 
able to form new NS which could be propagated for 7 passages without any sign of reduced 
proliferation (fig 1’B). When seeded as single cells in a 96 well plate, these Tomato+ cells 
formed new NS (diameter > 300 µm) with a frequency of 7.6% which is similar to the frequency 
observed with Tomato- cells (11%). Characterization of Tomato+ NS by WB and IF indicated 
that they express proteins typically found in neural stem cells such as SOX2 (fig 1’C) and 
VCAM1 (Kokovay et al., 2012) (fig 1’G). We next tested the multipotentiality of Tomato+ NS 
cells by placing them in differentiation condition. In this situation, we observed the formation 
of cells with different morphologies (fig 1’D) and expressing markers typical for astrocytes 
(GFAP), neurons (MAP2, DCX, βIII TUB) and oligodendrocytes (CNPase, OLIG2) (fig 1’E, 
F) which demonstrates the ability of the Tomato+ cells to generate several cell types.  
Msx1 expression is positively-regulated by BMP morphogens during development (Ramos and 
Robert, 2005). The strong expression of Bmp6 and Gdf10/Bmp3b transcripts in the dorsal EZ 
(fig S3A) led us to explore whether the roof MSX1+ cells co-expressed these morphogens in 
vivo. However we were unable to obtain convincing staining by IF, possibly due to the limited 
abundance of these morphogens. In contrast, in vitro, BMP6 and GDF10 proteins were readily 
detected by WB in NS derived from Tomato+ cells (fig 1’G). These Tomato+ cells also 
expressed a low level of MSX1 protein (fig 1’H) and this can be further increased by adding 
BMP6 in the media (10 ng/ml), as evidenced by WB and IF. As previously reported for BMPs 
(Martynoga et al., 2013; Sabourin et al., 2009), BMP6 addition also led to a drastic reduction 
of proliferation (fig 2’H). 
Next, the absence or low proliferation of roof MSX1+ cells in vivo (fig 5G) and the increase of 
MSX1 (fig 1’H) concomitantly with the reduction of proliferation induced by BMP6 (fig 2’H) 
in vitro prompted us to question the influence of MSX1 on spinal cord neural stem cells. We 
designed two inducible-lentiviruses in which MSX1 or a control gene (luciferase) can be tightly 
regulated by doxycycline (fig S1’A). Compared to the luciferase virus, induction of MSX1 in 
growing NS derived from adult spinal cord led to a sharp reduction of cell number after 5 days 
of growth, which was associated with a reduced proliferation rate as evidenced by EdU 
incorporation (fig 1’I). The influence of MSX1 in NS placed in differentiation condition was 
also explored. We observed that induction of MSX1 led to a reduction of OLIG2+, DCX+ and 
MAP2+ cells while the fraction of GFAP+ astrocytic cells was increased (fig S1’B). 
Taken together, these data indicate that MSX1+ cells have a low potential to form NS and that 
MSX1 overexpression reduces neural stem cell proliferation and promote astrocytic 
differentiation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1’: In vitro properties of Tomato+ cells. A: Tomato+ neurosphere (size > 200 µm) 
observed in a spinal cord culture (P0) derived from Msx1-CreERT2/Rosa-Tomato mouse. B: 
FACS sorted Tomato+ cells formed new NS which can be propagated for at least 7 passages. 
C: IF for SOX2 on Tomato+ cells. D: After differentiation, Tomato+ NS generate cells with 
different morphologies (black and red arrows). E: IF analysis with indicated markers of cells 
obtained after differentiation of Tomato+ neurospheres. Yellow arrows indicate double positive 
cells. F: Quantification of differentiation of Tomato+ cells (average of % of positive cells +/- 
S.E.M, n=3 independent experiments, test=one-way ANOVA + Tukey posttest). G: Detection 
of BMP6, GDF10 and VCAM1 by WB in proteins extracted from Tomato+ neurospheres. H: 
Upper panels: Detection of MSX1 by IF in growing Tomato+ cells without and with BMP6 
10ng/ml. Lower left panel: Average % +/- S.E.M of cells showing a nuclear strong expression 
of MSX1 (n=3 independent experiments, unpaired t-test). Weak cytoplasmic detection of 
MSX1 could be observed in untreated cells but was not quantified. Lower right panel: Detection 
of MSX1 by WB in cells with and without BMP6 10 ng/ml. Numbers show relative 
quantification of Msx1 signal normalized by actin. I: Effect of MSX1 overexpression on spinal 
cord stem cell growth (n=3 independent experiments, test=one-way ANOVA + Tukey posttest). 
Upper diagram shows the cell number ratio +/- S.E.M obtained after 5 days with and without 
doxycyclin in cells infected with Msx1 or control (luciferase) lentivirus. Lower panel shows 
the ratio of EdU+ cells +/- S.E.M (3 hour EdU incorporation) obtained in the different 
conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID4 expression is negatively regulated by RAS pathways and positively by BMP6 in spinal 
cord stem cells 
ID proteins are important proteins controlling stem cell fate (Ruzinova and Benezra, 2003). The 
identification of a conserved and specific expression of ID4 in EZ cells and the even higher 
expression observed in dorsal MSX1+ quiescent cells (fig 3) led us to explore how ID4 was 
expressed in adult spinal cord NS. Unexpectedly, ID4 protein was barely expressed in growing 
NS but sharply increased after differentiation when co-localized with GFAP+ astrocytic cell 
but not cells (fig 2’A, B, C). This increase in ID4 was reversible as reintroduction of the 
EGF/FGF2 growth factors in the culture reduced ID4 expression at the protein and RNA levels 
(fig 2’A, B). This suggested that ID4 expression was negatively regulated by pathways 
downstream of EGF/FGF2 most likely by the MAPK/ERK signaling. We tested this hypothesis 
by infecting differentiated cells with lentiviruses expressing activated-RAS or luciferase as a 
control. As expected RAS virus led to strong phosphorylation of ERK (fig 2’D) and cell cycle 
re-entry, as evidenced by the presence of proliferating cells and the sharp increase of KI67+ 
cells (fig 2’E). ID4 was strongly reduced in these cultures compared to control virus infected 
cells (fig 2’F). After one week, the RAS-infected cultures spontaneously generated NS which 
can be grown and passaged in the absence of growth factors (fig 2’G). When placed in 
differentiating conditions in the presence of serum, these cells have a reduced ID4 level 
compared to control NS thus indicating that activated RAS inhibits ID4 expression (fig 2’G).  
Next, as ID proteins are positively regulated by BMP proteins (Ruzinova and Benezra, 2003), 
we tested the influence of BMP6 on ID4 in growing NS. This resulted in ID4 induction and as 
mentioned previously, in reduction of KI67+ cells (fig 2’H). Finally, we explored the influence 
of ID4 on spinal cord stem cell growth by overexpressing it in growing NS using a retrovirus 
approach (fig S1’C). As shown on (figure 2’I), a reduction in cell number was observed which 
was concomitant with a decrease in EdU incorporation. It could be hypothesized that this could 
be accompanied by an astrocytic differentiation of the cells, however, conversely, WB analysis 
in growing spinal cord NS infected with ID4 virus showed a reduction of GFAP compared to 
control virus (fig S1’D). Collectively, these results identified ID4 as a negative regulator of 
spinal cord stem cell proliferation which is tightly regulated by MAPK/ERK and BMP 
signaling.  
  
 
 
  
Fig 2’: Regulation of ID4 in neural stem cells. A: IF for ID4 in spinal cord neural stem cells 
placed in the indicated conditions for EGF/FGF2 (EF). Cells were analyzed in the presence of 
growth factors (+) which were removed for 3 days (-) to induce differentiation and then added 
back for 3 days (+). B: WB (left panel) and QPCR (right panel) for ID4 in neural stem cells 
placed in the indicated conditions (n=3 independent experiments, test=one-way ANOVA and 
Tukey posttest). Numbers on the WB show relative quantification of ID4 signal normalized by 
C: IF for ID4/GFAP and ID4/MAP2 in differentiated neural stem cells show that ID4 
is preferentially detected in GFAP+ not in MAP2+ cells (white arrows). D: IF for p-ERK in 
differentiated neural stem cells infected with control (luciferase) or activated RAS lentivirus. 
Quantification is provided on the right panel (average % of cells +/- S.E.M, n=3 independent 
experiments, t=unpaired t-test). E: Left panel: Aspect of differentiated neural stem cells 
infected with control (luciferase) or RAS lentivirus. Round and probably mitotic cells are 
present (black arrow) with the activated RAS virus. Ki67 IF and quantification confirmed the 
presence of a high number of proliferative cells with the activated RAS virus (average % of 
cells +/- S.E.M, n=3 independent experiments, t=unpaired t-test). F: IF for ID4 in differentiated 
neural stem cells infected with control (luciferase) or activated RAS virus. Quantification is 
provided on the right panel (average % of cells +/- S.E.M, n=3 independent experiments, 
t=unpaired t-test). G: Images of NS derived from activated RAS virus infected cells and 
growing without growth factors (upper image). In the same condition, no NS were obtained 
from luciferase virus-infected cells (lower image). When placed in differentiation conditions 
with serum, RAS-infected NS generated few ID4+ cells and many Ki67+ cells compared to 
normal NS (middle panel). Right panel provides quantification for ID4+ and Ki67+ cells 
(average % of cells +/- S.E.M, n=3 independent experiments, t=unpaired t-test). H: IF for ID4 
and Ki67 in growing neural stem cells treated with or without BMP6 10 ng/ml. Quantification 
is provided on the right panel (average % of cells +/- S.E.M, n=3 independent experiments, 
t=unpaired t-test). I: Effect of overexpression with control (GFP) or ID4 retrovirus on neural 
stem cell growth. (n=3 independent experiments, t=unpaired t-test). The upper diagram shows 
the cell number ratio +/- S.E.M obtained after 5 days in GFP or ID4 retrovirus-infected cells. 
The lower panel shows the % of EdU+ cells +/- S.E.M (3 hours EdU incorporation) obtained 
in the different conditions.  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig S1’: MSX1 and ID4 overexpression. Related to Figure 7. A: IF of MSX1 on cells infected 
with luciferase or MSX1 inducible-lentivirus, with or without doxycycline (dox). B: Effect of 
MSX1 overexpression on spinal cord stem cell differentiation (n=3 independent experiments, 
test=one-way ANOVA + Tukey post-test). Diagrams show the average of fold change +/- S.E.M 
of cells positive for the indicated marker. C and D: ID4 overexpression in growing 
neurospheres (passage 3) derived from the adult spinal cord. C: IF of ID4 on cells infected with 
control (GFP) or ID4 retrovirus. Quantification is provided on the right panel (average % of 
ID4+ cells +/- S.E.M, n=3 independent experiments, test=unpaired t test). D: WB performed 
on proteins extracted from cells infected with control (GFP) or ID4 virus showing increased ID4 
but decreased GFAP. 3 independent experiments (Exp.) are shown. MW=molecular weights. 
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The first part of the project is an interesting shift in understanding the environment of the NSCs 
cell niche. Our study is the first to show transcriptomic, morphological and functional 
differences in the stem cell niche of human and mouse spinal cord. In this publication we 
identified the genetic profile of the mammalian (human and mouse) EZ, in which we identified 
the genes commonly and differentially expressed among both species. In addition, this study 
led us to identify various sub-population of cells that reside in the niche, focusing on the 
signaling pathways regulating their initiation and quiescence. Starting from this study we could 
go further to unravel other mysteries behind the human and mouse EZ niche.
Starting with differences identified in the ventral part of the EZ regarding the existence of CSF-
contacting neurons. In fact we showed that CSF contacting neurons reside in the ventral part of 
the central canal and they express various specific markers such as DCN, PKD2L1 and TAL1 
[1]. Similar profile was identified in the niche of regenerative models such as zebra fish and 
salamander [1], but those cell types remained almost unchanged in response to injury. An 
intriguing question is, what is the difference between CSF-Ns in regenerative and mouse 
models? And do they participate in the regeneration process after injury? To answer this 
question one could use transgenic mouse models targeting this specific population of cells and 
perform lineage study to follow their initiation. Following this, transcriptome analysis is 
necessary and to be more precise single cell analysis should be done, this allows to identify sub-
populations within CSF-Ns and to identify the genetic signature of those cells. Comparing these 
data to already existing data base on CSF-N from regenerative models allow to understand what 
makes the differences among different species. Another interesting question is, why mammals 
do not regenerate after injury? And how CSF-Ns could be modulated in the context of 
regeneration? Interestingly similar comparative analysis is required that will lead to understand 
the function of CSF-Ns in injury context and how they differ from CSF-Ns in regenerative
species. As these models showed an active regeneration by generating new neurons from the 
ventral part of the EZ niche. However CSF-N markers did not label the ventral part of the human 
EZ central canal, rather DCN for example is expressed in blood vessels [2]. One explanation is 
that this population of cells doesn’t exist in the human, or it is labeled with other markers that 
to be identified.  For that a detailed analysis using our data set and other data from the literature 
we might identify human genes that codes for the CSF-Ns markers.
In this publication we showed that CSF-Ns (DCN+/PKD2L1+/TAL1+) in the mouse ventral 
EZ expressed FOXA2, this population of cells were different from the ventral ARX+ cells. 
Interestingly in the human ventral EZ, FOXA2+ cells were also ARX+ indicating that there is 
at least two different population of cells that differ between mouse and human (figure S2 and 
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S4). Also this could point again on the absence of CSF-Ns in the human or there are other genes 
that encodes for other human specific CSF-Ns in the human. It will be interesting to target 
FOXA2+/ARX- cells in mouse EZ and the FOXA2+/ARX+ cells in human EZ and assess the 
differences in these two populations. This could be done using mouse transgenic models and 
single cell analysis to identify the genetic signature of both cell types and their characteristics, 
in which this analysis could lead to unravel the function of these two populations. One question 
could still under debate is whether the ARX+ cells found in human are derived from the floor 
plate as the mouse ARX+ cells? Or they have different origin?
Following this we identified another quiescent population of cells residing in the dorsal roof of 
the mouse and human EZ. This population of cells showed MSX1 expression co-localized with 
high ID4 expression under the regulation of BMP pathway. Moreover our in-vitro data showed 
that adding BMP6 caused increase in MSX1 and ID4 expressions and lead to decreased cell 
proliferation. In addition we identified a sub-population of MSX1+/ID4+ cells that are also 
positive to VEGFR3, in which this protein also labeled a population of ventral cells indicating 
dorsal-ventral regionalization. However it is interesting to follow the scenario in-vivo, and 
assess the influence of BMP6 and VEGR3 on the dorsal EZ cells in which it is lacking in our 
study. So what is the influence of induced high expression of BMP6 and/or VEGFc on the 
MSX1+/ID4+ cells and the dorsal ventral regionalization of EZ cells? To answer this question, 
two methods can be followed. The first is to inject the cytokines (BMP6 and VEGFc) directly 
in the spinal cord, then we can assess whether the in-vivo expression of MSX1 and ID4 
expression is modified and whether the dorsal-ventral regionalization is modified. In this 
manner we might encounter some limitations, for example whether there is effect or not it will 
be difficult to identify whether it’s due to endogenous or exogenous signals. The second way is 
through injection of BMP6-AVV and VEGFc-AVV into the lateral ventricle in the brain in 
which we could solve the problem raised by the first approach, so that we can follow and 
identify the exogenous cytokine we introduced. In addition to this it would be interesting to 
assess the activation of VEGFc on MSX1-Tomato+ cells in-vitro, a missing experiment in our 
study. This experiment can simply done by treating cell culture with VEGFc for few days and 
assess proliferation and differentiation. Such aims would allow us to identify the function of 
these pathways both in-vitro and in-vivo, and how they influence the protein expression profile 
within the EZ niche.
Focusing on the MSX1+ cell population it will be interesting to identify the RNA profile of this 
population in particular. In which we will launch a transcriptome analysis MSX1-tomato+ cells 
and control FOXJ1-GFP+ cells as FOXJ1 labels the EZ cells. The cells will be directly derived 
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from spinal cords of double transgenic mice MSX1-Tomato/FOXJ1-GFP. Such analysis will 
allow to identify several sub-populations within the MSX1 population evidenced by the 
presence of MSX1+/GFAP+/- and MSX1+/VEGFR3+/- in the paper I. An intriguing question 
is what could be the function of MSX1+ cells in intact and injured spinal cord? And could spinal 
cord injury activate quiescent MSX1+ cells in the dorsal roof of EZ? Performing acute SCI on 
MSX1-tomato mice would allow to answer both questions. We could follow activation, 
migration, and differentiation of MSX1-Tomato+ cells in the injured spinal cord. Also we could 
assess whether dorsal-ventral regionalization in the EZ is altered on not. In addition to this we 
can go so far by assess function of MSX1+ cells in context of degenerative diseases such as 
ALS and SMA, either through generating double transgenic by crossing MSX1-Tomato mouse 
with degenerative mouse model, or through transplantation of MSX1+ cells in injured spinal 
cord or in the spinal cord of degenerative model. Thus we can assess integration of these cells 
in the treated spinal cord and check for functional recovery through behavioral tests. Finally, 
we noticed in our study that the human EZ is all labeled with MSX1 with high expression in 
the dorsal roof. It will be interesting to investigate the different expression of MSX1 in mouse 
and human EZ. So whether this population of endougenous NSCs could could be a target for 
therapeutic purposes for SCI and degenerative diseases is still a debatable issue to be 
investigated.
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Part II
Spinal cord injury activates the central canal stem cell niche
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Spinal cord stem cell niche: from quiescence to 
activation after spinal cord injury. 
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Abstract
The spinal cord central canal harbors the ependymal zone (EZ), considered as the neural stem 
cell niche. Unlike the regenerative EZ in invertebrates, the adult EZ in mammals is quiescent. 
Spinal cord injury (SCI) is an event leading to neuron degeneration, cytotoxicity and functional 
deficits. On the other hand SCI is a leading cause of NSC niche activation. Our study showed 
the RNA profile differences of the EZ in intact and injured spinal cord, highlighting the main 
molecular pathways involved in the EZ activation. We identified the STAT3 signaling in the 
injured spinal cord that could be coupled with the activation of oncostatin (OSM) and its 
receptor (OSR) and may lead to hyper-activation of astrogliosis through driving GFAP, THBS2 
and CRYM expression. However there is a de-activation of the Hippo pathway characterized 
by the turn off of YAP/TAZ-TEAD transcription machinery. Finally our data showed 
upregulation of the transcription factor (TF) Olig1 in the EZ a characteristic of motoneuron and 
oligodendrocyte progenitor cells specification. These findings demonstrate that, the quiescent 
adult EZ zone is reactivated following injury through the activation of signaling molecules 
involved in astrogliosis and remodeling of the EZ through developmental TFs over-expression. 
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Introduction
Spinal cord injury or neurodegenerative diseases are major causes of neuron loss, in which these 
neurons are not replaced in mammals [3]. Following an injury, spinal cord faces the formation 
of inhibitory glial environment, intensive demyelination and axon degeneration, and neural cell 
death. Combined together these factors inhibit the complete regeneration and functional 
recovery after injury [4]. Although these factors such as glial scar formation played a role 
against the self-repair mechanism in the first hours after injury, novel studies showed that 
astrocytes and ependymal cells might have pro-regenerative effect [5], [6]. So therapeutically, 
endogenous ependymal cells could be an alternative method targeted to treat SCI, or the other 
way round SCI could activate the quiescent state of the stem cell niche  [7], [8].
The adult mammalian stem cell niche in the spinal cord is relatively quiescent. The mammalian 
ependymal zone (EZ) is a pseudo-epithe???????????????-catenin and CD24) originating mainly 
from the ventral part of the developing neuroepithelium. This niche is characterized by the 
existence of various cellular populations expressing specific set of transcription factors (as 
shown in the first publication). Talking about lower vertebrates it’s well-known that SCI 
activate the neurogenic niche and derive the proliferation of precursor/stem cells, and they 
contribute to the regeneration mechanism [9]. On the other hand, the contribution of these cells 
into the regeneration process in rodents is still controversial, while in human it is almost absent 
[10].
On behalf of the first publication, the RNA profile of the EZ after injury is still lacking. And 
since one clinical interest is to address the effect of SCI on the endogenous stem cell activation. 
This study is providing a detailed RNA profiling comparing intact spinal cord EZ Vs. injured 
spinal cord EZ in mouse. This study allows to identify the key genes inducing the activation of 
the quiescent NSCs. As well as could unravel the role of key endogenous NSC in the context 
of repair after injury. This study could be the first to undertake a comparative description of the 
importance of cells in the ependymal zone between regenerating and non-regenerating 
vertebrate species.
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Materials and Methods
1. Animals
Mice were handled following the guidelines of the Animal Care and Use Committee of the 
National Institute of Health and Medical Research (INSERM) who approved this study in 
accordance with the European Council directive (2010/63/UE) for the protection and use of 
vertebrate animals. Adult CD1 mice (3 months, Charles River, France) were used for micro-
dissection, RNA profiling and comparison between non-injured vs. injured spinal cord. 
C57BL6 wild type mice (3 months) were used for histological analysis. Msx1-CreERT2/Rosa-
Loxed Tomato transgenic line [11] was obtained from Y Lallemand (Pasteur Institute, Paris). 
To induce recombination in Msx1-CreERT2 animals, 100 µl of tamoxifen (Sigma, T5648, 20 
mg/ml dissolved in corn oil) was injected intraperitoneally for 4-5 days. These mice were used 
for spinal cord injury, and histological analysis.
2. Spinal cord Injury
Adult CD1 mice (3 months old) were anesthetized after inhalation of 1.0%–1.5% isoflurane 
gas; following vertebral thoracic 9 level (T9) laminectomy a lateral spinal cord hemisection 
(HS) was performed under microscope using a micro knife (10315–12, fine science tools 
(FST)), as described previously [12]. Lesions were done at T9 level to obtain monoplegia. Both 
muscles and skin over-laying the lesion area were sutured, and animals remained under visual 
monitoring during 2 h over the recovery period before returning them to their home cages. 4 
mice were used to micro-dissect the central canal for the RNA profiling that is performed after 
48 hours following injury. Same laminectomy was followed on 3 mice for histological studies 
that are dissected 48 hours following injury. 
3. Tissue micro-dissection
Same procedure was followed as described in the first publication. Briefly, mice spinal cords 
(injured and non-injured) were flash frozen in N2 without chemical fixation. Frozen sections 
(30 µm thick, T9-T10 thoracic part for mouse) were obtained at –23°C to prevent RNA 
degradation using a CM3050S microtome (Leica Microsystems, Wetzlar, Germany) and were 
mounted on PEN-membrane 1 mm glass slides (P.A.L.M. Microlaser Technologies AG, 
Bernried, Germany) that had been pretreated to inactivate RNase. Immediately following 
dehydration, laser microdissection was performed using a PALM MicroBeam microdissection 
system version 4.6 equipped with a P.A.L.M. RoboSoftware (P.A.L.M. Microlaser 
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Technologies AG, Bernried, Germany). To limit RNA degradation, samples were collected for 
up to 15 minutes per slide and microdissected tissue was lysed with 250 µl of lysis buffer 
?????????? ??????????????????????????????????????????????????????????????????????????????
using the ReliaPrep RNA cell Miniprep System (Promega, Madison, USA) according to the 
manufacturer’s protocol and eluted w??????????????????-free water. 
4. RNA profiling and bioinformatic analysis
Same procedure was followed as described in the first publication. Briefly, RNA profiling was 
performed using Affymetrix microarray technology. Hybridization targets were obtained 
following a double amplification procedure according to the protocol developed by Affymetrix 
(GeneChipTwo-Cycle Eukaryotic Target Labeling Assay; Affymetrix, USA). A hybridization 
mixture containing 10 µg of biotinylated cRNA was generated. The biotinylated cRNA was 
hybridized to HT_HG-U133_Plus_PM (human) and HT_MG-430_PM (mouse) Affymetrix 
microarrays. Four mice samples of each condition (EZ) were analyzed in total. The microarrays 
were scanned using the Affymetrix Gene Atlas scanner. Gene lists were analyzed with DAVID 
Bioinformatics Resources 6.8 for gene enrichment analysis. Data are available at the functional 
genomics data Gene Expression Omnibus (GEO) repository (series record GSE118445).
5. Mouse histology
Same procedure was followed as described in the first publication. Briefly, Mice were 
anesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg) and perfused 
intracardially with 10 ml of phosphate-buffered saline (PBS) followed by 50 ml of 4% 
formaldehyde-PBS solution (pH 7.0). After dissection spinal cords were post-fixed in the same 
solution for one hour and cryopreserved by successive immersion in 10, 20, and 30% sucrose 
solutions in PBS for at least 6 h. Cervical, thoracic and lumbar parts of the spinal cord were cut, 
embedded in OCT medium, rapidly frozen in liquid N2-cooled isopentane and cryosectioned 
(14µm) (Leica apparatus). 
Immunofluorescences (IF) were performed with primary antibodies listed below 
(supplementary table 1) on sections permeabilized for one hour with 0.1% Triton 100x and 5% 
donkey serum. Secondary antibodies (Alexa488 or Alexa594-conjugated species-specific anti 
mouse, rabbit or goat) were purchased from the Jackson Laboratories. Incubations without 
primary antibody or with antibody recognizing antigens not present in the sections (monoclonal 
anti DYKDDDDK Tag) were used as negative controls. Nuclei (blue in all images) were stained 
with Hoechst 1 µg/ml for 10 min. The quality of staining was evaluated by two independent 
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investigators (HG, and JPH). Images were taken using optical sectioning with structured 
illumination (Zeiss apotome microscope). 
6. Statistical analysis
All experiments and stainings were performed at least twice and most of them were done three 
times. Significances: *** (p<0??????????????????????????????
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Results
Genes enriched in the intact mouse spinal cord vs. injured spinal cord.
As previously described in the first paper, the RNA profile of human and mouse EZ has been 
described and identified (refer to paper I). Similar study has been launched to identify the RNA 
profile of mouse spinal cord EZ in intact and injured states. Such RNA profiling study will 
allow to identify the differential gene expression in quiescent and activation state of the EZ. 
The EZ of intact and pinched spinal cord was micro-dissected (figure 1A), and microarrays 
were performed on both RNAs.  Heat map of the four samples indicated adequate clustering of 
the EZ in each condition (figure 1B). Volcano plot showed the up-regulation of 875 genes and 
????????????????????????????????????????????????????????????????????????????????????????????????
(figure 1C). Some of the identified genes on the volcano plot were represented in a table, in 
which genes marked in red were also checked at the protein level to confirm the transcriptome 
data (figure 1D). The volcano plot data only shows some of the genes that are significantly up 
and down regulated. Gene ontology revealed the molecular functional mechanisms of the up 
and down-regulated genes (figure 1E, F). Interestingly, genes involved in cell adhesion were 
also up-regulated such as extracellular matrix protein 1 (ECM1) and Fibronectin. Moreover, 
genes involved in mitotic nuclear division were also up-regulation, an indication of enhanced 
activation and proliferation of EZ cells. Of these genes, Ccnd1, encoding cyclin D1 is a major 
candidate involved in mitotic division (supplementary excel file). On the other hand, a massive 
down-regulation was observed in the genes involved in cilium movement (figure1 F). The 
decrease in cilium movement is not an indication of decreased Foxj1 expression, a marker of 
ciliogenesis. Rather it could influence the response of cilia to flow and receiving external 
signals, and disrupt the regulation of signal transduction [13].
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Figure 1: RNA profiles of mouse EZ following SCI. (A) Schema showing the procedure of lase-micro 
dissection of intact and injured spinal cord EZ. Microdissected EZ region is delimited with dotted 
circles. Scale bars = 100 µm. (B) heat map of hierarchical clustering of genes expressed in EZ region in 
the 4 control mice and 4 injured mice samples. (C) Volcano plot showing the up-regulated and down-
regulated genes (606 and 875 ??????????????????????????????????????(D) Summary of the most regulated 
genes. (E, F) gene ontology showing up and down-regulated genes and their corresponding functional 
mechanisms after SCI.
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Validation of the up-regulated genes by Immunofluorescence
Following RNA profiling of the mouse EZ, we confirmed the up and down-regulation of some 
genes at the protein level. Mice were subjected to the same injury as the mice used for RNA 
profiling. Immunostaining revealed decreased ACTA1 (Actin alpha 1) expression in the EZ 
after injury, with a staining restricted to few cells in the parenchyma (supplementary figure 1).
It is a conserved protein of the actin family that play a role in cell motility, structure and 
integrity. Among its related pathways are Integrin Pathway and SMAD Signaling Network [14].
Gene Ontology (GO) annotations related to this gene include structural constituent of 
cytoskeleton and myosin binding. On the other hand there were an up-regulation in CRYM 
(Mu-Crystallin), almost exclusive to the ependymal zone (figure 2). Fibronectin showed 
increase in the EZ as well as in the parenchyma, while ECM1 (extracellular matrix) increase 
was major in the parenchyma rather than the EZ (supplementary figure 1 on page 181). This 
increase could help the rearrangement and reorganization of the spinal cord environment after 
injury, and could be interpreted by the increase in cell adhesion (figure 1E). A remarkable up-
regulation of Gas1 and Netrin genes after SCI, which has been confirmed by 
immunofluorescence. The EZ of injured spinal cord is highly positive for GAS1 and NETRIN 
compared to control (figure 2). GAS1 is induced by Wnt signaling is required for proliferation 
of progenitors of the cerebellar granule cells and Bergmann glia [15], while NETRIN could be 
implicated in axon guidance in response to injury [16]. The EZ was immunonegative for ETV5 
in the control spinal cord, but interestingly there was a massive increase in the ETV5 nuclear 
expression following SCI (figure 2). This increase could be related to the increase in GFAP, 
and Thbs2 (figure 1D) as ETV5 corresponds to the ETs family that play a role in perinatal 
gliogenesis mainly astrogenesis [17], [18]. This was coupled with an activation of another 
astrogenesis inducer [17], P-STAT3. Remarkably the control EZ was expressing cytoplasmic 
p-STAT3, and upon injury it is activated and translocated to the nucleus. Combined together 
those two TFs may induce astrocytes from the EZ. The phosphorylation and activation of 
STAT3 can be induced in part by the increased expression of OSMR after injury (figure 2). 
Some data showed that OSMR increase after inflammation enhancing the activation of STAT3 
[19], on the other hand STAT3 could be required for GFAP-OSMR clustering to induce 
astrocyte differentiation [20]. OSMR is activated by oncostatin (OSM) which is also increased 
after injury (supplementary figure 1). Although RNA profiling data showed almost no change 
of OSM expression in the EZ after injury, but immunostaining showed increased OSM 
expression in the EZ and parenchyma. Moreover, our RNA profile data showed a significant 
up regulation of the phospho-extracellular signal-regulated kinase (p-ERK). This data was 
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confirmed by p-ERK immunostaining that increased in the EZ after injury (figure 2). 
Interestingly, p-ERK is a protein known to play a role in cell division, growth, and proliferation. 
One of the identified pathways that could play a key role in the activation and proliferation of 
EZ cells, is the hippo pathway that involves YAP/TAZ, and TEAD transcription factors.
Immunostaining showed similar expression of both YAP (supplementary figure 1), and 
YAP/TAZ (figure 2) in control and injured spinal cord, while TEAD expression is decreased in 
the EZ of the injured spinal cord, and its cytoplasmic expression is restricted to few cells in the 
parenchyma (figure 2). To the knowledge, activated YAP, and YAP/TAZ enter the nucleus, 
dimerize and couple with DNA binding TEAD protein to activate gene expression [21]. How 
the decrease of TEAD1 protein could influence the transcriptional machinery after injury is still 
unclear.
Another striking results observed both in RNA data and immunostainings is, the significant 
increase of Olig1 TF in the EZ following injury (figure 1 & 2). One to two cells were observed 
either dorsally or ventrally in the EZ, however not all sections showed Olig1+ cells. During 
development Olig1 is expressed mainly ventrally in the EZ, where those Olig1+ cells give rise 
to motor neurons. The EZ expression of Olig1 decrease in the early postnatal stages to disappear 
late in the adult stage when neuron specification has occurred [21]. The re-expression of Olig1 
in the EZ of injured spinal cord is promising for active repair mechanism.
Combined together these data showed activation of the extracellular matrix responsible 
proteins, coupled with enhancement of pathways required for cell activation, proliferation and 
gliogenesis, with Olig1 a promising target for injury repair. 
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Figure2: EZ characterization of intact vs. injured spinal cord. IF for the indicated proteins in the 
adult mouse EZ (thoracic level). Images are oriented with ventral part to the bottom. The white arrow 
on OLIG1 staining show positive cell in the dorsal part. Presented images are representative of 6 sections 
per animal, n=2 mice analyzed. Scale bar (shown on first image) = 20 µm, and Hoechst is used as a 
nuclear stain in blue. 
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Discussion
In this study RNA profiling was used to explore the adult mouse EZ in control and injured 
spinal cord. We built a new corpus of knowledge on this particular CNS region following an 
injury. Our preliminary data revealed important and new characteristics of the activated stem 
cell niche following an injury compared to the quiescent niche. Our data revealed an up-
regulation of genes implicated in increased proliferation, adhesion, axon guidance and 
astrogenesis. Thus the EZ stem cell niche is an active zone and a territory of endogenous stem 
cells that are implicated in the repair mechanism.
Following a spinal cord injury, there is a massive destruction of the neuronal function in the 
spinal cord [22]. It is caused by axonal damage, dysfunction, and degeneration, and this damage 
is irreversible [22], [23]. CRYM is known to be expressed in a wide range of tissues, including 
brain where it is expressed in the descending projection neurons of the motor cortex [24]. While 
in the spinal cord it is expressed in descending corticospinal tracts axons that are localized 
dorsally and ventrally in the grey and white matter [23]. To the knowledge, Pawar et al showed 
that CRYM is co-localized with NF-200, an axonal marker, in which those double positive 
fibers appeared to cross the injured area and reenter the adjacent spared parenchyma. Thus, 
CRYM expression is increased after injury and support the regeneration of descending axons, 
where its increase in the EZ (figure 1 & 2) following injury requires a further investigation.  It 
could be possible that CRYM is involved in driving stem cells to enhance axonal regeneration 
and guidance as well as it could be possible that it enhance the inflammatory response through 
macrophages as a minority of cells are co-labeled with F4/80 a positive marker of macrophages 
[24]. In addition to this single cell analysis on the V-SVZ NSCs in the brain revealed the 
existence of 5 sub-populations of astrocytes, in which astrocyte type-2 are enriched in the 
expression of CRYM. It appeared that astrocyte type-1 cells are involved in deriving activation 
of quiescent stem cells into transit amplifying cells to generate OB neurons. Also they showed 
that this lineage is coupled with the generation of OPCs during the activation process [25]. So 
the increase of CRYM particularly in the EZ following injury could be an indication of the 
presence of astrocyte type-2 cells that are undergoing activation.
One of the major events that follow the SCI is the morphological changes in the intermediate 
filament content and extracellular matrix material that may push EZ cells to undergo epithelial-
mesenchymal transition [26]. Interestingly we showed an increase of the adhesive glycoprotein 
fibronectin in the EZ as well as a significant increase of ECM1 protein in the parenchyma 
(figure 1 & 2), this could indicate a repair mechanism is ongoing following SCI, as EZ cells are 
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undergoing EMT and a rearrangement procedure, and it is a major indication of ependymal 
outgrowth, and axon regeneration. Moreover those two mentioned proteins could be localized 
with vimentin and GFAP an indication of endogenous stem cell changes as well as astrogliosis 
[26]–[28]. Another protein involved in neurite outgrowth and axon guidance is NETRIN1, 
where it showed an up-regulation in the EZ after injury (figure 1 & 2). NETRIN1 are secreted 
proteins expressed in various cell types during development and in subset of neurons, where 
coupling with its receptors play a role in axon attraction or repulsion [29], [30]. Genetic 
mutation to this protein causes defects in motor neuron axon projections, and this protein 
receptor coupling is known to be highly affected in Huntington disease, in which NETRIN1 
can be a target for treating axon degeneration and guidance [16], [31]. However its expression 
in EZ stem cells is still not well illustrated, and further investigation is required to understand 
the overexpression of NETRIN in the EZ following an injury.Whether the ependymal cells are
the source of secreting this protein? Or is it the target of NETRIN binding to its receptor? 
Questions have to be addressed to identify the role of netrin in stem cell activation.
Of the identified genes, are those regulating cell fates during development. GAS1 was identified 
as a negative regulator of the SHH signaling in various tissues [32] while recent data showed 
that GAS1 is an agonist of the SHH signaling [33], [34]. In which GAS1 mutants showed 
phenotypic defects due to decreased shh.  As ventral neural development is regulated by shh 
signaling, GAS1 could be a major regulator of the ventral cell fate identity and patterning. The 
scenario starts at the ventral midline with the specification of floor plate cells that require the 
highest level of Shh signaling [35]. The scenario involves a localized expression and activation 
of FoxA2, a direct transcriptional regulator of Shh [15]. Importantly, despite the strong 
expression of Gas1 in dorsal domains, GAS1 mutants showed no changes in the specification 
of general dorsal cell identities (Pax6+, Pax7+) and specific Msx1+ roof plate and Math1+ dp1 
progenitors. Thus Gas1 functioning to specifically modulate the level of Shh signal that cells 
are exposed to during neural tube patterning [34], [35]. However the increase of GAS1 in the 
EZ after injury was not ventrally restricted, rather its expression appeared dorsally and ventrally 
(figure 2). And this could be also explained by the fact that GAS1 is induced by Wnt signaling 
that controls the dorsal patterning. And it is proven that Wnt induce GAS1 expression that is 
required for proliferation of progenitors of the cerebellar granule cells and Bergmann glia [15], 
[33]. We can conclude from our data and from the literature that, SCI injury enhance both Wnt 
and Shh signaling that influence dorsal and ventral expression of GAS1 which regain the 
embryonic feature patterning and enhance proliferation in the EZ. 
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Staying in the scenario of patterning during embryonic development, one gene family that could 
fit is the Gli family, which is also regulated by the Shh signaling. As described previously, the 
most ventral cell type in the neural tube, requires higher levels and longer durations of Shh 
signaling than p3 cells. Consistent with this, mice lacking the trans-membrane protein Smo or 
Gli transcription factors, which are involved in the transduction of Shh signal, demonstrated 
that FP specification requires Shh signaling [36], [37]. Gli3 which belongs to the Gli family is 
known to be a positive contributor to shh signaling and act with GAS1 in patterning, this could 
explain the increase of its expression after SCI (supplementary figure 1). Gli3 along with Gli2 
are able to activate shh signaling, in which loss of Gli3 function results in reduced shh. Although 
Gli proteins are not essential to derive all motor neurons and V0-V2 interneurons, but they are 
essential to regulate normal motor neurons differentiation and the normal patterning of ventral 
cell types [38], [39]. Gli3 mutant embryos showed additional phenotype resulted in massive 
proliferation in the ventral most part of the spinal cord. This was tested by the incorporation of 
BrdU that increased in the ventral part including ventral midline with the loss of Gli function. 
The increase of BrdU is concomitant with the increase of cyclin D1, a G1 cyclin and a target of 
shh which indicates the over-proliferation is due to the disruption of the cell cycle [39], [40]. In 
addition to the involvement in the spinal cord patterning, Gli3 could be involved in controlling 
cell fate and adhesion to establish a proper neurogenic niche [41]. Shh signal plays a critical 
role in maintaining the proliferation of NSCs and other progenitor cells in adults [42]. However 
Gli3 is expressed by RGCs prior to shh in embryonic stage, so one could raise a question 
whether Gli3 in the SVZ plays a role in the development of the neurogenic niche in the absence 
shh signal? 
Expression study showed that Gli3 is expressed in the NSCs and ependymal cells of the SVZ, 
while Gli1 (shh signaling) was so restricted embryonically and not involved in OB neurogenesis 
until E18.5. Instead Gli1 is expressed in cells capable of proliferation in the SVZ. For that Gli3 
act as a repressor in RGCs during development and postnatal ependymal cells [43]. Conditional 
removal of Gli3 in RGCs before shh activation but after embryonic patterning is established, 
showed abnormal organization of the neurogenic niche [41]. Normally in the developing 
?????????????????? ??????????????????????????????????-catenin+) are arranged in a pinwheel 
structure at the lateral wall of the lateral ventricles [44]. In contrast to this, in the absence of 
Gli3 there was no apparent pinwheel structure with an up-regulation of GFAP in RGCs 
suggesting a delay in the niche maturation. On the other hand, it showed up-????????????????
tubulin+ ciliary bodies suggesting mature ependymal cells with persistence of GFAP over-
expression. So GFAP played a role in the distinction of NSCs and ependymal cells that failed 
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to develop in the absence of Gli3 [45]. The malformation of the neurogenic niche observed at 
P21 could also be due to the delay in ependymal cells maturation and the lack of proper 
specification of cell identity. This was clear by the decrease of Foxj1, a marker of mature 
ependymal cells, in the absence of Gli3 function, as well as due to the presence of 
Foxj1+GFAP+ cells in the Gli3 mutant embryos but not in the control ones [45]. Thus, Gli3 
mutant cells with double identity are no more functional and are not proliferative in which they 
lost the NSCs characteristics, causing structural defects in the neurogenic architecture and 
leading to severe diseases. This confirms the importance of Gli3 function in maintaining niche 
structure and cell fate, a reason why it increased slightly after SCI (figure 2). 
One could raise a question about the downstream events leading to the ectopic expression of 
GFAP in Gli3 mutant SVZ? So analyzing gene expression for identified genes that are involved 
in Shh and/or Notch pathways and contain Gli3 binding sites, could answer the question [46].
Such analysis is carried on E16.5 forebrain tissue from wild type embryos with that from Gli3 
null mutant animals, a time point in which active Shh signaling is absent and any phenotypes 
observed is attributed to the loss of Gli3 function. Surprisingly, one of the dramatically changed 
genes was il6st that encodes a protein named gp130, a co-receptor subunit shared by the IL-6
family of cytokines including CNTF, OSM, IL-6, LIF and CT-1 [47], [48]. JAK-STAT 
molecules are downstream effectors activated by gp130 and the cytokine-specific receptors that 
transduce cytokine signals. Gp130 dimerization leads to phosphorylation of cytoplasmic 
tyrosine residues of the chimeric receptor protein, subsequent STAT3 and ERK1/2 
phosphorylation, and transcriptional activation of gp130 target genes [49] . In E16.5 forebrain 
of Gli3 mutant both il6st and gp130 protein levels were increased, however, the expression 
levels of all the cytokine-specific co-receptors were unchanged [45], [47], [48]. Interestingly in 
our study we showed a significant increase of OSM and its receptor as well as a slight increase 
in the STAT3, in which p-STAT3 translocated from the cytoplasm to the nucleus after SCI 
(figures 1 & 2). Gp130 promotes GFAP expression and glial cell fate through the 
phosphorylation of the STAT3 transcription factor where a transient activation of STAT3 in a 
small population of SVZ cells at P4 is observed [50], [51]. To the knowledge, majority of p-
STAT3+ cells also expressed GFAP, confirming that, increased gp130 level induce ectopic 
activation of STAT3 to induce GFAP overexpression. So it’s clear that pSTAT3 directly 
activates GFAP gene transcription by binding to its promoter sequence [45], [52]. Focusing on 
the STAT3, it is a pathway widely addressed in the context of regeneration and CNS injury. 
Xenopus laevis tadpoles are characterized to have two developmental stages, pre-metamorphic 
and metamorphic Xenopus stages. It’s know that xenopus laevis tadpoles can regenerate a 
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spinal cord after injury but this capability is lost during metamorphosis [53], [54]. Interestingly, 
these two developmental stages could allow to understand the molecular mechanisms of spinal 
cord regeneration. JAK-STAT pathway is one of the signaling pathways known to control 
several cellular responses after SCI in mammals. This pathway is involved in the transduction 
of several cytokines and growth factors such as OSM and its receptor. Activation of the JAK-
STAT pathway leads to the phosphorylation of STAT3, which causes its translocation to the 
nucleus to bind DNA regulatory sequences and regulate gene expression  [49], [55]. Following 
SCI different components of the JAK-STAT pathway have been used to characterize pathway 
activation such as an increase in the levels of cytokines [56] or phosphorylated STAT3 (figure 
1 & S1) [57], as well as the increase of direct targets of this pathway, such as SOCS3 [58]. In 
addition to this, the activation of STAT3 is necessary for astrocyte involvement in the glial scar 
formation, which in turn ac??????? ???? ???????????? ????????? ???? ???????? ????? ?????????????
[59], [60]. Moreover gain of JAK-STAT function proved to be implicated in axon regeneration 
and collateral sprouting, enhancing motor recovery [61]. Following the increase of pSTAT3 in 
the EZ (figure 1 & S1), Sox2+ ependymal cells from the VZ proliferate after SCI and are 
necessary for spinal cord regeneration [54]. Taken together STAT3 co-localized with Sox2+ 
cells in the VZ, and there is stage-dependent differences in JAK-STAT activation in relevant 
cell types for spinal cord regeneration [54], [62]. Finally p-STAT3 increased expression after a 
SCI could play a critical role in promoting corticospinal remodeling and functional recovery 
[63].
Previous studies on brain ischemia and TBI showed that, STAT3 activation mediates astrocytes 
phenotypic changes that are characterized by cytoplasmic enlargement, elongation of their 
processes, and up-regulation of GFAP; this change is termed reactive astrocytosis. The GFAP 
upregulation is coupled with the upregulation of oncostatin (OSM), a major component of the 
STAT3 pathway [64]. Similar data were obtained in our study after the translocation of STAT3 
into the nucleus, where OSM and OSMR are upregulated in the EZ following injury compared 
to the control (figure 1, 2, & S1). OSM belongs to the IL-6 cytokine family and signals using 
the gp130 receptor. OSM and OSR significantly increased in the EZ and parenchyma after SCI 
(figure 1, 2, & S1). Where OSM could mediate and provide neuroprotective effect against 
cytotoxic injury and promotes repair in demyelinated regions after injury [65]. Also it has been 
shown that OSM promotes activation of STAT3 selectively in Muller cells in the retina, which 
promotes protection of photoreceptors in a mouse model of retinal degeneration, suggesting 
that OSM may serve to induce glial-neuronal protective effects in other injury models [66]. So 
in our model the up-regulation of OSM and OSR may promote neuronal survival and 
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regeneration with evidence of decreasing lesion size, may be necessary to allow for the 
activation of neuroprotective pathways and inhibit the deleterious effects associated with 
reactive astrocytosis. and may serve a novel neuroprotective function and may be a new 
therapeutic target to enhance neurite growth and functional recovery  [67], [68].
Another pathway appeared to be involved in the molecular changes and proliferation of the EZ 
following SCI is the Hippo pathway. It is a conserved pathway that regulates organ size and 
tumorigenesis through negatively regulating the oncogenic transcriptional co-activators yes-
associated protein (YAP) and TAZ (WWTR1) [69]–[71]. Following activation, the Hippo 
pathway phosphorylates YAP, in which p-YAP undergoes subsequent degradation. On the 
other hand, when de-phosphorylated it enters to the nucleus after dimerizaton with TAZ, and 
interact with DNA binding protein family TEAD. Thus deriving transcriptional gene machinery 
that are involved in regulating various cellular processes, including cell survival, proliferation 
and differentiation [72]–[74]. However the function of YAP, YAP/TAZ, and TEAD in multiple 
organ development has been well described, while their function in the CNS development and 
injury still not yet clear. In our study we observed almost no change in YAP, Yap/TAZ 
expression in SCI compared to the control, but strikingly the nuclear expression of TEAD in 
the EZ of control SC decreased and almost disappeared from the EZ of the injured SC (figure 
2 & S1). These data should be further analyzed by assessing the function of YAP in-vitro to 
understand its role in the context of EZ following SCI. In a normal situation, YAP is involved 
in the BMP suppressed differentiation of embryonic NSCs through a direct interaction with 
Smad1. BMP2 and other growth factors are highly expressed in mouse NSCs, suggesting a vital 
role of this family in maintaining NSC quiescence in the adult CNS [75], [76]. Various in vitro 
studies confirmed that BMP2 activation influenced self-renewal and proliferation of mouse 
embryonic NSCs through the neurosphere assay. Cultures were treated with BMP2 showed 
fewer neurospheres with smaller sizes, suggesting an inhibitory effect of BMP2 on self-renewal 
and proliferation of NSCs [77].  We obtained similar data when treated cultures with BMP4 
through upregulating MSX1 and ID4 (refer to the first paper). YAP is the target of BMP2 
signaling, in which activation of BMP2 signaling represses the YAP/TEAD transcriptional 
machinery in embryonic NSCs. These data suggests that BMP2 signal reduces the YAP/TEAD 
coupling and enhance the YAP/Smad1-4 interaction to maintain NSCs in their quiescent state 
or promotes neocortical astrocytic differentiation [78]. In fact this activity is reversed by noggin 
treatment a BMP antagonist [77], [79]. Moreover, in the developing brain, YAP was selectively 
expressed in NSCs and astrocytes [21], in which its deletion resulted in reactive astrogliosis. 
This drives microglial activation that is associated with decreased BBB function. Thus YAP in 
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astrocytes counter-act the hyper activity of the JAK/STAT3 inflammatory signaling through 
the induction of suppressor of cytokine signaling (SOCS) family gene expression [80]. This 
could explain our observation in which STAT3 pathway is activated with the up regulation of 
OSM and OSMR and the inhibition of YAP/TAZ through the decrease of TEAD1 in the EZ 
following SCI (figure 1, 2, & S1).
Of the major results we obtained following SCI is the presence of Olig1 cells in the EZ (figure
2). Normally intact adult EZ is devoted of Olig1, as its expression in the EZ is restricted to the 
developmental stage [81]. Evidence showed that Olig1 play essential roles in oligodendrocyte 
progenitor cell specification and differentiation in the developing embryonic spinal cord and 
brain. Also there is an evidence about Olig1 over-expression following SCI in the white and 
gray matter, but nothing is mentioned about EZ stem cell niche [82], [83]. During development 
Olig1 not only essential for oligodendrocytes but also essential for motoneurons from the 
ventral EZ and a subset of astrocytes and ependymal cells [84].  So our data demonstrates that 
the EZ regained the developmental phenotypes by expressing Olig1 following SCI. This might 
enhance the generation of motoneurons, oligodendrocytes, astrocytes, and maintaining 
ependymal cells in the SVZ. Thus Olig1 could be a therapeutic target to control endogenous 
stem cells in the EZ following injury. This study pave the way to identify vital molecular event 
involved in the use of endogenous stem cells as a therapeutic target for degenerative diseases 
and CNS injury.
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Supplementary figure1 (S1): EZ characterization of intact vs. injured spinal cord. IF for the 
indicated proteins in the adult mouse EZ (thoracic level). Images are oriented with ventral part to the 
bottom. The white arrow on OLIG1 staining show positive cell in the dorsal part. Presented images are 
representative of 6 sections per animal, n=2 mice analyzed. Scale bar (shown on first image) = 20 µm, 
and Hoechst is used as a nuclear stain in blue.
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Supplementary table 1: List of antibodies used for the histological analysis.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Species Supplier Reference DF for IF
Acta1 Rabbit Sigma A2066 1/100
CRYM Rabbit Proteintech 12495-1-AP 1/200
ECM1 Rabbit Proteintech 11521-1-ap 1/500
ETV5 Rabbit Abcam Ab102010 1/500
Fibronectin Mouse Sigma F-6140 1/400
Gas1 Goat R&D bio-techne AF2644 1/100
GlI3 Goat Santa-cruz SC6154 1/200
Galactin1 Rabbit GeneTex GTX101566 1/500
Netrin Rabbit Abcam ab126729 1/500
Olig1 Goat R&D AF2417 1/100
OSMR Goat R&D AF662-SP 1/100
P-EGFR Rabbit Abcam AB68470 1/250
p-Erk Rabbit Cell signaling 4370 1/200
P-STAT3 Rabbit Cell signaling TYR705 1/100
YAP Rabbit Cell Signaling 14074 1/100
YAP/TAZ Rabbit Cell Signaling 8418 1/200
TEAD Mouse BD 610922 1/200
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The importance of our study is that, it gives a clear and deep characterization of the genetic 
signature of the niche EZ in intact and injured spinal cord. Our study showed the major genes 
that are up-regulated in the activated niche, a major study to address the vital genes involved in 
the activation and proliferation of the quiescent EZ. So this study pave the way to address many 
questions regarding ependymal niche cells and NCSs and the regenerative mechanism.
An intriguing question one could assess is what are the genes implicated in the activation of the 
stem cell niche? And what is the function of these genes? In our study we showed the up-
regulation of ETV5 following spinal cord injury. ETV5 is a member of the Ets transcription 
factor family, as a likely mediator of perinatal gliogenesis [18], [85]. It could be possible that 
the translocation of ETV5 into the nucleus is an indication of activated endogenous stem cell 
niche to encounter NSC depletion and enhance gliogenesis, processes tightly regulated by 
ETV5. So it would be interesting to mask the activity of ETV5 to confirm its function, in which 
using ETV5 floxed mice could be a possible way to KO the gene. 
Similarly, we showed up regulation of STAT3 and the translocation of its active form p-STAT3 
into the nucleus, at the same time we showed up-regulation of OSM and OSMR in the EZ 
following injury compared to the control. A pathway involved in astrocyte involvement in the 
?????? ????? ??????????? ?????? ??? ????? ????????? ???? ???????????? ????????? ???? ???????? ?????
regeneration (Deming, and Michael 2016). Also it could mediate and provide neuroprotective 
effect against cytotoxic injury and promotes repair in demyelinated regions after injury [65].
SO it is interesting to confirm the function of these genes both in-vivo and in-vitro. Again the 
use of specific gene-floxed mouse models would be a tool to knock-out the gene and validate 
its function in the EZ. One could check for increased severity of SCI responses in the absence 
of the gene. Also knocking out OSMR from cultured cells in-vitro through using Crispr-cas9 
or siRNAs could also identify the function of OSMR in NSCs. Interestingly, the other way 
round could be done through overexpressing one of these genes in purpose to ameliorate defects 
following injury through the activation of the endogenous stem cell pool. For example, injecting 
OSMR directly into the spinal cord could be one possible method to check for OSMR over-
expression effect on the EZ. Or the use of OSMR-AAV injection into the V-SVZ could be a 
better second method to over-express OSMR. In this manner we can check for OSMR effect on 
activating the quiescent EZ and check for cell fate after differentiation, and if OSMR could alter 
the dorsal-ventral regionalization within the EZ. Following up on what mentioned before about 
YAP, YAP/TAZ, and TEAD, in which they control proliferation in various organs including 
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the V-SVZ NSCs in the brain. There function is still unclear in the quiescent EZ in intact and 
injured spinal cord. So similar methods are followed recently in the lab, using the YAP-floxed 
mice and over-expression of YAP by lentivirus. Thus i twill allow to identify and unravel the 
function of this complex in the spinal cord EZ NSCs.
One of the in intriguing questions is to which extent endogenous stem cells are recruited after 
lesion or diseases? Few studies focused on the endogenous stem cell pool changes in 
degenerative diseases. In order to answer this question one could look and use mouse models 
of ALS, SMA, and MS, this allows to define differences and similarities in cellular responses 
and environmental cues. For example MS is a demyelinating inflammatory chronic disease that 
can be studied in EAE mice. There is little evidence about reactive ependymal cells to EAE, 
but previous studies already assessed proliferation activity [86], or fate mapping methods that 
covered a small subset of ependymal cells [87]. So it would be interesting to assess if ependymal 
cells are activated and recruited in EAE or any other degenerative model, and study whether 
they contribute to ameliorate the symptoms of the disease. Thus they could be an efficient 
therapeutic target to treat degenerative diseases. 
In the context of the glial scar and the ability to modulate the scar in a beneficial way, first it’s 
crucial to understand the detailed view of the scar environment and the distinct domains of the 
scar. This is related to a new findings of the existence of 5 subtypes of astrocytes in V-SVZ 
NSC niche in the brain [25]. One of the subtypes is astrocytes type-2 that have a high expression 
of CRYM, a protein highly up-regulated in the EZ niche of the injured spinal cord (paper 2). 
So is the glial scar mainly derived of Astro2 cells or it’s a more heterogenic zone? Is CRYM 
up-regulation derive the proliferation of the Astro2 cells and derive their migration into the glial 
scar? So the use of Crym transgenic mouse model would allow to follow the EZ CRYM+ cells 
after injury and assess their response to spinal cord injury. Thus these cells can be targeted to 
modulate the injury environment as a future therapeutic approach. 
Recent study published by the lab of Fiona Doestch showed that there is a functional 
heterogeneity in the NSC niche of the V-SVZ. This study showed that the lateral wall is more 
neurogenic producing neural progenies while septal wall is more gliogenic in which it generates 
glial progenies [25].  In the first paper, we showed a dorsal-ventral regionalization and 
heterogeneity in the EZ, also we showed in-vitro that dorsal cells (MSX1+ cells) generate both 
astrocytes and oligodendrocytes. This raises the question if individual ependymal cells are 
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multipotent in vivo and if the same ependymal cells generate scar-forming astrocytes and 
oligodendrocytes? Also is there a neurogenic/gliogenic potential of the dorsal-ventral EZ 
following injury? To address the first part of the question one could do in vivo clonal cell 
analysis of individual ependymal cells. That’s why we started with evaluating the response of 
quiescent dorsal MSX1+ cells to injury and assess whether they can generate both astrocytes 
and oligodendrocytes after injury. A perspective was mention in the first part. Now to answer 
the second part of the study regarding dorsal-ventral potential of neurogenic/gliogenic potential 
it will be interesting to follow the same approach of the first publication. So laser micro-
dissection of the dorsal, later, and ventral parts of the EZ after SCI coupled with the same RNA 
profiling approach used before will allow to identify the genetic signature of the different parts 
allowing to identify the neurogenic/gliogenic potential of each EZ part if it exist. This RNA 
profiling approach is not the best to be used in such study. What would be more interesting and 
precise is the use of single cell RNA sequencing of cells sorted from the three various parts. 
The use of various transgenic mouse models we have in the lab and the creation of double 
transgenic models labeling various cell types in the EZ will allow to sort differentially cells 
from the dorsal and ventral parts. Thus such approach will give a detailed analysis of the 
different populations and the specific neurogenic/gliogeneic potential of each cell population 
following SCI.
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Abstract
Glial-neuronal interactions are very important mechanisms for supporting and keeping neurons 
intact. One of these glial cells is the satellite oligodendrocyte or so called perineuronal satellite 
cells (PNCs). PNCs are tightly associated to the soma of large neurons and widely spread in the 
grey matter of the CNS both the cortical layers as well as the spinal cord. However the cellular 
properties and functional roles of these unmyelinating oligodendrocytes are not yet discovered. 
In this study, we detected by using nestin-GFP mouse that 21% and 24% of GFP-positive cells 
are associated to neurons immunostained for neuronal nuclear antigen in both cortex and spinal 
cord respectively. Although we identified PNCs as 2’, 3’-cyclic nucleotide 3’-
phosphodiesterase-positive cells, but they were negative for oligodendrocyte progenitor cells 
specific markers and myelinating oligodendrocyte specific markers. So PNCs are neither 
oligodendrocyte progenitor cells (PDGFRa negative) nor myelinating oligodendrocytes (MBP 
negative). We designed the nestin-GFP/Olig2-Tomato mice a new tool to isolate and 
characterize PNCs, as well as study their interaction with motor neurons. Our data suggest that 
PNCs are newly formed oligodendrocyte cells that could be integrated into the glial syncytium. 
Also it could be implicated in neurodegenerative diseases such as multiple sclerosis and 
amyotrophic lateral sclerosis due to their interaction with motor neurons.  
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Introduction
Central nervous system (CNS) is characterized by a wide cellular diversity, in which the cells 
communicante together for the CNS to function [1]. In addition to stem cells, there are the 
neurons that constitute the core component of the CNS that are integrated in the glial syncytium 
formed by glial cells [2]. Astrocytes, microglias, oligodendrocyte progenitor cells (OPCs), and 
myelinating oligodendrocytes are well known to support and protect neurons from shearing [3].
Focusing on the role of oligodendrocytes in the CNS, it is known that OPCs will proliferate and 
generate mature oligodendrocyte that are able to myelinate neuron axons [4]. Recent study 
identified 13 subpopulations of cells that belong to the oligodendrocyte lineage showing the 
phenotype of each cell population using single cell approach [5]. This study excluded the 
satellite oligodendrocyte cells or peri-neuronal cells (PNCs). PNCs are found in the gray matter 
of the CNS in a satellite position with the soma of neurons. These cells are widley distributed 
in the cortex and spinal cord, and attached to at least two types of neurons glutamatergic sensory 
neurons and cholinergic motor neurons [6]. Non-proliferating PNCs could be a type of 
oligodendrocyte lineage cells that are not well identified. PNCs are neither OPCs nor 
myelinating oligodendrocyte due to the fact that these cells do not express the specific markers 
that corresponds to these cell stages [6], [7]. So further studies are needed to confirm whether 
these cells are myelinating or non myelinating cells. But in fact, PNCs express markers that 
may correspond to the newly formed oligodendrocytes, a stage in which the cells are arrested 
by signals depending on CNS needs. The function of PNCs are not well illustrated, and it is 
restricted to providing metabolic support [6], [7], or regulating action potential firing and 
preventing neuronal burst [8]. So cytochemical and cytological characteristics of PNCs are 
identified, but the functional characteristics are not fully discovered yet. In this study, a new 
approach was followed using a different transgenic mouse that could target PNCs specifically 
with attempts to purify those cells in-vitro and assess their function.
In this peoject we highlited that the glial-neuronal interactions are very important mechanisms 
for supporting and keeping neurons intact. One of these glial cells is the satellite 
oligodendrocyte or so called perineuronal satellite cells (PNCs). PNCs are tightly associated to 
the soma of large neurons and widely spread in the grey matter of the CNS both the cortical 
layers as well as the spinal cord. However the cellular properties and functional roles of these 
unmyelinating oligodendrocytes are not yet discovered. In this study, we detected by using 
nestin-GFP mouse model that 21% and 24% of GFP-positive cells are associated to neurons 
immunostained for neuronal nuclear antigen in both cortex and spinal cord respectively. Also 
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we identified PNCs as 2’, 3’-cyclic nucleotide 3’-phosphodiesterase-positive cells. CNPase 
positive cells were immunonegative to other glial cells (astrocytes and microglia) as well as 
OPCs. This lead to the fact that PNCs are neither oligodendrocyte progenitor cells (PDGFRa) 
nor myelinating oligodendrocytes (MBP). For the in vitro part, we designed a new tool to isolate 
and characterize PNCs, as well as study their interaction with motor neurons. Our data suggest 
that PNCs are newly formed oligodendrocyte cells that could be integrated into the glial 
syncytium. Also it could be implicated in neurodegenerative diseases such as multiple sclerosis 
and amyotrophic lateral sclerosis due to their interaction with motor neurons.
 
185
Methods 
1. Animal care and models used
Animal experiments were performed in compliance with institutional and national guidelines 
for animal use. All mice were in a controlled environment (12 h light/dark cycle, 22 ±2 °C). All 
animals were handled under pathogen-free conditions and fed chow diet ad libitum. For this 
study we used : C57BL6 Nestin-GFP mice  for histological experiments and cell cuture, Msx1-
CreERT2/Rosa-Loxed Tomato transgenic described before for the EDU injection, Hes 5-GFP 
mouse line for histological analysis, and olig2 -CreERT2/Rosa-Loxed Tomato mice (Pascale 
Durbec) crossed with C57BL6 Nestin-GFP mice  to generate the Nestin-GFP/Olig2 tomato 
mice for the in vitro and RNA sequencing. Transgenic (TG) mice were identifed by PCR, males 
and females aged from 3-5 months were used for all experiments.
2. EdU injection and EdU assay
Four Msx1 transgenic animals (3 months ; used in paper I) were injected intraperitoneally with 
with EdU for 5 days twice a day (50 mg/kg), then sacrificed to assess EDU incorporation using 
the EDU cell proliferation kit (Base click). Spinal cord sections were washed twice with 3% 
bovine serum album (BSA) in phosphate buffer saline (PBS 1X) (washing solution), then 
permeabilized with 0.5% triton X-100 in PBS (PBST) for 20 min at room temperature (RT). 
Permeabilization was followed by two washing steps with the washing solution. The reaction 
cocktail (deionized water, 10X reaction buffer, catalyst solution, 10 mM dye azide, and 10X 
buffer additive) was added for 30 min and sections were protected from light. Sections are 
washed three times, hoechst 33342 was used as a nuclear staining, finally the slides were 
mounted for analysis.
3. Mice spinal cord and brain tissue preparation
Mice were anesthetized and perfused with PBS 1X followed by 4% paraformaldehyde solution 
(PFA) (pH 7.0). Collected and dissected spinal cords are post fixed with 4% PFA for a 
maximum of 90 min, and brains for maximum of 2h. Spinal cords were cryoprotected in 
successive 10, 20, and 30% sucrose in PBS solutions for at least 6 h, then frozen in embedding 
medium (OCT). While brains are washed in PBS 1X for at least 2h. Thoracic part of the mice 
spinal cords were sectioned coranally (20µm) on cryostat (lecia), and sections were mounted 
on a glass slides for IF. While brains are sectioned on vibratome (50µm) and preserved in 24 
well plates for histology analysis.
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Human spinal cords were collected at the Montpellier GUI de Chaulliac Hopital from various 
organ-donor patients or post-mortem (the post-mortem interval was less than 48h) with strict 
observance of the legal and institutional ethical regulations. Spinal cord blocks were directly 
fixed with 4% PFA for 20 min, then cryoprotected in 30% sucrose solution and then frozen in 
embedding medium (OCT). Spinal cords were cut into 14 µm on a cryostat and mounted on 
slides for IF.
4. Immunocytochemistry and immunofluorescence
Frozen spinal cord sections were cooled down to RT for 30 minutes. Spinal cord sections and 
??????????????????????????????????????were permeabilized PBS 1X-0.1% triton X-100 (PBST) 
and blocked with 5% donkey serum in PBST solution for 1 hour. Thereafter tissues were 
?????????????????????????????????????????????????????????????????????????????????e-conjugated 
secondary antibodies with species-specific Alexa 594 or Alexa 488 conjugated secondary 
antibodies (Molecular Probe), for 1 hour at RT. Hoechst 33342 was used as nuclear staining 
(blue). All the stainings were conducted in biological triplicate and more, and the staining 
quality was invesitgated by two investigators (HG and JPH).
5. Fluorescent microscopy, image analysis and Cell counting
Images were acquired on microscope upright 2 (Zeiss Axiolmager apotome) or LSM 700 
confocal microscope in Z-stack using 40x or 63x objective lenses. Images of entire spinal cord 
sections were taken at 20x objective lenses. Clarification of mouse spinal cord was performed 
with protocol described in [9] and Imaris software was used for image treatments and 3D 
reconstruction. Counts were done manually on at least 3 mice, using more than 6 sections per 
animal, and no statistical methods were used yet.
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Table 1: List of the antibodies used in this project.
Name Species Supplier Reference DF for IF 
NG2 Rabbit Chemicon ab5320 1/500 
?????? Rabbit Cell signaling 3174 1/800 
Gpr17 Rabbit Gift from David Lecca  1/500 
CNPase Rabbit Gift from N, Chauvet  1/500 
Olig2 Rabbit IBL  1/500 
Olig1 Gaot R&D AF2417 1/100 
Sox10 Rabbit Abcam ab155279 1/500 
NKx2,2 Mouse Hybridoma Bank  1/500 
MBP Mouse Merck MAB384 1/500 
PLP Mouse Biorad MCA839G 1/500 
GFAP Rabbit Dako Z0334 1/1000 
ChAT Gaot Gift from Cedric Raoul  1/400 
NeuN Mouse Chemicon MAB377 1/500 
GFP Chicken Abcam ab13970 1/1000 
GFP Rabbit Abcam ab183734 1/800 
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Results 
Characterization of PNCs
To characterize PNCs in the CNS, Nestin-GFP mouse was used which is a good model for in-
vivo studies but it is not the best one for the in-vitro purification of PNCs.
1- The study  of Nestin-GFP mouse model
To characterize the GFP cells within the Nestin-GFP mouse, several antibodies were used to 
target various proteins specific for several cellular types. First GFP cells were distributed in the 
white and gray matter as well as in the central canal, a reason why this model cannot be used 
for the invitro culture (figure 1A). White matter GFP cells showed a wide diversity from the 
protein expression profile (figure 1B). GFP cells (15-20% of total GFP+ cells) in the white 
matter were immunopositivity for OPCs (NG2 and PDGFRa) and mature OLs (PLP and MBP) 
specific markers. On the other hand the majority (80-85% of total GFP+ cells) were 
immunopositive for markers that are specific for the immature OLs such as (CNPase, NKx2.2, 
Olig2, Olig1 and Sox10). In addition GPR17 presence was restricted to a small population of 
cells a marker of very early differentiation stage.
Moreover, the grey matter GFP cells are subdivided into GFP non-Perineuronal cells and GFP 
Perineuronal cells according to the morphology and cellular localization. Protein profile 
revealed the characteristics of both cellular types. GFP+ non-Perineuronal cells showed nearlly 
a similar protein profile as the white matter GFP cells (figure 1C). In both spinal cord 
compartments GFP+ cells were negative for astrocytic (GFAP) marker and microglial (Iba1) 
marker (data not shown). Detailed comparison of the spinal cord GFP cells are summarized in 
(figure 1D). These data suggested a diversity in the GFP population that corresponds to the 
oligodendrocyte lineage cells.
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Figure 1: Cellular phenotype of GFP cells in the spinal cord. (A) Schematic representation of the 
distribution of GFP+ cells in the white, grey matter and the central canal of the spinal cord. (B) cellular 
characterization of the white matter GFP+ cells. (C) cellular characterization of the white matter GFP+ 
cells. (D) Table summarizing the protein expression of nestin-GFP+ cells. Each marker was done three 
times on 3 different mice aged 3 months, with at least six tissues were analysed.
2- PNCs localized in layers IV and V of the cortex, as well as in the dorsal and 
ventral parts of the spinal cord
After confirming the direct association of PNCs with neurons, their distribution in the CNS was 
studied. As published previously, PNCs are distributed in the deep cortical layers of the cortex 
(layer V) [8]. But the hypothesis is that PNCs could be observed in different layers of the cortex 
and could be found in the spinal cord as well. So by staining neurons in the cortex and the spinal 
cord, PNCs exist in both compartments of the CNS. PNCs are concentrated mainly in layers IV 
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and V but also observed in layers III and VI of the cortex, on the other hand these cells are 
present in the dorsal and ventral horns of the spinal cord (figure 2). 
Figure 2: distribution of PNCs in the CNS. Immunostaining showing the distribution of GFP+/PNCs 
in the different layers of the cortex (layers III-VI), where they are much more concentrated in layers IV 
and V. Also GFP+/PNCs are present in the grey matter of the spinal cord in the dorsal and ventral horns, 
where PNCs are denser in the ventral horn. D: dorsal; V: ventral
3- PNCs interact directly with the soma of neurons in the CNS
Among the identified GFP+ cells in the grey matter we found 60% of them referred to as peri-
neuronal cells (figure 3A) that were found in a close proximity with the neurons in both cortex 
and spinal cord grey matter. To confirm whether PNCs are in close proximity or in direct 
association of with neurons, neurons were stained with the neuronal marker NeuN and checked 
for the direct association that was obvious between the two cells (figure 3C). After 
quantification, 21% and 24% of the neurons are coupled to PNCs in the cortex and spinal cord 
respectively (figure 3B). To further confirm this direct association, brain and spinal cord were 
clarified and 3D reconstruction was done (data not shown). Reconstruction showed that PNCs 
(GFP+) were in direct contact with the soma of neurons (NeuN+) where it makes a concave 
shape on the neuron where it resides.
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Figure 3: Attachment of PNCs with the soma of neurons in the CNS. (A) The percentage of 
GFP+/PNCs in the spinal cord and brain cortex. (B) Imuunofluorescence showing the GFP+ PNCs are 
attached to the soma of neurons stained with NeuN (red). (C) Graph showing the percentage of the 
neurons coupled to PNCs in spinal cord (24%) and cortex (21%). 
4- PNCs are attached to different types of neurons including motor neurons
The presence of PNCs in the spinal cord was interesting and it was important to specify the 
types of neurons that are coupled by PNCs. As mentioned in the paper of (watanabe, M 2010)
that PNCs are attached to glutamatergic neurons, which may be linked to their high expression 
of glutamine synthesizing enzymes. With regards to the spinal cord, their presence in the ventral 
horn suggest that PNCs could interact with motor neurons. To confirm this, motor neurons in 
the ventral horn were stained with a motor neuron specific marker, the acetylcholine transferase 
enzyme ChAT. Using this marker, IF confirmed that PNCs are also coupled to motor neurons, 
where 43% of motor neurons are associated to PNCs (figure 4). This allowed us to study in-
vitro whether this interaction influence the properties and survival of motor neurons.
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Figure 4: Attachment of PNCs to motor neurons in the spinal cord. (A) GFP+ PNCs (white arrow) 
are attached to the soma of motor neurons stained with NeuN (asetrix) in the ventral horn. (B) 
Quantification showing 43% of motor neurons are coupled to PNCs in the ventral horn of the spinal 
cord.
5- PNCs are non-proliferating cells 
The proliferation state was assessed to check whether these cells are proliferating or resting 
cells. Four mice were injected intraperitoneally with EdU for one week, then brains and spinal 
cords were collected, sliced, and stained for EdU. PNCs where immunonegative for Edu (figure 
5A), quantification on 4 different mice confirmed the immunostaining results (figure 5B). 
These data suggest that PNCs did not incorporate EdU unlike the progenitor cells that 
incorporated EdU. This make PNCs resting cells that reside in the CNS maybe to be activated 
by a neuronal signal that could be due to an injury or in neurodegenerative diseases.
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Figure 5: Proliferation state of cortical PNCs. (A) PNCS (blue DAPI-white arrow) coupled to neuron 
(red) didn’t incorporate EDU (green- yellow arrow). (B) Graph showing the quantification of EdU 
incorporation of PNCs in the CNS, n= 4 mice. 
6- PNCs belong to the Oligodendrocyte lineage and they could be newly formed 
Oligodendrocytes
PNCs were characterized by identifying the proteins expressed by these cells. Our analysis 
indicated that these cells are not a new type of glial cells and they are closely related to cells of 
the oligodendrocyte cell lineage. Their immunonegativity to neural/glial antigen 2 (NG2), and 
platelet derived growth factor receptor alpha (PDGFRa); myelin basic protein (MBP), and 
proteolipid protein (PLP) make these cells neither oligodendrocyte progenitor cells nor 
myelinating oligodendrocytes respectively (fig 6A, and B). On the other hand, other markers 
that could mark newly formed oligodendrocytes or mature non myelinating oligodendrocytes 
were studied. IF showed that, PNCs express CNPase, Olig1&2, NKx2.2 and Sox10 (figure 6C). 
PNCs were negative for other glial markers such as GFAP for astrocytes and Iba1 for microglia. 
This suggested that PNCs could be derived from OPCs and rested at the soma of the neurons to 
be activated later and give oligodendrocytes in case of oligodendrocyte depletion.
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Figure 6: Characterization of PNCs in the CNS. (A) PNCs indicated in green and white in the cortex 
and spinal cord are immunonegative for the oligodendrocyte progenitor markers NG2 and PDGFRa. (B) 
PNCs indicated in green and white arrows are immunonegative for mature oligodendrocyte markers 
MBP and PLP in red. (C) PNCs indicated in green and white in green are immunopositive for newly 
formed oligodendrocyte markers such as CNPase and olig2.
7- PNCs are affected in neurodegenerative diseases 
To assess whether the profile of PNCs changes in the context of degenerative diseases, we used 
two mouse models of SMA and ALS. We used P9, P16 mouse of SMA and wild type, these 
two time points refer to the pre-symptomatic and post-symptomatic stage of the disease 
respectively. On the other hand we used ALS and wild type mouse models aged 2 and 4 months 
that corresponds to the pre-symptomatic and post-symptomatic stage of the disease 
respectively. For each time point taken the soma of the motor neurons is still intact while 
degeneration is at the axonal level, so we can assess PNCs accurately. Soma of motoneurons 
were stained with a specific marker choline acetyltransferase (ChAT), and PNCs were labeled 
by Olig2 staining (Figure 7A) and CNPase (images not shown). We quantified the percentage 
of motoneurons coupled to PNCs, interestingly the percentage of motoneurons associated to 
PNCs increased in the post-symptomatic stage of SMA disease compared to the control (figure 
7B). On the other hand there was an increase in the percentage of motoneurons associated to 
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PNCs in both pre and post-symptomatic stage of ALS disease (figure 7C). These data suggest 
that degenerative diseases influence the PNCs coupling to motoneurons, and this influence was 
at earlier stage in the ALS model.
Figure 7: PNCs in the context of degenerative diseases. (A) Immunofluorescence labeling 
motoneurons in red and PNCs in green in SMA spinal cord sections. (B) Quantification of the % of 
motoneurons associated with PNCs in SMA model. (C) Quantification of the % of motoneurons 
associated with PNCs in ALS model. Quantifications are don on n=3.
8- Designing a new transgenic mouse model to purify PNCs
The second approach aims to ease the purification of PNCs, it was to design a new mouse model 
that allow the enrichment of our culture in PNCs and to deplete central canal derived GFP+ 
cells. So for this reason, the Nestin-GFP mouse model was crossed with a new mouse model 
the Olig2-tomato provided by P Durbec’s lab (figure 8A). The properties of the Olig2 mouse is 
that the central canal cells are negative for Olig2 (figure 8B), while PNCs are positive for this 
marker (figure 6C). So by crossing these two mice we were expecting to highly mark PNCs and 
to deplete central canal cells. As expected, using this model we obtained three population of 
cells, Nestin-GFP, olig2-tomato, and PNCs double positive cells (figure 8A). We first 
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confirmed in-vivo the distribution of double positive cells, as PNCs exist in the gray matter 
only. So immunofluorescence showed that the majority of double positive cells reside in the 
grey matter and a very few minority was found in the white matter, provided by quantifying the 
distribution of the three population of cells in the spinal cord (figure 8 C&D). Further we 
confirmed that double positive cells are the PNCs and they are attached to the soma of neurons 
unlike the other two populations (figure 8E). Second, the main issue was to see if we will be 
able to sort these three populations, and indeed FACS (figure 8F) indicated that Tomato+ GFP+ 
were readily observed and sorted. These data validate the double transgenic Nesting/olig2 as a 
useful model to study PNCs in-vitro.
Figure 8: Creation of new mouse model for PNCs purification. (A) The schematic diagram explains 
the new mouse model where Nestin-GFP mouse is crossed with Olig2-Tomato mouse resulting in a 
mouse model that label three different cell populations. (B) GFP+ cells in the central canal are negative 
for Olig2/Tomato. (C) The double positive cells reside in the grey matter of the spinal cord. (D) Graph 
shows the distribution of the different populations in the spinal cord. (E) Double positive PNCs are 
attached to the soma of neurons. (F) The three different populations can be detected and sorted easily 
by FACS.
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Discussion
In this study we aimed to characterize the protein profile of PNCs trying to unravel a specific 
marker to target those cells and to purify them in vitro. The outcome revealed a new poorly 
described cell population within the oligodendrocyte lineage. For the time being it has been 
confirmed that PNCs are attached to the soma of neurons in the CNS, including brain cortex 
and spinal cord. These cells are wide spread in different layers of the cortex and in both horns 
of the spinal cord. This led us to identify the different types of neurons that might be coupled 
with PNCs, where we identified at least two types of neurons; glutamatergic sensory neurons 
and cholinergic motor neurons.  Protein expression profiled revealed that PNCs are neither 
OPCs nor OLs since they lack the specific markers of these two cell stages NG2, and PDGFRa; 
PLP, and MBP respectively. While these cells could be newly formed oligodendrocytes or 
mature non myelinating oligodendrocytes due to their expression of specific markers (CNPase, 
NKx2.2, Olig 1&2, and Sox10) that labels this cell stage. The presence of active Notch 
signaling in PNCs, as suggested by the study of Hes5-GFP mice, indicates that PNCs may be 
halted in their oligodendrocyte differentiation by Notch. Unraveling this code of repression 
could open up new approaches to elicit remyelination in demyelinating diseases such as 
multiple sclerosis.
Previous work has used the glutamate decarboxylase 67 (GAD67)-GFP mouse model where 
they referred to PNCs as CNPase+ cells [6]. In this study they used postnatal day P0-P21 a 
developmental stage we didn’t check in our study. Similarly, they studied the distribution of 
PNCs in the brain cortex only focusing on the glia specific or glia enriched metabolic enzymes. 
Of the identified enzymes, PNCs were positive for enzymes involved in glutamate-glutamine 
cycle such as creatine synthetic enzyme, while they were negative for the glutamate transporters 
such as GLAST.  This could allow PNCs to attach more to the soma of glutamatergic neurons 
rather than GABAergic interneurons, which were identified by specific neuronal markers. The 
weakness of this study is that they used a single protein the CNP to identify PNCs where CNP 
could be found in other OLs types not only PNCs. Therefore in-vitro purification and analysis 
is impossible. Also this study neglected the fact that PNCs could be attached to other neuronal 
cell types not only glutamatergic and GABAergic neurons, a property could allow to identify 
the function of these PNCs. 
Beyond the cytochemical and cytological properties of PNCs [6], the genetic signature of PNCs 
revealed their unique phenotype. In this study they used mouse, rat, and human brains to study 
PNCs. CNP-GFP mouse model stained by the OTMP Ab were used to mark PNCs.  A 
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combination of markers revealed the OLPs (A2B5+) identity of PNCs, thus they do not 
synthesize the myelin basic protein. The non-myelinating profile of PNCs is due to the fact that 
PNCs are enriched in Pea3 TF which is functionally linked to receptors and adhesion molecules. 
As our results and results from other labs [6] revealed the immune-negativity of PNCs to 
???????? ??????????? ????????? ????? [7] ????????? ???? ??????????? ??? ????? ?????? ?? ?? ??
transcripts. Both transcripts increased as OLPs transition to non-myelinating PNCs. Even 
though transcripts are expressed it doesn’t indicate the expression of an active protein, a case 
that maintain cells in their specific stage. Microarray analysis from [7] uncovered a set of  TFs 
which has been confirmed by our study such as Olig1/ 2, SOX10 TFs.  The two sets of TFs are 
related to either acquisition of the myelinating fate (DLX1/ 2, Olig1/ 2, SOX10 and ASCL1) 
[11] or essential for motor neurons (LHX2, PEA3 and OTX2) [12]. The second set of cells 
could explain the existence of PNCs in the spinal ventral horn where they are tightly associated 
to motor neurons. Where the changes in the percentage of motor neurons coupled to PNCs in 
SMA and ALS could be explained by changes in the expression of those TFs. 
Identification of Notch signaling through Hes5 expression was interesting and indicative but 
still how this signaling pathway is controlling PNCs fate is unknown yet. Same results were 
already found in [7], where they showed up regulation of Hes5 in PNCs, a Notch target and 
inhibitor of the myelinating genes [13]. In addition to Notch, Shh and Wnt pathways are key
pathways involved in regulating PNCs fate. As described before PDGFR ??????????????????
where this expression is regulated by Shh, also Fzd2 transcript is highly expressed by PNCs an 
indication of active Wnt/ ?-catenin pathway. The involvement of these pathways regulate the 
onset of both neurogenesis and oligogenesis as well as prevent the differentiation of OLPs [14].
In our study we were unable to unravel the function of PNCs as we failed to purify these cells 
and we were unable to select specific marker that we can target. This was a long standing 
challenge to define the exact function of PNCs. In 1979 Ludwin proposed that PNCs have the 
ability to remyelinate denuded axons that is activated after a demylinatation machinery, which 
has been suggested lately by the study of [7], in which PNCs maintain untranslated copies of 
myelin genes as a reservoir in case of demyelination episode. Indeed, in the study of [6] they 
speculated that the function of PNCs as to fulfill the metabolic support to the associated cortical 
neurons rather than controlling synaptic transmission. In fact this refers to the idea that PNCs 
are attached to glutamatergic neurons and they express Glutamate enzymes, thus they are 
involved in the glutamate-glutamine cycle. Several reports claiming the involvement of PNCs 
abnormalities associated with mental disorders and they could play a role in development and 
homeostasis of prefrontal cortex [15], [16]. They confirmed in these reports that the number of 
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PNCs decreased in psychiatric disorders where it was correlated to a glutamine transporter 
Slc38A1, which is highly expressed in PNCs compared to myelinating OLs. This gene could 
be a target to understand how could PNCs be involved in the disorder diagnosis, and 
progression?
Functional studies continued to unravel the exact function of PNCs, using electrophysiological 
approaches. In this study they used PLP-ECFP-positive animals to target PNCs where in our
study PNCs where negative for this protein, so this could be due to activation of the gene but 
not the protein at this stage. Simultaneous whole-cell patch-clamp recordings were used to 
investigate the function of PNCs. Results showed that PNCs are residing next to the AIS where 
they exhibit time-locked Ba2+ currents in response to APs from associated neurons. On the 
other hand the APs generated evoke inward K+ currents not through Kir4.1 channels expressed 
by PNCs rather by tight junction coupling PNCs and neuron. PNCs in the glial syncytium 
restrict APs during accumulation of high concentration of K+ in response to repetitive high 
frequency AP [17]. Thus PNCs-neuron coupling not only critical for axonal myelination but 
also for regulating neuronal excitability and protecting neurons from APs burst [8].
The emergence of single cell analysis and assessing the cellular heterogeneity within OLs 
lineage using this approach, led to the identification of 13 distinct populations that are 
diversified into six mature states within the OLs lineage [5]. Comparing the RNA-seq database 
to our results, it could be suggested that PNCs might belong to the newly formed OLs. These 
data showed a high expression of SOX10 in the NFOLs 1&2 unlike other identified cells which 
coincide with our results.  Some of the identified genes we didn’t check were Tcf7l2, Itpr2, and 
Tmem2. ITPR2 protein encodes for an intracellular Ca2+ channel that overlapped up to 100% 
with SOX10+ cells. They showed that those ITPR2+ cells differ from OPCs, but they are 
PDGFRa+ cells. So activation of OPCs by motor learning on a wheel for example increase the 
number of these cells that trigger their differentiation into ITPR2+/ SOX10+ cells. Thus this 
could be a strategy in which ITPR2+/ SOX10+ cells contribute to early learning by facilitating 
electric transmission through pre-myelinating function [5], [18]. Interestingly applying RNA-
seq on the sorted cells from the Nestin/Olig2 mice we could be able to unravel the gene 
expression of GFP+/Tomato+ cells and compare them to the other cellular type as well as 
compare our database to the previous study. This could help in identifying whether PNCs could 
belong to the NFOLs state or they are a new sub type within the OLs lineage. Furthermore 
Tcf7l2, Itpr2, and Tmem2 could be used on our model to confirm their expression by PNCs 
where they could be specific markers of this subpopulation.
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With the emergence of the new mouse model (Nestin-GFP/Olig2-Tomato), it would be 
interesting to conduct the following experiments:
1- Purifying Nestin+/Olig2+ (PNC) cells, Olig2+ (i.e. OPC and OL) cells, GFP+ (central 
canal) cells, and negative (other) cells from the brain and spinal cord.  This objective 
has been already started where we failed in exctracting good quality RNA for the RNA-
seq analysis due to many complications in the sorting and RNA extraction. To avoid 
such complications, we suggested to follow the same purification protocol but using 
single cell RNA-Seq, this could be more helpful and more accurate than the RNA-seq 
of a bulk of sorted cells where we could miss some data. This technique will allow us 
to define and compare the RNA profile of PNCs and compare it with OPCs and OLs. 
Thus it allows to achieve a better characterization of these cells especially by identifying 
the specific genes that could allow to identify its function. 
2- So far we have not detected any proliferation of PNCs in the normal situation. Thus, it 
could be possible that  PNC can start proliferation in three different situations : 1) 
training mice on exercice wheels and check for increased PNC proliferation, through 
the number of GFP+/Olig2+ cells and/or incorporation of EdU. 2) a second strategy 
could be through crossing Nestin+/Olig2+ mice with an ALS mouse model found in the 
lab (SOD mice) in collaboration with Dr C Raoul to see if PNC cells react to 
motoneurons degeneration by proliferation. 3) to check for proliferation, migration, and 
differentiation in the context of spinal cord injuy
3- So far, studying PNCs in-vitro has been difficult due to the fact that there was no specific 
marker for these cells to be isolated and cultured. To deal with this issue we took 
advantage of using Nestin+/Olig2+ mice to purify PNCs to culture them in vitro and see 
if they are able (i) to survive and grow, (ii) or alternatively if they can dedifferenciate 
into OPC like cells by reexpressing PDGFRa receptor and NG2, (iii) to differentiate,  
interact and myelinate motoneurones.
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4- As it is also important to study PNCs in the in-vivo context, it will be interesting to go 
through cell transplantation methods. PNCs transplantation in the spinal cord could be 
done in a mouse with SCI or in a shiverer  mouse model (a demylination mouse model). 
This approach allow to address if these cells can generate mature oligodendrocytes or 
other cell types (notably astrocytes) upon injury or demylination condition, and to 
follow their fate in this context.
5- We showed previously that motoneurons support the survival of PNCs in-vitro, while 
PNCs has no effect on motoneurons survival. This experiment was performed on 
motoneurons derived from a wild type mouse. Combining the in-vivo increase of PNCs 
in the spinal cord of ALS and SMA models, it could be interesting to apply the same in-
vitro approach but using motoneurons derived from the degenerative models and assess 
back the effect of PNCs on motoneuron survival.  
6- PNCs could influence the growth and survival of motoneurons and the opposite might 
be correct and it might integrate into the glial syncytium. To study the influence of PNCs
on motoneuron and vice versa, co-culture is a good approach to answer this questions. 
So co-culturing PNCs with and without motoneurons we could assess the effect of 
motoneuron on PNCs survival and growth. On the other hand co-culturing motoneurons 
with PNCs in the presnce and absence of neurotrophic factors we could assess whether 
PNCs could substitute the absence of factors and enhance motonruton survival and 
growth.
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The adult spinal cord harbors a NSC niche that is weakly studied compared to the brain NSC 
niches. Little is known about the EZ of the central canal that harbor this niche. In the lab we 
took advantage, and we aimed to characterize the EZ of adult mouse and human to unravel and 
answer vital questions in the field. Is their evidence of regeneration and neurogenesis in the 
spinal cord? In fact the adult spinal cord has limited regenerative potential, due to the quiescent 
state of the NSCs in the EZ. This might result in poor recovery after spinal cord injury. 
Therefore, this thesis sheds some light on the genetic signature of the NSC niche in the EZ 
where we unraveled major characteristics of the niche and identified different cell populations 
of different properties. Also we unraveled the genetic changes in the EZ after injury to 
understand the different regeneration capacity after SCI during adulthood. 
In Paper I, RNA profiling was used to explore the adult human and mouse EZ and to build a 
new corpus of knowledge on this particular CNS region. Our findings revealed important and 
new characteristics of this poorly-defined spinal cord neural stem cell niche. We discovered 
that the mammalian EZ harbors a heterogenic NSC niche, in which this region is highly 
conserved and regionalized. The EZ regions appeared to be composed of a mosaic of cells with 
different embryonic origin and expressing different types of TF. This led to identify cell 
populations residing in the dorsal roof of the EZ as well as in the ventral floor in both mouse 
and human. Of the populations identified, is the dorsal roof cells that expressed MSX1 protein, 
those cells are present in both species and are quiescent. They are derived from the roof plate 
during early stages of development, and resided in the dorsal EZ during adult. We identified 
the protein profile of these cells and we assessed their function in-vitro. MSX1+ cells are low 
proliferating cells under the control of BMP6 pathway and they are multipotent they generate 
astrocytes and oligodendrocytes. This new corpus of knowledge on the organization and genes 
expressed in EZ will help to explore this adult stem cell niche further and will also be useful to 
shed light on ependymoma, a rare type of tumors that can arise in the human spinal cord EZ.
In Paper II, After addressing the genetic signature of the ependymal zone both in mouse and 
human and unravelling the cellular composition of this zone, for the moment the genetic 
signature of the EZ after injury is still lacking. And since one clinical interest is to address the 
effect of SCI on the endogenous stem cell activation. in accordance to the first article, RNA 
profiling was used to explore the adult mouse EZ in control and injured spinal cord. We built a 
new corpus of knowledge on this particular CNS region following an injury. Our preliminary 
data revealed important and new characteristics of the activated stem cell niche following an 
injury compared to the quiescent niche.  Our data revealed an up-regulation of genes implicated 
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in increased proliferation, adhesion, axon guidance and astrogenesis. Thus the EZ stem cell 
niche is an active zone and a territory of endogenous stem cells that are implicated in the repair 
mechanism.
In Part III, I focused on the progenitor cells that could be derived from the EZ but resided in 
the parenchyma of the spinal cord. In this part of the study I focused on the satellite peri-
neuronal cells that are neglected for a long time ago. In this study we sought to characterize the 
protein profile of PNCs trying to unravel a specific marker to target those cells. The outcome 
revealed a new poorly described cell population within the oligodendrocyte lineage. For the 
time being we confirmed that PNCs are attached to the soma of neurons in the CNS, including 
brain cortex and spinal cord. These cells are wide spread in different layers of the cortex and in 
both horns of the spinal cord. This led us to know the different types of neurons that might be 
coupled with PNCs where we identified at least two types of neurons; glutamatergic sensory 
neurons and cholinergic motor neurons.  Protein expression profiled revealed that PNCs are 
neither OPCs nor OLs since they lack the specific markers of these two cell stages NG2, and 
PDGFRa; PLP, and MBP respectively. While these cells could be newly formed 
oligodendrocytes or mature non myelinating oligodendrocytes due to their expression of 
specific markers (CNPase, NKx2.2, Olig 1&2, and Sox10) that labels this cell stage. The 
presence of active Notch signaling in PNCs, as suggested by the study of pHes5-GFP mice, 
indicates that PNCs may be halted in their oligodendrocyte differentiation by Notch. Unraveling 
this code of repression could open up new approaches to elicit remyelination in demyelinating 
diseases such as multiple sclerosis or SMA and ALS in which I found an increase in the number 
of motorneurons coupled to PNCs.
Finally we can conclude that the human and mouse Spinal cord is a territory of diverse neural 
stem/progenitor cells, with different properties, phenotypes and functionality, In which they 
can be targeted as a therapeutic approach for injury repair and functional recovery in 
degenerative diseases.
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Abstract: Anamniotes can regenerate a spinal cord after lesion due to endogenous stem/ 
progenitor cells activation. Investigating the presence and properties of such cells in mammals 
one could possibly harness those cells toward regeneration including neurons. We conducted 
RNA profiling to compare human vs mouse stem cell niche and lesioned vs non lesioned mouse 
spinal cord stem cell niche. At least 5 cell types were revealed and here a new dorsal cell type 
expressing Msx1 and Id4 transcription factors was identified. Our data indicated that the adult 
spinal cord niche in mouse and human is a mosaic of cells with different developmental origin. 
Though after lesion, niche stem cells are activated, through pathways favoring astrocyte 
generation. Glial-neuronal interactions supporting and keeping neurons intact can influence 
neurodegenerative diseases. One of these glial cells is the perineuronal satellite cells. PNCs are 
are neither oligodendrocyte progenitor cells nor myelinating oligodendrocytes and tightly 
associated to the soma of large neurons. Our data suggest that PNCs could be implicated in 
neurodegenerative diseases such as multiple sclerosis and amyotrophic lateral sclerosis due to 
their interaction with motor neurons.
Keywords: Spinal cord, Stem cells, Niche, PNCs
Résume: Les anamniotes peuvent régénérer la moelle épinière après une lésion en raison de 
l'activation de cellules souches / progénitrices endogènes. En recherchant la présence et les 
propriétés de telles cellules chez les mammifères, on pourrait exploiter ces cellules vers la 
régénération, y compris les neurones. Nous avons procédé au profilage de l'ARN afin de 
comparer la niche de cellules souches humaine vs souris et la niche de cellules souches de la 
moelle épinière de souris non lésées. Au moins 5 types de cellules ont été révélés et un nouveau 
type de cellules dorsales exprimant les facteurs de transcription Msx1 et Id4 a été identifié. Nos 
données ont indiqué que la niche de la moelle épinière chez la souris et chez l’homme est une 
mosaïque de cellules d’origine développementale différente. Après la lésion, les cellules 
souches de niche sont activées par des voies favorisant la génération d’astrocytes. Les 
interactions gliales-neuronales soutenant et maintenant les neurones intacts peuvent influencer 
les maladies neurodégénératives. L'une de ces cellules gliales est la cellule satellite 
périneuronale. Les PNC ne sont ni des cellules progénitrices des oligodendrocytes ni des 
oligodendrocytes myélinisants et sont étroitement associés au soma de gros neurones. Nos 
données suggèrent que les PNC pourraient être impliquées dans les maladies 
neurodégénératives telles que la sclérose en plaques et la sclérose latérale amyotrophique en 
raison de leur interaction avec les motoneurones.
Mots clés: Moelle épinière, Cellules souches, Niche, PNCs.
